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FOREWORD 
“Community pharmacies are a valuable and trusted public health resource. With millions of contacts 
with the public each day, there is real potential to use community pharmacy teams more effectively 
to improve health and wellbeing and reduce health inequalities.” 
Department of Health (2010) Healthy Lives, Healthy People: Our strategy for Public Health in England [white paper] 
London: Stationery Office (Cm 7985) 
“Pharmacies will become healthy living centres: promoting and supporting healthy living and health 
literacy; offering patients and the public healthy lifestyle advice, support on self-care and a range of 
pressing public health concerns; treating minor ailments and; supporting patients with long-term 
conditions.” 
Department of Health (2008) Pharmacy in England: Building on strengths, delivering the future [white paper] London: 
Stationery Office (Cm 7341) 
The development of community pharmacies, as healthy living centres, has the potential to make a 
significant impact on optimising health gains and reducing health inequalities. 
For many years pharmacies across the country have provided public health interventions at a local 
level, such as smoking cessation or sexual health services. Until now these services have mostly been 
delivered in isolation based on local needs and the relationships between local contractors and 
commissioners. The Healthy Living Pharmacy concept has the potential to pull these services 
together and change the public perception of pharmacy as a simple dispenser of medicines into a 
trusted Public Health provider. 
John Morrison 
Chief Pharmacist, Worcestershire Health and Care Trust 
February 2014 
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EXECUTIVE SUMMARY 
E.1. Community pharmacy’s traditional functions were focussed on the procurement, storage 
and compounding of medicines. Over the last three decades, the focus of activity of 
community pharmacy has shifted away from these technical aspects towards a patient-
oriented focus on pharmaceutical care and the delivery of health-improving and harm-
reducing services to the public. 
E.2. The 2008 pharmacy White Paper ‘Pharmacy in England’, proposed the concept of 
pharmacies as ‘healthy living centres’, which would see pharmacies become a primary and 
trusted source of advice for healthy living and health improvement within local 
communities. 
E.3. Since the publication of Pharmacy in England, the healthy living centres concept has been 
adopted by the professional leadership body for pharmacy (the Royal Pharmaceutical 
Society), numerous pharmacy contractor organisations (e.g. the National Pharmacy 
Association, the Company Chemists’ Association) and community pharmacy’s negotiating 
body in NHS matters (the Pharmaceutical Services Negotiating Committee), and has been 
rebranded as the ‘Healthy Living Pharmacy’ (HLP) concept. 
E.4. NHS Portsmouth (at the time, the organisation responsible for the provision of NHS primary 
care services to the residents of the city of Portsmouth) assumed some degree of leadership 
for the HLP concept by developing a model for HLPs which was launched in December 2009. 
The ‘Portsmouth model’ was characterised by an ‘HLP framework’ which formed the basis 
for accreditation frameworks across England in areas taking part in a national pathfinder 
programme. 
E.5. It was as part of this pathfinder programme that Heart of Birmingham teaching Primary Care 
Trust (HoBtPCT) began to accredit HLPs within its geographical boundaries. The HLP scheme 
in HoBtPCT was launched with a prospectus which was published in March 2011. This 
document highlighted the PCT’s commitment to the HLP concept, detailed the PCT’s vision of 
an HLP, outlined the PCT’s approach to developing HLPs and invited local community 
pharmacies to participate in the programme. 
E.6. HoBtPCT provided healthcare services for approximately 300,000 people in the geographical 
centre of Birmingham. The area covered by the PCT incorporated Birmingham city centre 
and numerous ‘inner-city’ wards including Aston, Ladywood, Nechells and Sparkbrook. 
HoBtPCT planned and developed services with in excess of 170 General Practitioners (GPs) 
operating from approximately 75 practice premises. 
E.7. The community pharmacies of central Birmingham are located in some of the most deprived 
areas of England. Their location affords an opportunity to meet the health needs of those 
most in need of access to healthcare services but who find it most difficult to access such 
services. 
E.8. This report details the findings from a review of the implementation of HLPs within HoBtPCT. 
Data on service provision for four healthcare services (early pregnancy testing, emergency 
hormonal contraception, minor ailments scheme, and smoking cessation) were analysed, 
along with data from a series of interviews with service providers and from a service-user 
questionnaire deployed via touchscreen kiosks located within the ten HLPs included in this 
study. 
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E.9. Data on service provision presented in this report suggest that people accessing the services 
provided by the community pharmacies in central Birmingham are, unsurprisingly given their 
geographical location, predominantly from areas of high socioeconomic deprivation. 
E.10. Analysis of the data from the smoking cessation scheme suggests that participants at HLPs 
are more likely to have been from sections of society commonly considered to be ‘hard-to-
reach’ – men, people from black and minority ethnic groups, those who had never worked or 
were long-term unemployed and those from the most-deprived areas of central 
Birmingham. While this phenomenon was not observed universally across all four services 
analysed, smoking is the most important single behavioural cause of health inequalities 
making such observations notable. 
E.11. Of particular note in relation to the analysis of the data from the minor ailments scheme was 
the large quantity of medicinal products which were supplied via the scheme but which are 
not supported by robust evidence to support their efficacy. Any continuation or extension of 
the minor ailments scheme should be accompanied by a review of the items which are 
available for supply so as to minimise any expenditure on potentially ineffective 
interventions. 
E.12. This evaluation has revealed no evidence that HLP accreditation improves activity levels or 
outcomes in the services examined (early pregnancy testing, emergency hormonal 
contraception, minor ailments scheme, and smoking cessation). However, data from the 
minor ailments scheme suggests that HLP accreditation may influence how participants 
become aware of the services offered by pharmacy. 
E.13. Results from the service-user questionnaire suggest that satisfaction with the services 
provided by HLPs is very high. Particularly notable are the high proportions of respondents 
who reported that they preferred to access the service they had used at the HLP rather than 
at their GP surgery. 
E.14. Qualitative data suggest that a motive for contractor engagement with the HLP programme 
was a belief that accreditation of their pharmacies as HLPs would provide reassurance to 
commissioners that they were consistent deliverers of high quality services and that the 
accreditation would help to differentiate HLPs from non-HLPs with HLPs being favoured in 
future commissioning decisions. The NHS landscape has changed markedly since the data 
were collected and given such change, additional effort will need to be made if the initial 
momentum behind HLPs in central Birmingham is not to be lost. 
E.15. The concern expressed by pharmacy contractors around remuneration for additional 
services should be noted. There was a belief that remuneration for such services was 
insufficient to divert activity away from the dispensing function towards patient-centred 
care. Whilst such considerations may be outside the scope of local pharmacy and health 
bodies, strategic level consideration should be given to how remuneration for pharmacies 
can be altered to support role extension and the HLP concept. 
E.16. Of additional note were the observations by non-pharmacist staff (Health Trainers and 
Health Trainer Champions – HT/HTCs) that the depth of training in relation to the delivery of 
certain services was insufficient and that the awareness levels of the HLP scheme by general 
practitioners were low. Any development of the HLP model will need to ensure adequate 
training levels for pharmacy staff and an increase in the level of awareness within the local 
general practitioner population of the programme. 
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E.17. The study has made the following recommendations: 
• Recommendation 1 – Further research is recommended to identify whether the uptake 
of the stop smoking service in traditionally ‘hard-to-reach’ groups via Healthy Living 
Pharmacies can be replicated in other geographical areas. 
• Recommendation 2 – Further research is needed to establish whether the existence of 
pharmacy-based health services is more actively promoted in Healthy Living Pharmacies 
than in non-Healthy Living Pharmacies and whether more active promotion increases 
activity levels and improves the outcomes of such services. 
• Recommendation 3 – Any continuation or extension of the minor ailments scheme 
should be done in parallel with a review of the items provided via the scheme to ensure 
that any medicines included are supported by a robust evidence base so as to minimise 
any expenditure on potentially ineffective interventions. 
• Recommendation 4 – In any future commissioning of services through pharmacies, 
consideration needs to be given to the role pharmacies with Healthy Living Pharmacy 
accreditation, with their high level of service user acceptance, can offer in the effective 
delivery of health care services. Given the lack of randomisation in observational studies, 
a randomised study – perhaps in the form of a pragmatic cluster randomised controlled 
trial – should be conducted to establish whether HLPs achieve better outcomes than 
non-HLPs. 
• Recommendation 5 – In order for the number of Healthy Living Pharmacies to expand 
and for the number of services offered via Healthy Living Pharmacies to increase, further 
consideration needs to be given to the levels of training and support made available to 
pharmacy staff, especially at the Health Trainer/Health Trainer Champion level, and the 
level of awareness of the programme within the local general practitioner population. 
• Recommendation 6 – To ensure the success of any future roll-out of services via Healthy 
Living Pharmacies, consideration should be given at a strategic level as to how 
remuneration for pharmacies can be altered to support role extension and the Healthy 
Living Pharmacy concept, along with research conducted at the local level to examine 
the impact of Healthy Living Pharmacy accreditation on non-Healthy Living Pharmacies 
within an area. 
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GLOSSARY 
 
For the purpose of this report and for ease of reporting, the following terms have been used: 
Term Refers to: 
‘Health programme’ Health services that requires a patient to attend a series of sessions over a period of time e.g. 
Smoking Cessation (SC) and Weight Management (WM). 
‘Health services’ Services such as Minor Ailments Scheme (MAS), Emergency Hormonal Contraception (EHC), Early 
Pregnancy Testing (EPT, diabetes/blood pressure tests,) etc. 
‘Health-service related 
role’ 
Health-service related responsibilities e.g. provision of advice/delivery of health 
services/signposting activities - undertaken by interviewees both prior to the HLP accreditation 
and after qualifying as a HTC or HT. 
‘HLP’ Healthy Living Pharmacy. 
HoB The Heart of Birmingham i.e. central areas of Birmingham. 
HoBtPCT Heart of Birmingham teaching Primary Care Trust. 
‘HT’ role Health Trainer i.e. an interviewee who has undertaken the City & Guilds Certificate for Health 
Trainers at Level 3 qualification. 
(http://www.cityandguilds.com/Courses-and-Qualifications/health-and-social-care/health/7562-
health-trainers) 
‘HTC’ role Health Trainer Champion i.e. an interviewee who has undertaken the RSPH Level 2 Award in 
Understanding Health Improvement qualification. 
(http://www.rsph.org.uk/en/qualifications/qualifications/qualifications.cfm/Level-2-Award-in-
Understanding-Health-Improvement) 
‘Mr Pharm’ An animated character which enables users to navigate through online resources (on health 
related information) accessed via touchscreen screen kiosks-deployed in all HLPs.  
MUR Medicines Use Review. 
‘Non-HLP’ A Pharmacy that has not undertaken HLP accreditation. 
‘NPA’ National Pharmacy Association. 
‘Pharmaceutical-
related role’ 
The supply and sale of medicines (under the supervision of the pharmacist) undertaken by HTs 
and HTCs. 
‘Patient’/’Customer’ Were used interchangeably by interviewees (depending on the context) to refer to an individual 
who accesses either a pharmaceutical service or a health related service. Therefore, for ease of 
reporting, the term ‘patient’ is used in Stage B of this report. 
‘PCT’ 
‘Primary Care Trust’, an abbreviated form to denote the Heart of Birmingham teaching Primary 
Care Trust (HoBtPCT), which later merged with other proximal PCTs to become the Birmingham 
and Solihull NHS Cluster. However, the interviews took place after the merger and therefore the 
majority of interviewees continued to refer to the ‘Cluster’ as the ‘PCT’. 
‘PLT’ Protected Learning Time sessions for pharmacists and pharmacy teams– funded by the PCT.  
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Chapter 1 INTRODUCTION 
This research, conducted in conjunction with Heart of Birmingham teaching Primary Care Trust 
(HoBtPCT) and funded by the Pharmaceutical Trust for Educational and Charitable Objects (PTECO) 
(which was subsequently merged with the Pharmacy Practice Research Trust (PPRT) to become 
Pharmacy Research UK), evaluates the impact of the Healthy Living Pharmacy (HLP) concept in the 
geographical area formerly covered by HoBtPCT. The research took place against a backdrop of 
organisational upheaval within the National Health Service (NHS) as a result of the Conservative-
Liberal Democrat Coalition Government’s programme of reforms. The Health and Social Care Act 
2012 abolished PCTs on 31st March 2013.1 In the time leading up to this date there was considerable 
flux within HoBtPCT including changes in personnel. These changes had no effect on the availability 
of data for this evaluation although it did complicate the data collection process somewhat as 
engagement with partner/successor organisations proved necessary. 
1.1 THE HEALTHY LIVING PHARMACY CONCEPT 
Community pharmacy’s traditional functions were located in the procurement, storage and 
compounding of medicines. Over the last three decades, the focus of activity of community 
pharmacy has shifted away from these technical aspects towards a patient-oriented focus on 
pharmaceutical care and the delivery of health-improving and harm-reducing services to the public. 
This change of focus has been consistently supported by government policy amidst a narrative of 
community pharmacists being over-trained for their current functions and under-utilised in terms of 
their potential to improve the health of the public.2–6 It was in this context that the 2008 pharmacy 
White Paper ‘Pharmacy in England’, proposed the concept of pharmacies as ‘healthy living centres’.5 
This would see pharmacies become a primary and trusted source of advice for healthy living and 
health improvement within local communities. It would also see increased pharmacy involvement in 
public health interventions such as smoking cessation services and weight management services. 
Pharmacy staff (i.e. non-pharmacist members of staff) would also be encouraged to become ‘health 
trainers’ so as to help pharmacy users to make informed choices about their health and lifestyle. 
Since the publication of Pharmacy in England, the healthy living centres concept has been adopted 
by the professional leadership body for pharmacy (the Royal Pharmaceutical Society), numerous 
pharmacy contractor organisations (e.g. the National Pharmacy Association, the Company Chemists’ 
Association) and community pharmacy’s negotiating body in NHS matters (the Pharmaceutical 
Services Negotiating Committee), and has been rebranded as the ‘Healthy Living Pharmacy’ (HLP) 
concept.7 
NHS Portsmouth (at the time, the organisation responsible for the provision of NHS primary care 
services to the residents of the city of Portsmouth) assumed some degree of leadership for the HLP 
concept by developing a model for HLPs which was launched in December 2009. Initially, pharmacies 
within Portsmouth could apply to be accredited as HLPs by NHS Portsmouth if they delivered active 
health promotion campaigns, targeted respiratory medicines use reviews (MURs), a stop smoking 
service and at least one other service from the ‘Local Enhanced Services’ level of the pharmacy 
contracta.8 The ‘Portsmouth model’ was characterised by an ‘HLP framework’ which formed the 
basis for accreditation frameworks across England in areas taking part in the pathfinder 
programme.7 
                                                            
 
 
a The community pharmacy contract in England and Wales has three different levels of service – essential, advanced and 
enhanced (rebranded since the Health and Social Care Act 2012 as ‘locally commissioned services’). Essential services are 
provided by all contractors. Advanced services can be provided by any contractor but both the pharmacy premises and the 
pharmacist delivering the service have to be accredited to provide the service. Enhanced services are commissioned from 
community pharmacies on the basis of local need. 
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It was as part of this pathfinder programme that Heart of Birmingham teaching Primary Care Trust 
(HoBtPCT) began to accredit HLPs within its geographical boundaries. 
1.2 POPULATION CHARACTERISTICS OF HEART OF BIRMINGHAM TEACHING PRIMARY 
CARE TRUST 
HoBtPCT provided healthcare services for approximately 300,000 people in the geographical centre 
of Birmingham. The area covered by the PCT incorporated Birmingham city centre and numerous 
‘inner-city’ wards including Aston, Ladywood, Nechells and Sparkbrook. HoBtPCT planned and 
developed services with in excess of 170 General Practitioners (GPs) operating from approximately 
75 practice premises.9 
The population resident in the areas formerly served by HoBtPCT is disproportionately young with 
almost a third of the resident population aged under 19 years of age. Seventy per cent of people in 
the area are from Black and Minority Ethnic groups – the highest proportion of people from BME 
groups of any PCT in England.10 According to the Indices of Multiple Deprivation 2010 (IMD 2010), 
HoBtPCT was the most socioeconomically deprived PCT in England with two thirds of the population 
living in neighbourhoods that are in the most deprived quintile of neighbourhoods in England.9 
Unemployment rates within the area formerly served by HoBtPCT, particularly for men, are high. 
Religious belief plays an important part in the lives of a large number of residents in the area 
formerly served by HoBtPCT and there is considerable diversity in religious faith. According to 2001 
Census data, amongst residents in the area, 44% identified themselves as Christian, 25% identified 
themselves as Muslim, 7% as Sikh and 4% as Hindu (Office for National Statistics, 2012).11 
Migration has been a feature of Birmingham life for generations and it continues to be a prominent 
aspect of life within central Birmingham. Recently the area has witnessed an influx of immigrants 
from Eastern Europe and Sub-Saharan Africa, either as economic migrants or asylum seekers. This 
makes language a major barrier to accessing services, particularly to women.10 A ‘language barrier’ 
does not present exclusively among ‘recent’ arrivals to the area however. One fifth of adults in the 
parliamentary constituencies which formerly constituted the area covered by HoBtPCT area can only 
read and write English to pre-GCSE level and approximately 64% of dependent children aged 0-15 
are estimated to have ‘language needs’ (an indicator based on the likelihood that the first language 
spoken at home is not English).10 
Life expectancy within the boundaries of HoBtPCT was shorter than the England average (76 years 
for men and 81 years for women versus 78 years and 82 years respectively (2006/8 figures)).12 
Diabetes is a major cause of ill health and shortened life expectancy in the local area and rates of 
heart disease, strokes and cancer are also higher than the England average. At least 20% of adults in 
the area formerly covered by HoBtPCT report a limiting long term illness which restricts their daily 
lives.10 This has notable implications for the delivery of health services and expenditure on the 
management of long-term conditions. 
1.3 HEALTHY LIVING PHARMACIES IN HoBtPCT 
The HLP programme in HoBtPCT was launched with a prospectus which was published in March 
2011.13 This document highlighted the PCT’s commitment to the HLP concept, detailed the PCT’s 
vision of an HLP, outlined the PCT’s approach to developing HLPs and invited local community 
pharmacies to participate in the programme. HoBtPCT also detailed the key features of their HLPs 
including the consistent provision of high quality services and a proactive approach to supporting 
and promoting health and wellbeing in order to become an accessible, valued and trusted 
healthcare resource which is engaged in the wider healthcare team and in the community they 
serve. 
 16 | P a g e  
 
Aston University HLP Study 
HoBtPCT developed a framework for an HLP, which detailed three different levels of service at which 
community pharmacies could be progressively accredited in a step-wise fashion (i.e. a community 
pharmacy would be accredited at level 1 before accreditation at level 2 and so on). Level 1 HLPs 
would be promoting health, wellbeing and self-care, level 2 HLPs would progress to optimising 
medicines interventions and level 3 HLPs would progress to the provision of treatment (see Figure 
1). 
In the first instance, HoBtPCT’s approach was going to be to try and establish their pharmacies at 
level 1.13 The service framework was supported by three foundations/enablers; workforce 
development, premises and engagement (see Figure 1). 
Reflecting the aims of the 2008 pharmacy White Paper, HLPs in Birmingham would train staff – via 
accredited courses – to become ‘health trainer champions’ and/or ‘health trainers’ in order to 
engage members of the communities that the HLPs served.5 Premises would have to be appropriate 
for the delivery of public health messages and health care services with consideration given to 
ensuring access to networked computers in consultation rooms, facilities for the disposal of clinical 
waste and facilities to promote patient comfort. The final foundation concerned engagement, with 
HLPs becoming engaged with primary care colleagues, the wider community, and then becoming a 
community leader as they moved through the levels of accreditation.13 
The prospectus also detailed the many services, a number of which pharmacies within HoBtPCT 
were already delivering and were well-established, and the services that pharmacies could 
potentially deliver in order to obtain level 1 HLP accreditation (services required for level 1 HLP 
accreditation in HoBtPCT are highlighted in bold)13: 
• Smoking cessation. 
• Weight management. 
• Chlamydia screening. 
• Early pregnancy testing (EPT). 
• Emergency hormonal contraception (EHC). 
• Alcohol misuse services. 
• Minor ailments scheme (MAS). 
• Substance misuse and harm reduction. 
o Needle exchange. 
o Supervised administration of substitution therapy. 
• Men’s health. 
• MURs for specific long-term conditions (e.g. asthma). 
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Figure 1: Service delivery framework for HLPs within HoBtPCT 
Public Health Need Essential Services Level 1 Level 2 Level 3 
Smoking 
Promotion of health 
and wellbeing, 
support for self-
care, signposting 
Stop smoking NRT 
Proactive advice 
and signposting 
PGD treatment, 
brief intervention 
COPD risk 
assessment 
NHS Health Check 
Obesity 
Promotion of health 
and wellbeing, 
support for self-
care, signposting 
Weight 
management; 
Proactive advice 
and signposting 
PGD Treatment, 
brief intervention NHS Health Check 
Sexual Health 
Promotion of health 
and wellbeing, 
support for self-
care, signposting 
EHC PGD, Fast track 
pregnancy testing 
and referral, 
condom distribution 
Chlamydia 
screening, PGD 
Treatment, brief 
intervention 
Contraception 
service, HPV/HepB 
Vacc, screening 
Alcohol 
Promotion of health 
and wellbeing, 
support for self-
care, signposting 
Alcohol risk 
assessment, brief 
intervention and 
appropriate referral 
Alcohol specific 
non-planned 
interventions 
Structured care 
planned alcohol 
treatment 
Minor Ailments 
Promotion of health 
and wellbeing, 
support for self-
care, OTC supply 
Pharmacy First; 
assessment, advice 
and treatment with 
GSL and P meds 
PGD Treatment Pharmacist prescribing 
Substance Misuse 
Promotion of health 
and wellbeing, 
support for self-
care, signposting 
Supervised 
consumption 
Harm reduction, 
screening, needle 
exchange 
Client assessment 
and support. Hep B 
Vaccination 
Men’s Health 
Promotion of health 
and wellbeing, 
support for self-
care, signposting 
Pro-active health 
promotion targeted 
at men; prostate 
and testicular 
cancer awareness 
Early identification 
of some 
cancers/cancer 
treatment 
adherence support 
NHS Health Check 
Long-term 
conditions 
Promotion of health 
and wellbeing, 
support for self-
care, signposting. 
Adherence support 
(MUR, MUR+, 
targeted MURs, 
First prescription 
service) 
Condition 
parameter 
monitoring 
Appropriate referral 
Chronic medication 
service, 
pharmaceutical care 
planning 
Locally driven 
services 
(Maternal Health) 
Promotion of health 
and wellbeing, 
support for self-
care, signposting 
Early Pregnancy 
Testing 
Healthy start 
Maternal 
Smoking/weight 
interventions 
Pregnancy and 
diabetes service inc 
PGD 
Enabler Core Level 1 Level 2 Level 3 
Workforce 
Development Core Competencies 
Health trainer 
Champion 
(Assess & Signpost) 
Clinical skills 
Leadership 
Evaluation 
capability 
Accredited Health 
Trainer 
(Assess & Coach) 
Clinical skills 
Leadership 
Audit Capability 
Advanced 
clinical/Public 
Health skills (PhwSI, 
prescribers) 
Premises 
Fit for Purpose 
consultation room 
(Drug Tariff) 
Fit for purpose 
consultation 
room(s) 
DT/Enhanced Spec 
Health Screen 
Fit for purpose 
consultation 
room(s) 
Enhanced Spec 
Health Screen 
Fit for purpose 
consultation 
room(s) 
Enhanced Spec 
Health Screen 
Engagement 
Operational 
(RDS, EPS, 
collection and 
delivery services) 
Signposting and 
referral to other 
services 
Primary Care Community Engagement Community Leader 
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1.4 EARLY EVIDENCE OF THE IMPACT OF HEALTHY LIVING PHARMACIES 
Measuring the impact of HLP accreditation on the quality of services provided within community 
pharmacy is difficult and early evaluations have focussed largely on measuring the impact of HLP 
accreditation on levels of service activity. As HLPs are a comparatively new development, evidence 
of the effect of HLP accreditation on outcomes is sparse and the need for further research in this 
area is recognised.7 
Evaluation of HLPs in Portsmouth revealed that HLPs delivered smoking cessation interventions and 
targeted respiratory Medicines Use Reviews (but not weight management interventions, alcohol 
awareness interventions or the provision of EHC via a patient group direction (PGD)b) to more 
people than non-HLPs.14 This phenomenon was also observed in the national (England) evaluation of 
the pathfinder programme where increases in activity were observed in services including smoking 
cessation, the provision of EHC via a PGD, minor ailments schemes (MASs) and alcohol awareness 
programmes (although care should be taken when interpreting this data owing to the heterogeneity 
in reporting methods between different pathfinder areas and the absence of p-values to assess the 
significance of the reported differences).7 
Data on the impact of HLP accreditation on the effectiveness of services is sparse. However, in 
Portsmouth, 4-week smoking quit rates were higher in non-HLPs than in HLPs.14 Although smoking 
quit rates are reported in the pathfinder evaluation, owing to the reporting strategy, it is unclear 
whether quit rates increased or decreased after HLP accreditation. Similarly, a lack of aggregated 
data mean that it is not possible to determine whether quit rates were higher in HLPs or non-HLPs.7 
Public satisfaction with the services provided by HLPs was high with 98% of 1,034 individuals saying 
that they would recommend the service they had used to others. Furthermore, 60% of the sample 
stated that, in the absence of the service they used, they would have consulted their GP instead, 
with an additional 21% stating that they would not have consulted anyone. The authors of the 
pathfinder evaluation suggest that this means that community pharmacy could help to reduce the 
workload burden of GPs.7 
1.5 THE SERVICES PROVIDED BY HoBtPCT HLPs EVALUATED IN THIS REPORT 
This section provides background information and an overview of previously published research on 
each of the four specific services provided by HLPs in HoBtPCT and evaluated in this report. 
1.5.1 EARLY PREGNANCY TESTING 
The Early Pregnancy Testing (EPT) local enhanced service aimed to reduce infant mortality within 
HoBtPCT by facilitating early antenatal appointment booking and providing folic acid (to reduce the 
incidence of neural tube defects) at the earliest possible opportunity.15 
Provision of the service was advertised by participating pharmacies. Upon consultation by a woman 
wishing to access the service, and after consulting Fraser guidelines and assessing Gillick competency 
(where appropriate), addressing any safeguarding concerns and obtaining consent, an assessment of 
whether or not a pregnancy test was indicated was undertaken. Should a test be indicated then a 
test would be completed and the result would be communicated to the patient. In the event of a 
positive test result, folic acid tablets (400 mcg) would be supplied and the patient would be 
signposted to their GP to book a maternity/midwife appointment. In the event of a negative test, 
information would be provided on contraception and, should the patient express a desire to become 
                                                            
 
 
b Patient Group Directions enable the supply of prescription-only medicines to specific patient groups without a 
prescription. Their use should be reserved for situations where provision via PGD improves patient care without 
compromising patient safety. 
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pregnant, the importance of folic acid pre-conceptually (and how to obtain it) would be discussed. 
Regardless of the result of the test, other relevant advice would be provided where appropriate (e.g. 
information on smoking in pregnancy, medicines and pregnancy etc.). Where a patient had diabetes, 
was on an anti-epileptic medication or already had an infant who had suffered a neural tube defect, 
the patient would be referred on to their GP for either high dose folic acid (if pregnant) or pre-
conceptual advice and high dose folic acid (if not pregnant).15 
While both the provision of pregnancy testing and the provision of advice relating to folic acid in pre-
planned pregnancy via community pharmacy has been described before, a single service which 
combines both of these elements appears to be novel. There is insufficient evidence to suggest that 
such services are effective in improving outcomes or are delivered in a cost-effective manner via 
community pharmacy.16 
1.5.2 EMERGENCY HORMONAL CONTRACEPTION 
Emergency hormonal contraception (EHC) is used after unprotected penetrative vaginal intercourse, 
or after failure of a contraceptive method, to prevent a pregnancy. Levonorgestrel is the drug most 
commonly used as emergency contraception and, whilst it remains effective if used within 72 hours 
of unprotected intercourse, its efficacy decreases with time.17 It is vital therefore, that women are 
able to access EHC promptly if unwanted pregnancies are to be avoided. Despite this fact, previously 
published research has suggested that many women found it difficult to access EHC within the 72 
hours succeeding unprotected intercourse.18 
In England, EHC was a prescription-only medicine (POM)c until 2001 when it was reclassified as a 
pharmacy-only (P) medicine. The reclassification of EHC did not lead to any increase in the overall 
use of EHC although it did lead to an increase in the proportion of women obtaining EHC from 
community pharmacies.19 However, income is a barrier to purchasing EHC over the counter (OTC) via 
community pharmacy with higher income women being five times more likely to purchase EHC OTC 
than lower income women.19 Prior to reclassification in 1999, EHC became available free-of-charge 
to patients from community pharmacies in two areas of England without a prescription via the use 
of PGDs. Supply of EHC via community pharmacy in this manner removes income as a barrier to 
access to EHC. 
Reducing teenage conceptions and births was a key driver for reducing infant mortality within 
HoBtPCT and the HoBtPCT EHC scheme was one mechanism for furthering these aims.13 The scheme 
was designed to provide access to EHC and associated advice (e.g. advice on regular contraception 
and sexually transmitted infections) to local residents aged under the age of 21-years-old, free at the 
point of use via a PGD.20 
A 2006 structured review of the international literature on the community pharmacy supply of EHC 
found that pharmacy supply enabled most women to receive EHC within 24 hours of unprotected 
intercourse and that such services were highly rated by women.21 In addition, evidence from a US 
randomised controlled trial (RCT) suggests that pharmacy supply of EHC does not influence rates of 
use of regular contraception or increase the incidence of risky sexual behaviour.22  
  
                                                            
 
 
c Medicines for humans are divided into three classes under the Human Medicines Regulations 2012. Prescription-only 
medicines (POMs) are available from registered pharmacies upon the presentation of a prescription written by an 
appropriate prescriber (doctor, dentist, nurse independent prescriber, pharmacist independent prescriber, etc.). Pharmacy 
(P) medicines can be sold only from a registered pharmacy by a pharmacist or a person acting under the supervision of a 
pharmacist. General Sales List (GSL) medicines can be obtained in any retail outlet that can ‘close so as to exclude the 
public’. 
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1.5.3 MINOR AILMENTS SCHEME  
Minor ailments have been defined as “conditions that require little or no medical intervention”.23 
Examples of such conditions currently listed on the NHS Choices website include24:  
• Coughs and colds; 
• Skin conditions such as mild eczema and mild acne; 
• Constipation; 
• Hay fever; 
• Headaches; 
• Indigestion; and, 
• Vaginal thrush. 
Treatment of, or relief from the symptoms of, these conditions is often provided by non-prescription 
medicines – that is P and GSL medicines. However, cost may act as a barrier that prevents some 
people from accessing these medicines (although it should be noted that robust evidence to support 
this assertion is not available) and influences how people decide to manage their condition(s).25,26 It 
is estimated that 20% of total available general practitioner (GP) workload is dedicated to dealing 
with minor ailments, that 90% of consultations result in the issuing of a prescription and that the 
NHS spends £2 billion each year on the treatment of minor ailments by GPs.27 Furthermore, it has 
been estimated that 8% of attendances at NHS Accident and Emergency (A&E) departments could be 
appropriately managed by community pharmacists.28 
The theory underpinning the provision of bespoke, community pharmacy based minor ailments 
schemes (MASs) is that the financial burden placed on the NHS by minor ailments could be reduced 
by transferring patient flow away from higher cost GPs and A&E departments towards lower cost 
community pharmacists and by encouraging self-care.2 It is hypothesised that such schemes would 
then create more time for GPs to deal with the management of more complex conditions and reduce 
pressures on A&E departments.29 
Scotland and Northern Ireland introduced national MASs, delivered through all community 
pharmacies, in 2006 and 2009 respectively.30,31 A national scheme for Wales was rolled out in 
pathfinder areas in October 2013.32 In England, MASs are specified as a ‘locally commissioned’ 
(previously ‘enhanced’) service within the community pharmacy contract.33 These services are 
commissioned by local NHS bodies (previously PCTs but now Clinical Commissioning Groups (CCGs) 
and/or NHS Area Teams) on the basis of need. In 2012-13, 3,440 community pharmacies in England 
(30% of all pharmacies in England) provided MASs.34 
The HoBtPCT MAS was launched in 2005.13 The scheme was targeted at patients who are entitled to 
free prescriptionsd who would traditionally attend their GP for a consultation concerning a minor 
ailment, a phenomenon which was reflected in high GP prescribing rates for cough medicines, 
systemic decongestants and simple analgesics within HoBtPCT.35 The aims of the service were to 
allow better access to medicines to treat common, self-limiting conditions and to improve GP 
capacity. The conditions which were eligible for treatment and the treatments available for each 
condition are detailed in Table 1 below. 
                                                            
 
 
d There are a large range of exemption categories which entitle people to free prescriptions. These include exemptions 
based on age, pregnancy, exemptions for people claiming certain state benefits and exemptions for people with specific 
medical conditions. Further information on exemptions from the prescription charge can be found here: 
http://www.nhs.uk/NHSEngland/Healthcosts/Pages/Prescriptioncosts.aspx 
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Table 1: Conditions and accompanying treatments included in the HoBtPCT MAS 
CONDITION TREATMENT(S)/ADVICE AVAILABLE 
Athlete’s Foot Terbinafine 1% cream 
Cold Sores Aciclovir 5% w/w cream 
Constipation Senna tabs 
Contact Dermatitis Clobetasone 0.05% cream 
Hydrocortisone 1% cream 
Cough Simple Linctus (SF) 
Simple Linctus Paediatric (SF) 
Cystitis Potassium Citrate Mixture 200ml 
Sodium Citrate 4g sachet 
Diarrhoea Advice only 
Dry skin Aqueous cream 
Earwax Sodium Bicarbonate 5% ear drops 
Eczema Aqueous cream* 
Clobetasone 0.05% cream^ 
Hydrocortisone 1% cream^ 
Haemorrhoids Anusol® cream 
Anusol® suppositories 
Hay Fever Beclometasone nasal spray 
Cetirizine 10 mg tabs 
Chlorphenamine 4 mg tabs 
Chlorphenamine syrup 
Sodium Cromoglycate 2% eye drops 
Head Lice Detection comb 
Headache/earache/temperature  Ibuprofen 200 mg tablets 
Ibuprofen 100 mg/5 ml susp 
Paracetamol 500 mg tabs 
Paracetamol 120 mg/5 ml susp SF 
Paracetamol 250 mg/5 ml susp SF 
Indigestion/heartburn/tummy upset Gaviscon 250® tablets 
Magnesium Trisilicate Mixture 
Peptac® suspension 
Migraine Aspirin 300 mg tabs 
Aspirin 300 mg soluble tablets 
Ibuprofen 200 mg tablets 
Paracetamol 500 mg tabs 
Paracetamol 500 mg soluble tabs 
Mild Sunburn Aqueous cream 
Minor Burns Ibuprofen 200 mg tablets 
Paracetamol 500 mg tabs 
Mouth Ulcers Medijel® gel 
Nappy Rash Sudocrem® cream* 
Clotrimazole 1% cream^ 
Nasal Congestion Menthol and Eucalyptus inhalation 
Sodium chloride nasal drops 
Xylometazoline 0.1% nasal spray 
Pseudoephedrine 60 mg tabs 
Pseudoephedrine 30 mg/5 ml linctus 
Oral Thrush Miconazole 20 mg/g oral gel 
Period Pain Ibuprofen 200 mg tablets 
Paracetamol 500 mg tabs 
Scabies Permethrin 5% dermal cream 
Sore Throat Aspirin 300 mg soluble tablets 
Paracetamol 500 mg tabs 
Paracetamol susp SF 120 mg/5 ml 
Paracetamol susp SF 250 mg/5 ml 
Tyrozets® Lozenges 
Teething Dentinox® teething gel 
Threadworms Mebendazole 100 mg tablet(s) 
Vaginal Thrush Clotrimazole 1% cream 
Clotrimazole 500 mg pessary 
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Verruca Salatac® gel 
Warts Salatac® gel 
*ffirst line treatment option 
^second line treatment option(s) 
A 2013 systematic review of 31 evaluations of pharmacy-based MASs reported that the total number 
of GP consultations and prescriptions for minor ailments often declined following the introduction of 
MASs.36 Reconsultation (i.e. consultations with a GP after a MAS consultation) rates ranged from 2% 
to 23% and the proportion of patients reporting complete resolution of their symptoms after a MAS 
consultation ranged from 68% to 94%. MAS consultations (range £1.44-£15.90) were less expensive 
than GP consultations. The review highlighted that the extent to which MASs shifted demand away 
from higher cost settings was yet to be fully determined and that full economic evaluations of MASs 
were lacking.36 
1.5.4 SMOKING CESSATION 
Smoking is the single biggest cause of preventable morbidity and premature mortality in England 
and is the most important single behavioural cause of health inequalities.37,38 It causes a wide range 
of diseases and conditions including cancers, respiratory diseases, circulatory diseases and 
impotence.39 During pregnancy, smoking increases the risks of miscarriage, giving birth to a low birth 
weight baby, premature birth and still birth.40 Second-hand smoke (i.e. smoke from a lit smoking 
object (e.g. a cigarette) or smoke exhaled by a smoker) also increases the risks of cancers and 
sudden infant death syndrome.39 Decreasing the number of people who smoke has been a public 
health priority in government policy for a number of years.6,41 
Community pharmacists have regular contact with people who are healthy as well as those who are 
sick, providing an opportunity for health promotion and disease prevention activities including 
activities directed at smokers. Nicotine Replacement Therapy (NRT) is commercially available over 
the counter via community pharmacies and has been demonstrated to increasing smoking cessation 
rates by between 50% and 70%.42 More formalised, NHS-funded, pharmacy-based smoking cessation 
services typically consist of a brief intervention (advice, discussion, negotiation or encouragement 
and referral to more intensive treatment, where appropriate) accompanied by the supply of NRT.38 
Stop smoking services are specified as enhanced services in the community pharmacy contract in 
England.33 In 2012-13, 5,747 out of 11,495 (50%) contractors in England delivered a stop smoking 
service making this the most frequently delivered enhanced service in community pharmacies in 
England.34 The HoBtPCT pharmacy stop smoking service has been established for over ten years and 
has become a major component of the city’s stop smoking strategy, providing NRT to those wishing 
to stop smoking at no charge.13 
A 2004 (updated 2008) Cochrane review examining randomised controlled trials of community 
pharmacy based interventions for smoking cessation suggested that community pharmacist delivery 
of services may have a positive effect on smoking cessation rates although the lack of strong 
evidence to support this assertion was highlighted.43 A US-based RCT of a pharmacist-delivered 
smoking cessation programme demonstrated that pharmacists are effective providers of smoking 
cessation services, with the proportion of participants quitting in the treatment arm being larger 
than that in the standard care arm at all time points measured (from 1 day to 6 months).44 An 
evaluation of a community pharmacy-based initiative delivered via community pharmacies in a rural 
area of Scotland reported that 45% of clients had quit smoking at four weeks.45 Further research also 
suggests that community pharmacy delivery of smoking cessation services is cost-effective.46,47 
1.6 CHAPTER SUMMARY 
HLPs are a new concept that has been readily embraced by government, pharmacy contractor 
organisations and pharmacy’s professional leadership body in England. Early evidence as to the 
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effect of the concept on outcomes has been described as ‘positive’ although the need for further 
evidence is pressing. It is hoped that this report helps to further the evidence base around the 
effectiveness of the HLP concept in driving activity and improving outcomes whilst also providing 
insights into the views of the public and participating pharmacy staff on the HLP concept. 
1.7 HLP STUDY AIM AND OBJECTIVES 
The aim of the present study is to evaluate the implementation and impact of HLPs in HoBtPCT. The 
study has the following objectives: 
• To analyse the activity of HLPs using data obtained from compulsory returns to HoBtPCT 
from accredited HLPs. 
• To compare the activity and services provided from HLPs with the activity and services 
provided by those pharmacies within the Primary Care Trust (PCT) not currently involved in 
the HLP scheme. 
• To provide a quantitative estimate of the health gain generated by investments in HLPs. 
• To elucidate and analyse the views of service providers from the HLPs on their; 
o motivation for becoming an HLP within HoBtPCT; 
o experiences at the start of their involvement with the HLP scheme within HoBtPCT; 
o current experiences of being an HoBtPCT HLP; and, 
o future plans in relation to the HLP scheme. 
• To explore and evaluate the views of HLP service users. 
• To make recommendations on the future direction and impact of HLPs within HoBtPCT. 
1.8 ETHICAL APPROVALS 
1.8.1 NHS ETHICAL APPROVAL 
NHS ethical approval was not required, as the HLP study was classed as a ‘service evaluation’ by 
HoBtPCT.  
1.8.2 ASTON UNIVERSITY ETHICAL APPROVAL 
An application was submitted to the School of Life and Health Sciences (LHS) Ethics Committee at 
Aston University along with the following supporting documentation: 
• A Letter to GPs informing them about the HLP study. 
• A letter to pharmacists/HTCs/HTs introducing the HLP study. 
• A participant information sheet, which provided an assurance of confidentiality and 
explained the interview process, what would be required etc. 
• A poster (developed with assistance from the Cluster) to raise awareness of the service-user 
questionnaire. 
• The service-user questionnaire. 
Ethics approval was granted by the Aston University LHS Committee on 15th June 2012. 
1.8.3 THE CLUSTER’S INFORMATION GOVERNANCE PROTOCOLS 
The Aston research team worked in close collaboration with the Information Governance (IG) Team 
at the Cluster and complied with the recommendations made by the IG team; the following forms 
were completed and submitted to the IG team for approval: 
1. Two Caldicott Guardian forms. 
a. The first, to obtain permission for access to SC/MAS data; Caldicott Guardian 
approval was granted on 27th July 2012. 
b. The second, to obtain permission for access to EHC/EPT data; Caldicott Guardian 
approval was on 10th August 2012. 
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2. A ‘Cluster Data Sharing Protocol’ form. 
Both of the forms mentioned above required detailed accounts of processes and procedures 
implemented by the Aston research team to ensure: 
• Safe and secure collection/transfer/storage/deletion of all original datasets. 
• Confidentiality and anonymity of data used in all analyses and an assurance that the results 
of the data analyses would be aggregated to mitigate risk of identification. 
Furthermore, since identifiable data (i.e. full and partial postcodes and date of birth (DoB)) were 
included within the SC, MAS, EHC and EPT datasets, it was necessary to include an assurance within 
the Caldicott form (#1a and #1b) that the: 
3. Full postcodes would be converted into Lower Super Output Areas (as per the Index of 
Multiple Deprivation 2010). 
4. DoBs would be converted into age. 
The IG team were therefore notified in writing (via email) to confirm conversion of identifiable data 
to non-identifiable data and deletion of all identifiable data as outlined in #3 and #4. 
1.9 STRUCTURE OF THE REPORT 
In addition to this introductory chapter, the remainder of this report has been set out as follows. 
Chapters 2 to 4 provide an overview of the data collection methodology and a presentation of the 
results from the three core stages of the research. These stages were: 
• Chapter 2: Stage A – An analysis of service activity data. 
• Chapter 3: Stage B – Interviews with service deliverers. 
• Chapter 4: Stage C – The views of the service users. 
This is followed by Chapter 5, which summarises the results from the three stages of the project and 
discuss the key findings, before concluding and making recommendations for the future roll-out of 
HLPs and future research. 
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Chapter 2 STAGE A – AN ANALYSIS OF SERVICE ACTIVITY DATA 
2.1 METHODOLOGY 
2.1.1 DATA COLLECTION PERIODS 
Data collection periods for all four services (Emergency Hormonal Contraception, Early Pregnancy 
Testing, Smoking Cessation and Minor Ailments Scheme) varied according to the date of 
accreditation of the individual HLPs. While the first HLP in HoBtPCT was accredited in January 2012, 
the final three HLPs (of the ten HLPs which form the basis of this study) were not accredited until 
July 2012. Details of the time periods used for analysis for each service can be found in the relevant 
section of the results. 
2.1.2 METHODOLOGY FOR EHC AND EPT DATA EXTRACTION 
The data collated for both EHC and EPT were as follows: 
EHC  EPT 
• Date of supply  • Date of test 
• Age of service user at the time of treatment  
 
• Age of service user at the time of treatment 
• General Practitioner practice/name  • General Practitioner practice/name 
• Reason for consultationa  • Result of test (positive or negative) 
 
aAs defined by PCT data collection paperwork: ‘burst condom’, ‘unprotected penetrative sexual intercourse’, 
‘missed pill’ or ‘other’. 
The data extraction process for the EHC and EPT data was complicated by a number of factors: 
1. The EHC and EPT claims forms included information on both service users’ demographic 
characteristics and the fee claimed by pharmacists for the supply of the EHC/EPT services.  
2. The claims forms submitted to the Cluster (by pharmacists) were in paper format and the 
timing of submissions varied in that pharmacists submitted: 
a. EHC forms on a three-monthly basis. 
b. EPT forms on a monthly basis.  
3. The demographic data were not available in electronic format i.e. the data remained in 
paper format. Furthermore, the Cluster’s Information Governance protocols prohibited site 
to site (i.e. from the Cluster to a secure location at Aston University) transfer of the forms. 
Therefore, extraction of the demographic data required: 
a. Scanning of EHC/EPT Claims forms (at the Cluster) into an encrypted laptop, by 
members of the Aston research team.  
b. Manual entry of data from the scanned images (of the EHC and EPT Claims forms) 
into an Excel database and secure deletion of the scanned images thereafter. 
Additionally, two elements of the data analysis necessitated a staggered approach to 
extraction of the demographic data i.e.: 
c. Comparison of each HLP’s activity between two time periods, pre- and post-HLP 
accreditation, based on the date of accreditation of each HLP, which ranged from 
January 2012 to July 2012. 
d. Comparison of activity between each HLP and its equivalent non-HLP comparator 
across corresponding time spans (i.e. the pre- and post-accreditation dates as used 
in 3a. 
Consequently, a data extraction plan was developed to ensure identification of the 
appropriate non-HLP comparators and to ensure that the staged collection of the 
demographic data (as explained in 3a and 3b) remained within the scope of the project 
timespan. The data extraction plan therefore entailed: 
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e. Identification of ten comparator non-HLPs (equivalent to HLPs) contracted to 
supply EHC and EPT services; the selection criteria included: 
 Geographic proximity to the HLPs i.e. the nearest non-HLP to each HLP. 
• Where a non-HLP was the closest pharmacy to more than one HLP, the 
non-HLP was allocated to the HLP, which was furthest from the non-HLP 
so as to minimise the overall mean distance between HLPs and non-
HLPs. 
 Opening hours i.e. where a ‘100-hour’ HLP was matched with its nearest 
100-hour non-HLP. 
f. Establishing the pre and post time periods (for data extraction) for: 
i. EHC data, i.e. three months pre/post the date of accreditation 
ii. EPT data i.e. one month pre/post the date of accreditation.  
As an example, demographic data from EHC and EPT claims forms were extracted as follows 
for HLPs accredited in July 2012: 
 FOR HLPs ACCREDITED IN JULY 2012, DATA WERE EXTRACTED FROM CLAIMS FORMS 
SUBMITTED BY HLPs AND COMPARATOR NON-HLPs, FOR THE MONTHS OF: 
EHC EPT 
Pre-accreditation time period April, May and June 2012 June 2012 
Post-accreditation time period August, September and October 2012 August 2012 
Note: The data collection process for the EHC and EPT data did not conclude until December 2012. 
2.1.3 METHODOLOGY FOR SC AND MAS DATA EXTRACTION 
As mentioned earlier, all data (EHC, EPT, SC and MAS) were collected in stages. However, whilst MAS 
data (managed by Webstar) was collated in real time i.e. instantaneous data collection upon user 
input, SC data (managed by the PCT) was collated and converted into electronic format by a third 
party. Consequently, the SC data for October 2012 was not available for collection until March 2013, 
which resulted in the extension of the project timeline. Therefore, data for the SC and MAS services 
were requested for the following time periods: 
 DATA WERE REQUESTED FROM: 
For all pharmacies (both HLP and non-HLP) January 2012 to 31st October 2012 inclusive 
For HLP accredited pharmacies January 2010 to 31st October 2012 inclusive 
The data categories requested for the SC service included: 
DEMOGRAPHICS MEASUREMENTS PHARMACY DETAIL 
• Age 
• Gender 
• Full postcode 
• Occupation 
• Ethnicity 
• Carbon monoxide (CO) reading at recruitment. 
• CO reading at 4 weeks post-recruitment. 
 
• pharmacy ID,  
• Pharmacy name  
• Full address with postcode 
 
The data categories requested for the MAS service included: 
DEMOGRAPHICS OTHER INFORMATION PHARMACY DETAILS 
• Age at point of consultation 
• Gender 
• Full postcode 
• How service users heard about the scheme 
• Would the patient have seen GP normally? 
• Symptoms presented by the service user (as 
categorised in Minor Ailments Scheme paperwork). 
• Product supplied 
• Criterion for acceptance on to scheme 
• Details from ‘Declaration of Exemption (MAS1)’. 
• Pharmacy ID,  
• Pharmacy name  
• Full address with 
postcode 
 
2.1.4 DATA ANALYSIS 
Descriptive statistics are presented for all pharmacies and by HLP status. Bivariate analyses were 
also undertaken to determine whether there were associations between variables. The following 
statistical tests were applied to the data during bivariate analyses: 
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• In the majority of cases, data were categorical and, where categorical data are detailed, the 
chi-squared test of association was used. Unless otherwise stated, the p-values provided are 
a result of a chi-squared test of association. 
• When comparing the means of two samples, an unpaired- t-test was used unless the data 
could be paired (for example in comparing activity levels pre- and post-accreditation as an 
HLP), in which case a paired-t-test was used. Where an unpaired- or paired-t-test has been 
used, this is clearly stated in the relevant section of text, in the relevant table or 
immediately above the relevant figure. 
2.2 RESULTS 
2.2.1 SMOKING CESSATION ANALYSIS/RESULTS 
2.2.1.1 Number of consultations per quarter 
Data on service provision were obtained from all pharmacies (n=67) that provided the service in 
Heart of Birmingham Teaching Primary Care Trust (HoBtPCT) for consultations between 1st April 
2011 and 31st October 2012. During this timeframe, 3608 consultations occurred, 477 (13.2%) of 
which were via HLPs. Some seasonal variability in the number of consultations was observed (see 
Figure 2). No association was observed between the number of consultations per quarter and HLP 
status (p=0.062). 
Figure 2: Number of smoking cessation consultations per quarter (Q2 2011 – Q4 2012) 
 
*Only data for October 2012 were available 
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2.2.1.2 Demographic characteristics of individuals taking part 
Where an IMD 2010 score could be attached to a participant, 73.7% (n=2544/3454) of participants 
were from the most deprived quintile of LSOAs in England with only 1.0% (n=36/3454) of 
participants being from the least deprived quintile of LSOAs. The demographic characteristics of 
individuals accessing the smoking cessation scheme via HLPs and non-HLPs were heterogeneous. 
Participants in HLPs were older and were more likely to have been male, been from a black or 
minority ethnic group, have never worked or been long-term unemployed, and been from the most 
deprived areas of central Birmingham (see Table 2). 
Table 2: Demographic characteristics of individuals taking part in the smoking cessation service 
CHARACTERISTIC NUMBER (COLUMN %) OF CONSULTATIONSa P-value 
HLP Non-HLP Total 
Age 
13-29 25 (5.3) 142 (4.6) 167 (4.7) 0.018 
20-29 99 (20.9) 748 (24.1) 847 (23.7) 
30-39 113 (23.8) 889 (28.6) 1002 (28.0) 
40-49 110 (23.2) 664 (21.4) 774 (21.6) 
50-59 82 (17.3) 388 (12.5) 470 (13.1) 
≥60 45 (9.5) 276 (8.9) 321 (9.0) 
All 474 (100.0) 3107 (100.0) 3581 (100.0) 
Sex 
Female 165 (34.6) 1302 (41.6) 1467 (40.7) 0.004b 
Male 312 (65.4) 1829 (58.4) 2141 (59.3) 
All 477 (100.0) 3131 (100.0) 3608 (100.0) 
Ethnicity 
Asian 208 (47.1) 846 (28.6) 1054 (31.0) <0.001 
Black 63 (14.3) 356 (12.0) 419 (12.3) 
Mixed 24 (5.4) 170 (5.8) 194 (5.7) 
Other 10 (2.3) 60 (2.0) 70 (2.1) 
White 137 (31.0) 1524 (51.6) 1661 (48.9) 
All 442 (100.0) 2956 (100.0) 3398 (100.0) 
Occupationc 
Full-time student 24 (6.7) 189 (7.2) 213 (7.1) <0.001 
Home carer 11 (3.1) 91 (3.5) 102 (3.4) 
Intermediate 22 (6.1) 182 (6.9) 204 (6.8) 
Managerial/professional 39 (10.8) 471 (17.9) 510 (17.0) 
Never worked/long-term unemployed 164 (45.6) 880 (33.4) 1044 (34.9) 
Retired 33 (9.2) 234 (8.9) 267 (8.9) 
Routine and manual 36 (10.0) 425 (16.1) 461 (15.4) 
Sick/disabled and unable to work 31 (8.6) 162 (6.2) 193 (6.4) 
All 360 (100.0) 2634 (100.0) 2994 (100.0) 
IMD quintile 
1 (least deprived) 25 (5.4) 666 (22.3) 691 (20.0) <0.001 
2 90 (19.4) 601 (20.1) 691 (20.0) 
3 109 (23.5) 581 (19.4) 690 (20.0) 
4 92 (19.8) 599 (20.0) 691 (20.0) 
5 (most deprived) 148 (31.9) 543 (18.2) 691 (20.0) 
All 464 (100.0) 2990 (100.0) 3454 (100.0) 
aExcludes missing values 
bcontinuity correction applied 
cAlso excludes cases where response coded as ‘in prison’ (n=3) 
2.2.1.3 Quit success  
Quit status at 4 weeks showed seasonal variation (p<0.001) with a higher proportion of participants 
successfully quitting in the first two quarters of 2012 than in the other quarters for which data were 
available (see Figure 3). 
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Figure 3: Proportion of participants successfully quitting at 4 weeks per quarter (Q2 2011 – Q4 2012) 
 
Quit status at 4 weeks varied based on a number of demographic characteristics. Older participants, 
male participants and participants from higher occupational groups all had higher ‘quit’ rates than 
younger participants, female participants and participants from lower occupational groups 
respectively (see Table 3). 
Table 3: Influence of demographic characteristics on quit status at 4 weeks 
CHARACTERISTIC NUMBER (%) OF CONSULTATIONSa P-value 
Yes No Lost to follow up Total 
Age 
13-29 55 (32.9) 38 (22.8) 74 (44.3) 167 (100.0) <0.001 
20-29 360 (42.6) 175 (20.7) 311 (36.8) 846 (100.0) 
30-39 477 (47.7) 202 (20.2) 320 (32.0) 999 (100.0) 
40-49 400 (51.9) 151 (19.6) 220 (28.5) 771 (100.0) 
50-59 226 (48.3) 111 (23.7) 131 (28.0) 468 (100.0) 
≥60 183 (57.2) 71 (22.2) 66 (20.6) 320 (100.0) 
All 1701 (47.6) 748 (20.9) 1122 (31.4) 3571 (100.0) 
Gender 
Female 657 (44.9) 353 (24.1) 452 (30.9) 1462 (100.0) 0.001 
Male 1055 (49.4) 405 (19.0) 676 (31.6) 2136 (100.0) 
All 1712 (47.6) 758 (21.1) 1128 (31.4) 3598 (100.0) 
Ethnicity 
Asian 521 (49.6) 190 (18.1) 339 (32.3) 1050 (100.0) 0.150 
Black 200 (47.8) 84 (20.1) 134 (32.1) 418 (100.0) 
Mixed 89 (45.9) 46 (23.7) 59 (30.4) 194 (100.0) 
Other 37 (52.9) 16 (22.9) 17 (24.3) 70 (100.0) 
White 766 (46.3) 381 (23.0) 509 (30.7) 1656 (100.0) 
All 1613 (47.6) 717 (21.2) 1058 (31.2) 3388 (100.0) 
Occupationb 
Full-time student 88 (41.5) 49 (23.1) 75 (35.4) 212 (100.0) <0.001 
Home carer 48 (47.1) 26 (25.5) 28 (27.5) 102 (100.0) 
Intermediate 110 (53.9) 39 (19.1) 55 (27.0) 204 (100.0) 
Managerial/professional 293 (57.7) 73 (14.4) 142 (28.0) 508 (100.0) 
Never worked/long-term unemployed 425 (40.8) 253 (24.3) 363 (34.9) 1041 (100.0) 
Retired 152 (57.1) 62 (23.3) 52 (19.5) 266 (100.0) 
Routine and manual 228 (49.5) 99 (21.5) 134 (29.1) 461 (100.0) 
Sick/disabled and unable to work 78 (40.6) 41 (21.4) 73 (38.0) 192 (100.0) 
All 1422 (47.6) 642 (21.5) 922 (30.9) 2986 (100.0) 
IMD quintile 
1 (least deprived) 354 (51.5) 141 (20.5) 193 (28.1) 688 (100.0) 0.055 
2 332 (48.1) 148 (21.4) 210 (30.4) 690 (100.0) 
3 315 (45.8) 133 (19.3) 240 (34.9) 688 (100.0) 
4 344 (49.9) 144 (20.9) 201 (29.2) 689 (100.0) 
5 (most deprived) 306 (44.4) 167 (24.2) 216 (31.3) 689 (100.0) 
All 1651 (47.9) 733 (21.3) 1060 (30.8) 3444 (100.0) 
aExcludes missing values 
bAlso excludes cases where response coded as ‘in prison’ (n=3) 
*Only data for 
October 2012 
were available 
0.0
10.0
20.0
30.0
40.0
50.0
60.0
Q2
2011
Q3
2011
Q4
2011
Q1
2012
Q2
2012
Q3
2012
Q4
2012*
Pe
r c
en
t 
Quarter 
 30 | P a g e  
 
Aston University HLP Study 
Where quit status at 4 weeks post-enrolment was recorded (3598 consultations), 47.6% 
(n=1712/3598) of participants had successfully stopped smoking. Quit rates at 4 weeks were slightly 
higher amongst participants attending non-HLPs than in participants attending HLPs although this 
difference was not statistically significant (see Table 4).  
Table 4: Quit status at 4 weeks 
QUIT STATUS NUMBER (COLUMN %) OF CONSULTATIONSa P-value 
HLP Non-HLP Total 
Yes 222 (46.5) 1490 (47.7) 1712 (47.6) 0.154 
No 116 (24.3) 642 (20.6) 758 (21.1) 
Lost to follow up 139 (29.1) 989 (31.7) 1128 (31.4) 
All 477 (100.0) 3121 (100.0) 3598 (100.0) 
aExcludes missing values 
2.2.1.4 Impact of HLP accreditation on quit status 
To provide an indication of the impact of HLP accreditation on the effectiveness of the smoking 
cessation programme, quit status was compared between quarter 3 (July-September) 2011 and 
quarter 3 2012. Quarter 3 2012 was chosen as the period for post-accreditation analysis as this was 
the only quarter where the majority of pharmacies (n=7 – although data was missing for one HLP so 
only data from 6 HLPs were used for analysis) had been accredited as HLPs and data were available 
for a complete quarter. Quarter 3 2011 was selected as the pre-accreditation time period as an 
attempt to control for seasonal variations in both consultation rates and quit status at 4 weeks. 
There was no statistically significant difference in quit status at 4 weeks between HLPs before and 
after accreditation as an HLP. While there was a statistically significant difference in quit status at 4 
weeks between quarter 3 2011 and quarter 3 2012 in non-HLPs, this was a result of an increase in 
the number of participants lost to follow up rather than any change in the proportion of participants 
successfully quitting smoking (see Table 5). 
Table 5: Impact of HLP accreditation on quit status at 4 weeks 
PHARMACY TYPE QUIT STATUS DATE P-value 
Q3 2011 Q3 2012 
HLPa 
 Yes 36 (52.9) 30 (41.1) 0.369 
 No 16 (23.5) 22 (30.1) 
 Lost to follow up 16 (23.5) 21 (28.8) 
 Total 68 (100.0) 73 (100.0) 
Non-HLP 
 Yes 259 (48.2) 222 (48.1) 0.029 
 No 106 (19.7) 65 (14.1) 
 Lost to follow up 172 (32.0) 175 (37.9) 
 Total 537 (100.0) 462 (100.0) 
All 
 Yes 295 (48.8) 252 (47.1) 0.077 
 No 122 (20.2) 87 (16.3) 
 Lost to follow up 188 (31.1) 196 (36.6) 
 Total 605 (100.0) 535 (100.0) 
 
aHLPs accredited before July 2012 (n=6; data missing from one HLP accredited before July 2012). 
2.2.2 MINOR AILMENTS SCHEME ANALYSIS/RESULTS 
This section presents an analysis of data collected during consultations provided as part of the minor 
ailments scheme (MAS). It is divided into two subsections; a comparison of provision between all 
HLPs and all non-HLPs providing the service and a comparison between provision before and after 
accreditation as an HLP for the ten HLPs.  
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2.2.2.1 Comparison between provision via HLPs and non-HLPs 
Data on service provision were obtained from all pharmacies (n=71) that provided the service in 
Heart of Birmingham Teaching Primary Care Trust (HoBtPCT) for consultations between 1st January 
2012 and 31st November 2012. During this timeframe, 194,315 consultations occurred, 23,579 
(12.1%) of which were via HLPs (n=10). It is important to note that some patients may have 
presented with more than one minor ailment. In these instances, each ailment was recorded as a 
distinct consultation (i.e. one consultation does not equal one patient). Some seasonal variability in 
the number of consultations was observed. The mean number of consultations per HLP was 2358 
compared to 2805 per non-HLP. There was an association between the mean number of 
consultations delivered per month and HLP status (p<0.001). In all of the eleven months for which 
data were available, the mean number of consultations delivered through non-HLPs exceeded the 
mean number of consultations delivered through HLPs (see Figure 4). 
Figure 4: The mean number of MAS consultations delivered by HLPs, non-HLPs and all pharmacies per month (January 
2012-November 2012) 
 
More than 9 out of 10 (91.3%; n=170791/187082) MAS consultations were with people residing in 
the most deprived quintile of LSOAs in England (where IMD 2010 score was known). The 
demographic characteristics of individuals accessing the MAS via HLPs and non-HLPs were somewhat 
heterogeneous. Statistically significant associations were observed for age, IMD quintile, exemption 
status and acceptance criteria between consultations in HLPs and consultations in non-HLPs. 
However, the differences in the characteristics of participants in HLPs and non-HLPs were usually 
minimal and the fact that such differences were ‘statistically significant’ is probably attributable to 
the large number of observations as opposed to any notable differences between the two groups. 
Arguably, the one exception to this rule is the differences observed based on IMD quintile where 
41.7% of consultations delivered via non-HLPs involved a participant from the two most deprived 
quintiles within the cohort compared to 28.0% in consultations delivered via HLPs (see Table 6). 
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Table 6: Demographic characteristics of individuals taking part in the MAS 
CHARACTERISTIC NUMBER (COLUMN %) OF CONSULTATIONSa P-value 
HLP Non-HLP Total 
Age 
0-1 2503 (10.6) 16889 (9.9) 19392 (10.0) <0.001 
2-3 2517 (10.7) 17606 (10.3) 20123 (10.4) 
4-5 2130 (9.0) 15390 (9.0) 17520 (9.0) 
6-7 1417 (6.0) 11173 (6.5) 12590 (6.5) 
8-9 1257 (5.3) 8767 (5.1) 10024 (5.2) 
10-11 1007 (4.3) 7027 (4.1) 8034 (4.1) 
12-14 939 (4.0) 7012 (4.1) 7951 (4.1) 
15-19 924 (3.9) 6411 (3.8) 7335 (3.8) 
20-29 1348 (5.7) 11106 (6.5) 12454 (6.4) 
30-39 2744 (11.6) 20300 (11.9) 23044 (11.9) 
40-49 2246 (9.5) 15604 (9.1) 17850 (9.2) 
50-59 1470 (6.2) 12681 (7.4) 14151 (7.3) 
60-69 1187 (5.0) 8423 (4.9) 9610 (4.9) 
70+ 1890 (8.0) 12344 (7.2) 14234 (7.3) 
All 23579 (100.0) 170733 (100.0) 194312 (100.0) 
IMD quintile 
1 (least deprived) 5906 (25.8) 31510 (19.2) 37416 (20.0) <0.001 
2 5993 (26.2) 31424 (19.1) 37417 (20.0) 
3 4568 (20.0) 32848 (20.0) 37416 (20.0) 
4 2128 (9.3) 35289 (21.5) 37417 (20.0) 
5 (most deprived) 4282 (18.7) 33134 (20.2) 37416 (20.0) 
All 22877 (100.0) 164205 (100.0) 187082 (100.0) 
Exemption status 
Gets Income Support 2523 (10.7) 20127 (11.8) 22650 (11.7) <0.001 
Gets income-based Jobseekers' Allowance 1015 (4.3) 7551 (4.4) 8566 (4.4) 
Has a current Maternity Exemption Certificate 260 (1.1) 1496 (0.9) 1756 (0.9) 
Has a current Medical Exemption Certificate 936 (4.0) 4242 (2.5) 5178 (2.7) 
Has a current Prescription Pre-payment Certificate 85 (0.4) 829 (0.5) 914 (0.5) 
Has a partner who gets Minimum Income 
Guarantee 
18 (0.1) 167 (0.1) 185 (0.1) 
Has a War Pension Exemption Certificate 3 (0.0) 40 (0.0) 43 (0.0) 
Is 16, 17 or 18 and in full-time education 537 (2.3) 4163 (2.4) 4700 (2.4) 
Is 60 years of age or older 2935 (12.5) 19284 (11.3) 22219 (11.4) 
Is entitled to, or named on a valid NHS Tax Credit 
Exemption Certificate 
2978 (12.6) 26396 (15.5) 29374 (15.1) 
Is named on a current HC2 Charges Certificate 149 (0.6) 849 (0.5) 998 (0.5) 
Is under 16 years of age 12132 (51.5) 85555 (50.1) 97687 (50.3) 
All 23571 (100.0) 170699 (100.0) 194270 (100.0) 
Acceptance criteria 
Confirmation of Registration Document 1396 (5.9) 12118 (7.1) 13514 (7.0) <0.001 
From PMR/other pharmacy record 17270 (73.2) 121006 (70.9) 138276 (71.2) 
Medical card 4867 (20.6) 34103 (20.0) 38970 (20.1) 
Surgery Confirmed Registration 46 (0.2) 3505 (2.1) 3551 (1.8) 
All 23579 (100.0) 170732 (100.0) 194311 (100.0) 
aExcludes missing values 
Over half (52.1%; n=101213/194315) of all MAS consultations during the study period concerned 
headache, earache or a raised temperature. The number of consultations for 
‘headache/earache/temperature’ was over three times greater than the number of consultations for 
the next most commonly observed complaint ‘cough’ (16.0%; n=31065/194315). Fifteen separate 
conditions were the subject of less than one per cent of consultations (see Table 7). 
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Table 7: Number of MAS consultations for each listed condition between 1st January and 31st November 2012 
CONDITION NUMBER (%) OF CONSULTATIONS 
Headache/earache/temperature 101213 (52.1) 
Cough 31065 (16.0) 
Hay fever 14018 (7.2) 
Nasal congestion 8243 (4.3) 
Indigestion/heartburn/tummy upset 7786 (4.0) 
Sore throat 7601 (3.9) 
Nappy rash 4215 (2.2) 
Vaginal thrush 3747 (1.9) 
Teething 2071 (1.1) 
Mild sunburn 2015 (1.0) 
Othersa 12341 (6.4) 
Missing 174 (0.1) 
All 194315 (100.0) 
aAthlete’s foot, cold sores, constipation, contact dermatitis, cystitis, diarrhoea, earwax, 
head lice, haemorrhoids, migraine, mouth ulcers, oral thrush, scabies, threadworms and 
warts. All less than 1% of consultations. 
A total of 44 different medicinal products were supplied to patients via the MAS at participating 
pharmacies. Unsurprisingly, the medication supplied during MAS consultations reflects the 
conditions on which consultations were focussed. Analgesics (paracetamol and ibuprofen) were 
supplied in over half (52.2%; n=101,213/194,315) of MAS consultations between 1st January and 31st 
November 2012. Simple linctus was supplied in 16.0% (n=31,065/194,315) of consultations and hay 
fever remedies (chlorphenamine, cetirizine and sodium cromoglycate) were supplied in 6.5% 
(n=12,732/194,315) of consultations (see Table 8). 
Table 8: Medication (or advice) supplied via MAS between 1st January 2012 and 31st November 2012 
MEDICATION SUPPLIED NUMBER (%) OF CONSULTATIONS 
Paracetamola 88438 (45.6) 
Simple linctusb 31065 (16.0) 
Ibuprofenc 12775 (6.6) 
Tyrozets™ lozenges 7476 (3.8) 
Peptac™ liquid 5200 (2.7) 
Chlorphenamined 4892 (2.5) 
Cetirizine 10 mg tablets 4369 (2.2) 
Sudocrem 4215 (2.2) 
Clotrimazolee 3927 (1.9) 
Sodium cromoglycate eye drops 3471 (1.8) 
Sodium chloride nasal drops 3245 (1.7) 
Pseudoephedrinef 3219 (1.6) 
Dentinox™ teething gel 2071 (1.1) 
Aqueous cream 2015 (1.0) 
Gaviscon™ 250 tablets 1910 (1.0) 
Othersg 15827 (8.1) 
Advice only 26 (0.0) 
Missing 174 (0.1) 
All 194315 (100.0) 
a500 mg tablets, 500 mg soluble tablets, 250 mg/5 ml sugar-free suspension and 120 
mg/5 ml sugar free suspension 
bIncludes paediatric simple linctus 
c200 mg tablets and 100 mg/5 ml sugar free suspension 
d4 mg tablets and 2 mg/5 ml solution 
e1% cream and 500 mg pessary 
f60mg tablets and 30 mg/5 ml solution 
gAll less than 1% of consultations. 
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There were slight variations in medication supplied through HLPs and non-HLPs for the five most 
common conditions on which MAS consultations were focussed (see Table 9). While the differences 
observed achieved statistical significance in all five conditions, the differences were usually minimal 
and the fact that such differences were ‘statistically significant’ is probably attributable to the large 
number of observations as opposed to any notable differences between the two groups. 
Table 9: Condition/medication supplied via MAS by HLPs and non-HLPs between 1st January 2012 and 31st November 
2012 
CONDITION AND MEDICATION SUPPLIED (PACK SIZE) NUMBER (COLUMN %) OF CONSULTATIONSa P-value 
HLP Non-HLP Total 
Headache/earache/temperature 
Paracetamol 120mg/5ml susp SF (100ml) 4005 (32.9) 28945 (32.5) 32950 (32.6) <0.001 
Paracetamol 500mg tabs (32) 3517 (28.9) 26335 (29.6) 29852 (29.5) 
Paracetamol 250mg/5ml susp SF (100ml) 2094 (17.2) 15167 (17.0) 17261 (17.1) 
Paracetamol 500mg soluble tabs (24) 1206 (9.9) 7169 (8.1) 8375 (8.3) 
Ibuprofen 100mg/5ml susp SF (100ml) 894 (7.3) 6923 (7.8) 7817 (7.7) 
Ibuprofen tabs 200mg (24) 472 (3.9) 4486 (5.0) 4958 (4.9) 
Total 12188 (100.0) 89025 (100.0) 101213 (100.0) 
Cough 
Simple Linctus Paed SF (200ml) 2145 (49.7) 13923 (52.0) 16068 (51.7) 0.005b 
Simple Linctus SF (200ml) 2169 (50.3) 12828 (48.0) 14997 (48.3) 
Total 4314 (100.0) 26751 (100.0) 31065 (100.0) 
Hayfever 
Cetirizine 10mg tabs (7) 485 (33.5) 3884 (30.9) 4369 (31.2) 0.014 
Sod Crom 2% eye drops (5ml) 365 (25.2) 3106 (24.7) 3471 (24.8) 
Chlorphenamine 2mg/5ml Soln (150ml) 303 (20.9) 2817 (22.4) 3120 (22.3) 
Chlorphenamine 4mg tabs (30) 149 (10.3) 1623 (12.9) 1772 (12.6) 
Beclometasone 50mcg/dose nasal spr (100ml) 145 (10.0) 1141 (9.1) 1286 (9.2) 
All 1447 (100.0) 12571 (100.0) 14018 (100.0) 
Nasal congestion 
Menthol & Eucalyptus inhalation (100ml) 30 (2.7) 149 (2.1) 179 (2.2) <0.001 
Pseudoephedrine 60mg tabs (12) 127 (11.4) 1283 (18.0) 1410 (17.1) 
Pseudoephedrine 30mg/5ml liquid (100ml) 232 (20.8) 1577 (22.1) 1809 (21.9) 
Sodium Chloride nasal drops (10ml) 547 (49.0) 2698 (37.9) 3245 (39.4) 
Xylometazoline 0.1% nasal spray (10ml) 181 (16.2) 1419 (19.9) 1600 (19.4) 
All 1117 (100.0) 7126 (100.0) 8243 (100.0) 
Indigestion/heartburn/tummy upset 
Gaviscon 250 tabs (16) 76 (10.3) 1834 (26.0) 1910 (24.5) <0.001 
Magnesium Trisilicate mixture (200ml) 55 (7.5) 621 (8.8) 676 (8.7) 
Peptac liquid (500ml) 605 (82.2) 4595 (65.2) 5200 (66.8) 
All 736 (100.0) 7050 (100.0) 7786 (100.0) 
aExcludes missing values 
bcontinuity correction applied 
In almost four-fifths (79.8%; n=155,021/194,314) of consultations, patients reported being informed 
of the existence of the MAS by staff at their general practice surgery. In a further 19.9% 
(n=38,711/194,314) of consultations, patients reported learning about the service via posters and 
leaflets displayed in pharmacy premises. In the remaining 0.3% (n=582/194,314) of consultations, 
patients reported hearing about the service via other routes (there was one ‘missing’ value). There 
was an association between HLP status and how patients heard about the MAS with patients 
accessing the MAS via HLPs more likely to report having heard about the MAS through promotional 
materials (posters/leaflets) than at non-HLPs (see Table 10). 
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Table 10: How patients who had a MAS consultation between 1st January 2012 and 31st November 2012 heard about 
the existence of the MAS 
HOW PATIENT HEARD ABOUT THE MAS NUMBER (COLUMN %) OF CONSULTATIONSa P-value 
HLP Non-HLP Total 
Posters/leaflets 8748 (37.1) 29963 (17.5) 38711 (19.9) <0.001 
Surgery/receptionist 14814 (62.8) 140207 (82.1) 155021 (79.8) 
Other 17 (0.1) 565 (0.3) 582 (0.3) 
Total 23579 (100.0) 170735 (100.0) 194314 (100.0) 
aExcludes missing values 
Patients enrolled into the MAS were asked whether, in the absence of the service, they would have 
consulted their GP about their ailment. In almost every consultation (98.4%; n=191,235/194,315), 
the patient reported that they would have consulted their GP in the absence of the service. In the 
remaining consultations, patients reported that they wouldn’t have seen their GP. There was one 
‘missing’ value. A slightly higher proportion of patients accessing the MAS via HLPs reported that 
they would have seen the GP than in patients accessing the MAS via non-HLPs (see Table 11). 
Table 11: Whether patients who had a MAS consultation between 1st January 2012 and 31st November 2012 would 
have consulted their GP in the absence of the MAS 
IN ABSENCE OF MAS, WOULD PATIENT HAVE 
CONSULTED GP? 
NUMBER (COLUMN %) OF CONSULTATIONSa P-value 
HLP Non-HLP Total 
Yes 23556 (99.9) 167679 (98.2) 191235 (98.4) <0.001b 
No 23 (0.1) 3056 (1.8) 3079 (1.6) 
Total 23579 (100.0) 170735 (100.0) 194314 (100.0) 
aExcludes missing values 
bContinuity correction applied 
Each month, pharmacies were remunerated £3 for each consultation, up to 150 consultations, and 
£1 per consultation thereafter. They were also remunerated for any medication provided on a ‘cost 
+ VAT’ basis (data for drug costs were not available)e. During the period from 1st January 2012 to 30th 
November 2012, there were 194,315 Minor Ailments Scheme (MAS) consultations at a total cost of 
£355,965. This equates to a fee of £1.83 per consultation. Costs per consultation were higher in 
Healthy Living Pharmacies (HLPs) than in non-HLPs although this difference was not statistically 
significant (see Table 12). 
Table 12: Costs of MAS consultations, excluding drug costs (1st January 2012 – 30th November 2012) 
 HLP (n=10) Non-HLP (n=60) Total (n=70) p-valuea 
Number of consultations 23,579 170,736 194,315 - 
Number of consultations per pharmacy 2,358 2,846 2,776 0.472 
Total cost (£) of consultations 50,127.00 305,838.00 355,965.00 - 
Cost (£) per pharmacy 5,012.70 5,097.30 5,085.21 0.933 
Cost (£) per consultation 2.13 1.79 1.83 0.892 
aunpaired-t-test 
During each consultation, patients were asked if, in the absence of the MAS, they would have 
consulted their General Practitioner (GP). Using these data it is possible to provide an estimate of 
‘savings’ attributable to patients consulting a pharmacist rather than their GP about their minor 
ailment(s). However, it should be noted that such estimates are based on a number of assumptions 
and that these assumptions may lack rigour (the assumptions are detailed in Table 13 below). Whilst 
every effort has been made to base these estimates on the best available data, they remain 
speculative and should be treated with a commensurate degree of caution. Furthermore, these 
estimates are based solely on consultation costs and do not include the costs of medicines (for which 
                                                            
 
 
e The VAT was subsequently claimed back by the Primary Care Trust. 
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data were not available). For these reasons, the most conservative estimate (i.e. in the region of 
£2,000,000 per annum) should be given precedence.  
Table 13: Estimates of potential ‘savings’ attributable to MAS consultations (1st January 2012 – 30th November 2012) 
 HLP Non-HLP Total 
Number (%) of consultations where patient would have seen GP 23,556 
(99.9) 
167,679 
(98.2) 
191,235 
(98.4) 
a) Costs (£) to NHS if patients who would have seen had actually seen 
GP for their minor ailment (11.7 minute consultation)a 
1,012,908.00 7,210,197.00 8223105.00 
b) Costs (£) to NHS if patients who would have seen had actually seen 
GP for their minor ailment (3.19 minute consultation)b 
276,168.90 1,965,857.00 2,242,026.00 
c) Costs (£) to NHS from MAS consultations where patient would 
have consulted GP 
50,078.10 300,362.00 350,322.80 
d) Costs (£) to NHS from MAS consultations where patient would not 
have consulted GP 
48.90 5475.98 5642.24 
e) Potential cost savings (£) to NHS attributable to MAS consultations 
(based on 11.7 minute GP consultations) (= a – c – d) 
962,781.00 6,904,359.00 7,867,140.00 
f) Potential cost savings (£) to NHS attributable to MAS consultations 
(based on 3.19 minute GP consultations) (= b – c – d) 
226,041.90 1,660,019.00 1,886,061.00 
g) Potential costs savings (£) per annum (based on 11.7 minute GP 
consultation) (= e * (12/11)) 
1,050,307.00 7,532,028.00 8,582,335.00 
h) Potential cost savings (£) per annum (based on 3.19 minute GP 
consultation) (= f * (12/11)) 
246,591.20 1,810,930.00 2,057,521.00 
i) Potential cost savings (£) per MAS consultation (based on 11.7 
minute GP consultation) 
40.83 40.44 40.49 
j) Potential cost savings (£) per MAS consultation (based on 3.19 
minute GP consultation) 
9.59 9.72 9.71 
aBased on a figure of £43 per 11.7 minute surgery consultation.48 
bBased on a figure of £43 per 11.7 minute consultation adjusted to reflect the mean MAS consultation time of 3.19 
minutes reported by Whittington et al (2001) (quoted in Paudyal et al (2013)).36,48 
2.2.2.2 Comparison of provision of the MAS via HLPs before and after accreditation as 
an HLP 
Data were available for all MAS consultations taking place at HLPs from 1st January 2010 through to 
31st November 2012 (HLPs were accredited as HLPs at various points of 2012). In total, 68,932 MAS 
consultations occurred in these pharmacies during this timeframe. There was marked seasonal 
variation in the number of consultations with activity peaking in November/December each year and 
dropping off to a minimum in August each year (see Figure 5). 
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 Figure 5: Number of MAS consultations per month in pharmacies accredited as HLPs in 2012 
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Analysis of the mean number of consultations per HLP demonstrated an increasing trend in the 
amount of MAS activity from year to year. As data for December 2012 were not available, data from 
January to November for each year were utilised. There was a 6.3% increase in the mean number of 
consultations per HLP between Jan-Nov 2010 and Jan-Nov 2011 although this change was not 
statistically significant. Between Jan-Nov 2011 and Jan-Nov 2012 there was a statistically significant 
14.7% increase in the mean number of consultations per HLP (see Table 14). 
Table 14: Mean number of MAS consultations per HLP from January 2010 to November 2012 (values for December 
excluded) 
MONTH MEAN (95% CI) NUMBER OF CONSULTATIONS PER HLP CHANGE (%) 
Year 
2010 2011 2012 2010-11a 2011-12b 2010-12c 
Jan 172.6 (±77.8) 227.4 (±97.8) 217.4 (±98.4) 31.7 -4.4 26.0 
Feb 165.7 (±77.5) 163.6 (±70.4) 237.3 (±96.5) -1.3 45.0 43.2 
Mar 164.1 (±57.2) 197.3 (±86.2) 209.3 (±95.5) 20.2 6.1 27.5 
Apr 162.3 (±110.9) 156.7 (±72.7) 185.2 (±83.1) -3.5 18.2 14.1 
May 176.1 (±74.7) 173.5 (±72.0) 213.0 (±84.7) -1.5 22.8 21.0 
Jun 187.0 (±91.5) 164.9 (±84.8) 215.8 (±98.7) -11.8 30.9 15.4 
Jul 155.2 (±67.7) 175.6 (±82.0) 211.9 (±94.7) 13.1 20.7 36.5 
Aug 128.6 (±56.8) 128.6 (±60.0) 145.4 (±79.1) 0.0 13.1 13.1 
Sep 205.8 (±97.6) 187.0 (±84.2) 215.9 (±103.5) -9.1 15.5 4.9 
Oct 199.7 (±85.2) 229.6 (±98.9) 230.8 (±108.9) 15.0 0.5 15.6 
Nov 217.4 (±100.5) 251.3 (±117.3) 275.9 (±114.1) 15.6 9.8 26.9 
Jan-Nov 175.9 (±79.2) 186.9 (±80.8) 214.4 (±93.0) 6.3 14.7 21.9 
aChange not statistically significant (paired-t-test, p=0.171) 
bChange statistically significant (paired-t-test, p=0.003) 
cChange statistically significant (paired-t-test, p<0.001) 
The numbers of consultations before and after accreditation as an HLP were compared for all ten 
individual HLPs. The time period for data analysis varied from HLP to HLP depending on the month in 
2012 in which the HLP was accredited so as to minimise the impact of seasonal variations in 
potentially confounding the observations. An increase in the mean number of consultations per 
month was observed in the post-accreditation period in 8 of the 10 HLPs. However, this increase was 
only statistically significant in three pharmacies and activity decreased in two HLPs in the post-
accreditation period. When aggregating the data for all HLPs and comparing provision in the period 
August-November 2011 with August-November 2012, there was a slight increase in activity but this 
increase was not statistically significant (see Table 15). 
Table 15: Mean number of consultations per pharmacy pre- and post-accreditation as an HLP 
 PHARMACY 
NUMBERa 
ACCREDITATION 
DATE 
TIME PERIODS ANALYSED MEAN (95% CI) NUMBER OF 
CONSULTATIONS PER MONTH 
P-
valueb 
Pre-
accreditation 
Post-
accreditation 
Pre-accreditation Post-
accreditation 
1 Jan 2012 Feb-Nov 2011 Feb-Nov 2012 167.9 (±12.7) 218.2 (±18.9) <0.001 
2 Feb 2012 Mar-Nov 2011 Mar-Nov 2012 472.7 (±65.7) 540.0 (±42.5) 0.003 
3 Apr 2012 May-Nov 2011 May-Nov 2012 170.7 (±37.5) 179.4 (±31.4) 0.585 
4 Apr 2012 May-Nov 2011 May-Nov 2012 209.1 (±42.9) 326.4 (±65.3) 0.002 
5 Apr 2012 May-Nov 2011 May-Nov 2012 194.0 (±67.4) 281.0 (±56.2) 0.155 
6 Apr 2012 May-Nov 2011 May-Nov 2012 298.1 (±54.3) 223.7 (±71.0) 0.059 
7 Jun 2012 Jul-Nov 2011 Jul-Nov 2012 128.4 (±32.4) 143.8 (±37.1) 0.176 
8 Jul 2012 Aug-Nov 2011 Aug-Nov 2012 5 (±5.7) 6.5 (±11.5) 0.764 
9 Jul 2012 Aug-Nov 2011 Aug-Nov 2012 196.5 (±73.7) 199.3 (±64.3) 0.909 
10 Jul 2012 Aug-Nov 2011 Aug-Nov 2012 34.3 (±17.3) 31.0 (±6.8) 0.633 
All Jan-Jul 2012 Aug-Nov 2011 Aug-Nov 2012 199 (±89.3) 217 (±98.4) 0.391 
aPharmacies numbered in the order in which they were accredited (earliest =1) 
bpaired-t-test 
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As all 10 HLPs had been accredited by July 2012, data from August-November 2012 were used as the 
post-accreditation data and data from August-November 2011 were used as the pre-accreditation 
data to conduct further analyses of the impact of HLP accreditation on service delivery. The 
proportion of patients reporting that they had heard about the existence of the MAS through 
promotional materials (posters and leaflets) was higher in the post-accreditation period than in the 
pre-accreditation period with a commensurate decrease in the proportion of patients reporting that 
they had heard about the service via their GP surgery in the post-accreditation period (see Table 16). 
Table 16: How patients who had a MAS consultation at an HLP heard about the existence of the MAS in a period prior to 
accreditation and a period post-accreditation as an HLP  
HOW PATIENT HEARD ABOUT THE MAS NUMBER (COLUMN %) OF CONSULTATIONSa P-value 
Pre-accreditation 
(Aug-Nov 2011) 
Post accreditation 
(Aug-Nov 2012) 
Total 
Posters/leaflets 2486 (31.2) 3233 (37.2) 5719 (34.4) <0.001 
Surgery/receptionist 5473 (68.7) 5433 (62.6) 10906 (65.5) 
Other 5 (0.1) 14 (0.2) 19 (0.1) 
Total 7964 (100.0) 8680 (100.0) 16644 (100.0) 
aExcludes missing values 
Utilising the same pre- and post-accreditation timeframes, an association was observed (p=0.005, 
continuity correction applied) between patients’ reports of whether they would have consulted their 
GP in the absence of the MAS and date with patients in the post-accreditation period being slightly 
less likely (99.9%; n=8,667/8,680) to report that they would have consulted their GP than patients 
during the pre-accreditation period (100.0%; n=7,963/7,964). However, as per previous analyses in 
this section, the statistical significance observed here is unlikely to be in any way meaningful when 
the absolute difference between the two groups was so small. 
2.2.3 EMERGENCY HORMONAL CONTRACEPTION ANALYSIS/RESULTS 
Data extraction yielded a total of 79 consultations, 61 in HLPs and 18 in non-HLPs. A total of 37 of 
these consultations took place in the periods prior to accreditation of the HLPs and 42 after 
accreditation. In addition to comparisons of demographic data collected during consultations 
between HLPs and comparator non-HLPs, the number of consultations before and after 
accreditation as an HLP was compared for all ten individual HLPs. The time period for data analysis 
varied from HLP to HLP depending on the month in 2012 in which the HLP was accredited (see Table 
17). 
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Table 17: Accreditation dates and pre- and post-accreditation time periods analysed for EHC data 
PHARMACY NUMBERa ACCREDITATION DATE TIME PERIODS ANALYSED 
Pre-accreditation Post-accreditation 
1 Jan 2012 Oct-Dec 2011 Feb-Apr 2012 
2 Feb 2012 Nov 2011 - Jan 2012 Mar-May 2012 
3 April 2012 Jan-Mar 2012 May-Jul 2012 
4 April 2012 Jan-Mar 2012 May-Jul 2012 
5 April 2012 Jan-Mar 2012 May-Jul 2012 
6 April 2012 Jan-Mar 2012 May-Jul 2012 
7 June 2012 Mar-May 2012 Jul-Sep 2012 
8 July 2012 Apr-Jun 2012 Aug-Oct 2012 
9 July 2012 Apr-Jun 2012 Aug-Oct 2012 
10 July 2012 Apr-Jun 2012 Aug-Oct 2012 
aPharmacies numbered in the order in which they were accredited (earliest =1) 
Where the IMD 2010 score corresponding to the home address of participants was known, all 
participants were from the two most deprived quintiles of LSOAs in England (quintile 1 (most 
deprived) 76.9%; n=60/78, quintile 2 23.1%; n=18/78). Table 18 shows the demographic 
characteristics of people accessing EHC via PGD at HLPs and at the comparator non-HLPs. While 
there did not appear to be any association between age and HLP status, over half (55.6%; n=10/18) 
of individuals accessing the service at non-HLPs were from the most deprived quintile within the 
cohort compared to only one-in-ten (10%; n=6/60) individuals accessing the service via HLPs. 
However, owing to the small number of consultations examined, the conditions of the test statistic 
were not met for either comparison as greater than 20% of expected values were less than 5. 
Table 18: Demographic characteristics of people accessing EHC via PGD at HLPs and at comparator non-HLPs 
CHARACTERISTIC NUMBER (COLUMN %) OF CONSULTATIONSa P-value 
HLP Non-HLP Total 
Age 
≤18 17 (27.9) 1 (5.6) 18 (22.8) 0.203b 
19 20 (32.8) 6 (33.3) 26 (32.9) 
20 12 (19.7) 6 (33.3) 18 (22.8) 
21 12 (19.7) 5 (27.8) 17 (21.5) 
All 61 (100.0) 18 (100.0) 79 (100.0) 
IMD quintile 
1 (least deprived) 12 (20.0) 4 (22.2) 16 (20.5) <0.001b 
2 13 (21.7) 2 (11.1) 15 (19.2) 
3 16 (26.7) 0 (0.0) 16 (20.5) 
4 13 (21.7) 2 (11.1) 15 (19.2) 
5 (most deprived) 6 (10.0) 10 (55.6) 16 (20.5) 
All 60 (100.0) 18 (100.0) 78 (100.0) 
aExcludes missing values 
bGreater than 20% of expected values less than 5 
Unprotected penetrative sexual intercourse was the reason given for the service user accessing EHC 
in 50 of the 79 consultations (63.3%). A burst condom was provided as the reason for the 
consultation in 14 of the 79 (17.7%) consultations with an ‘other’ reason being provided on 5 
occasions (6.3%). There were 10 (12.7%) ‘missing’ reasons. 
The majority (53.2%; n=42/79) of consultations examined were conducted in the post-accreditation 
periods. Accreditation as an HLP did not appear to have any significant effect on activity with only 
one additional consultation taking place in the post-accreditation periods compared to the periods 
prior to accreditation (see Table 19). 
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Table 19: The number of EHC consultations conducted in HLPs and comparator non-HLPs in the periods before and after 
accreditation as an HLP 
PRE/POST-ACCREDITATION NUMBER (COLUMN %) OF CONSULTATIONS P-value 
HLP Non-HLP Total 
Pre-accreditation 30 (49.2) 7 (38.9) 37 (46.8) 0.617a 
Post-accreditation 31 (50.8) 11 (61.1) 42 (53.2) 
All 61 (100.0) 18 (100.0) 79 (100.0) 
aContinuity correction applied 
2.2.4 EARLY PREGNANCY TESTING ANALYSIS/RESULTS 
Data were collected for a total of 505 consultations. A total of 220 (43.6%) of these took place in 
HLPs and 285 (56.4%) in comparator non-HLPs. In the pre-accreditation period, there were 262 
(51.8%) consultations and in the post-accreditation period, there were 242 (47.9%) consultations 
(there was one ‘missing’ value). In addition to comparisons of demographic data collected during 
consultations between HLPs and comparator non-HLPs, the numbers of consultations before and 
after accreditation as an HLP were compared for all ten individual HLPs. The time period for data 
analysis varied from HLP to HLP depending on the month in 2012 in which the HLP was accredited 
(see Table 20). 
Table 20: Accreditation dates and pre- and post-accreditation time periods analysed for EPT data 
PHARMACY NUMBERa ACCREDITATION DATE TIME PERIODS ANALYSED 
Pre-accreditation Post-accreditation 
1 Jan 2012 Dec 2011 Feb 2012 
2 Feb 2012 Jan 2012 Mar 2012 
3 April 2012 Mar 2012 May 2012 
4 April 2012 Mar 2012 May 2012 
5 April 2012 Mar 2012 May 2012 
6 April 2012 Mar 2012 May 2012 
7 June 2012 Mar 2012 Jul 2012 
8 July 2012 Jun 2012 Aug 2012 
9 July 2012 Jun 2012 Aug 2012 
10 July 2012 Jun 2012 Aug 2012 
aPharmacies numbered in the order in which they were accredited (earliest =1) 
Over 9-in-10 (91.3%; n=438/480) EPT consultations were with women from the most deprived 
quintile of LSOAs in England (where IMD 2010 score was known). There was an association between 
IMD quintile and HLP status with almost half (47.7%; n=128/270) of individuals accessing the service 
at non-HLPs coming from the two most deprived quintiles within the cohort compared to 30.4% 
(n=64/210) at HLPs (see Table 21). There was no association between the age of service users and 
HLP status. 
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Table 21: Demographic characteristics of people accessing the EPT service at HLPs and at comparator non-HLPs 
CHARACTERISTIC NUMBER (COLUMN %) OF CONSULTATIONSa P-value 
HLP Non-HLP Total 
Age 
Under 25 49 (22.3) 60 (21.6) 109 (21.9) 0.764 
25-27 41 (18.6) 58 (20.9) 99 (19.9) 
28-30 42 (19.1) 57 (20.5) 99 (19.9) 
31-35 46 (20.9) 46 (16.5) 92 (18.5) 
36 and over 42 (19.1) 57 (20.5) 99 (19.9) 
All 220 (100.0) 278 (100.0) 498 (100.0) 
IMD quintile 
1 (least deprived) 50 (23.8) 46 (17.0) 96 (20.0) <0.001 
2 53 (25.2) 43 (15.9) 96 (20.0) 
3 43 (20.5) 53 (19.6) 96 (20.0) 
4 40 (19.0) 56 (20.7) 96 (20.0) 
5 (most deprived) 24 (11.4) 72 (26.7) 96 (20.0) 
All 210 (100.0) 270 (100.0) 480 (100.0) 
aExcludes missing values 
Sixty per cent (n=303/505) of consultations resulted in a ‘negative’ test result (i.e. the participant 
was not pregnant). The remaining tests (39.8%; n=201/505) provided a ‘positive’ result (there was 
one ‘missing’ value). 
There was an overall trend of fewer consultations taking place in the post-accreditation periods than 
in the pre-accreditation periods. This trend was most pronounced in HLPs where 42.3% (n=93/220) 
of consultations took place post-accreditation, in marked contrast to non-HLPs where provision 
increased in the post-accreditation periods (52.5% (n=149/284); see Table 22). 
Table 22: The number of EPT consultations conducted in HLPs and comparator non-HLPs in the periods before and after 
accreditation as an HLP 
PRE/POST-ACCREDITATION NUMBER (COLUMN %) OF CONSULTATIONSa P-value 
HLP Non-HLP Total 
Pre-accreditation 127 (57.7) 135 (47.5) 262 (52.0) 0.029b 
Post-accreditation 93 (42.3) 149 (52.5) 242 (48.0) 
All 220 (100.0) 284 (100.0) 504 (100.0) 
aExcludes missing values 
bContinuity correction applied 
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Chapter 3 STAGE B – INTERVIEWS WITH SERVICE DELIVERERS 
3.1 METHODOLOGY 
3.1.1 HLP PHARMACIST AND STAFF INTERVIEWS METHODOLOGY 
The following section describes the processes related to the:  
• interview process i.e. development of the ‘Pharmacist’ and ‘HT/HTC’ interview guides, 
participant recruitment and sample, and, 
• limitations of the chosen methodology. 
3.1.1.1 Development of two interview guides 
Two semi-structured interview guides (‘Pharmacist’ and ‘HT/HTC’) were developed by members of 
the Aston team based on three broad themes, to gain an understanding of participants’: 
• Motivation to engage in the HLP programme (from the pharmacists’ perspective) 
• Experience of the HLP accreditation process 
• Barriers and facilitators to service delivery and service uptake 
Both guides were refined internally through an iterative process prior to submission to the Steering 
Group for comment and review. Both interview guides were finalised thereafter. However, further 
adjustments were made to the Pharmacist guide, following completion of the first few interviews 
with HLP pharmacists (see Appendix 1 and Appendix 2). 
The table below provides top-level outlines of the topics covered in both interview guides (see Table 
23) 
Table 23: Outline of topics covered in the ‘Pharmacist’ and ‘HT/HTC’ interview guide 
3.1.1.2 Recruitment process 
In mid-July 2012, all pharmacists (and their staff) who had accomplished HLP Level 1 accreditation 
were invited to attend an ‘HLP Evaluation’ event organised by the PCT. This event provided an 
opportunity for two members of the Aston team to disseminate information on the Aston HLP study 
and explain the interview process. All HLP pharmacists were also contacted by telephone/email to 
personally inform them about the study.  
3.1.1.3 Recruitment sample 
The interview sample included the lead pharmacist (involved in the accreditation process) and one 
HT/HTC, from each of the ten pharmacies awarded HLP Level 1 status by end July 2012.  
‘PHARMACIST’ INTERVIEW GUIDE ‘HT/HTC’ INTERVIEW GUIDE 
• HLP concept and objectives. 
• Demographic profile of local communities and 
prevalent conditions. 
• HLP accreditation process/criteria and motivation to 
participate in the HLP programme and benefits 
noticed. 
• HT/HTC recruitment and training. 
• Resources provided by the PCT. 
• Health services provided and advice process. 
• Reasons why members of the public access services 
via pharmacies. 
• Public awareness of HLPs and services offered by 
HLPs. 
• Recommendations for the future. 
• Demographic profile of local communities and 
prevalent conditions. 
• HT/HTC motivation to undertake the HT/HTC role. 
• HT/HTC roles and responsibilities and  
• Health services provided and advice process. 
• Reasons why members of the public access 
services via pharmacies. 
• Public awareness of HLPs and services offered by 
HLPs. 
• Training undertaken to date. 
• Internal and external support mechanisms. 
• Public awareness of HLPs, HTs/HTCs and the 
reasons why members of the public access 
services via pharmacies. 
• Recommendations for the future. 
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Table 24 below shows the total number of pharmacies awarded HLP Level 1 status at various 
intervals from January to end July 2012. 
Table 24: Timeline of HLP awards 
MONTH (IN 2012) HLP LEVEL 1 STATUS 
WAS AWARDED 
TOTAL NUMBER OF PHARMACIES 
AWARDED HLP LEVEL 1 STATUS 
January 1 
February 1 
April 4 
June 1 
July 3 
3.1.1.4 Interview process 
Interviewees were initially provided with the following set of documents:  
• An ‘Invitation to Participate’ letter which provided a brief overview of the study’s aim and 
objectives as well as informing participants that the interview would focus on four of the five 
mandatory services commissioned by the PCT i.e. MAS, SC, EPT and EHC (see Appendix 3). 
• A ‘Participant Information’ sheet, which detailed information about the study and the 
interview process - in a ‘Frequently Asked Questions’ format (see Appendix 4). 
• A ‘Consent’ form, which enabled the participant to indicate a date/time/location of the 
interview and mode of interview i.e. telephone or face to face at the pharmacy (see 
Appendix 4). 
Following receipt of a signed ‘Consent’ form (by a member of the Aston team), interviews were 
scheduled with individual participants at a time/day, location and mode as indicated on the 
‘Consent’ form.  
All interviews (‘pharmacist’ and ‘HT/HTC’) were conducted between August 2012 and September 
2012, by a member of the research team (JH) who, on occasion, was accompanied by the Research 
Projects Coordinator (AP). 
The majority of interviews were conducted face-to-face (onsite – pharmacy location) with a small 
number conducted by telephone. 
Prior to commencing interviews: 
• Permission to audio record interviews was obtained from interviewees. 
• Participants were assured that their views and opinions would remain confidential and any 
comments later referred to in the report would be anonymised.  
In total, twenty interviews were conducted; two interviews per HLP (n=10): 
• one interview with the lead pharmacist, 
• one interview with an HT or HTC. 
3.1.1.5 Limitations 
At the time of the interviews, given the stepwise nature of the accreditation process employed by 
HoBtPCT, a small number of HLPs had only recently been accredited. Therefore, whilst the majority 
of pharmacists were able to describe their recent experiences of the HLP accreditation process with 
relative ease, insufficient time had elapsed to enable some interviewees to base their responses to 
questions concerning the benefits of acquiring HLP status, on actual experience. 
The duration of the interviews ranged from half an hour to over an hour. In a small number of 
interviews, the quality of both the ‘Pharmacist’ and ‘HT/HTC’ interviews may have been 
compromised by a combination of factors: 
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• Despite all interviews being scheduled at a time and date specified by the interviewee, 
pharmacy workload may have resulted in some interviewees being unable to provide 
comprehensive answers. Additionally, the interviewer’s awareness of interviewees’ time 
constraints may have precluded probing for deeper understanding.  
• Interviews held within a pharmacy setting predominantly took place in a room that was in 
close proximity to the dispensing area. Consequently, in some cases interviews were 
interrupted (by pharmacy staff needing to speak with the pharmacist on dispensing 
matters), which may have disrupted the flow of the interview. 
3.1.2 QUALITATIVE DATA ANALYSIS METHODOLOGY 
The ‘Pharmacist’ and ‘HT/HTC’ datasets were analysed separately because although both interview 
schedules were very similar, pharmacists provided responses that encompassed all aspects 
associated with the HLP experience, whereas HTCs and HTs provided candid views based on their job 
role and interactions with clientele. 
The purpose of this stage of the study was to gain an understanding of each individual’s perception, 
views, opinions, etc. and to discover commonalities between the interviewee data sets with a view 
to explaining the phenomena within the data sets. Data were analysed for emerging themes via 
constant comparison. Therefore, analysis of the qualitative data: 
• First began during the data collection process from field notes taken at interviews, which 
prompted a series of further questions and aided the initial identification of potential 
themes. 
• Included:  
o Immersion in the data and constant comparison of data through iterative 
examination of the datasets to enable development of a data coding structure as 
patterns emerged. 
o Categorisation of data (as relationships emerged between codes) to draw-out 
emergent themes.  
• Was not entirely pre-determined by the format of the semi-structured guide or the existing 
literature.  
3.1.2.1 Data analysis process 
All interviews were transcribed verbatim. The initial read through (whilst listening to the recording of 
the relevant interview at the same time), enabled familiarisation with the data, and facilitated a 
general awareness of interviewees’ experiences and opinions. This aided development of a broad list 
of primary codes i.e. all points of interest arising from the transcripts.  
Nvivo9f (a qualitative software tool) was used to assign text to the relevant primary codes. The texts 
contained within each primary code were re-read, to explore the data for recurring patterns i.e. 
commonalities or differences in opinions/experiences/issues. This iterative process led to the 
progressive understanding of the significance of emerging themes, whether recurring or deviant, 
and aided understanding of the relationships between themes.  
The emergence of themes and awareness of the relationships between themes enabled the texts 
within the primary codes to be broken down according to categories (themes). A hierarchical coding 
structure comprising of discriminate codes (themes) and sub-codes to which texts were assigned 
                                                            
 
 
f NVivo qualitative data analysis software, QSR International Pty Ltd. Version 10, 2012 
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was developed. The emerging themes were summarised into a coding framework and presented to 
all other members of the Aston research team for review and discussion.  
Texts within each code were then fully analysed further to gain a deeper understanding of the 
meanings contained within each code and sub-code.  
3.1.3 REPORTING STRUCTURE 
The findings from both the ‘Pharmacist’ and ‘HT/HTC’ datasets have been reported and summarised 
under two main sections entitled: 
• Findings from ‘pharmacist’ interviews 
• Findings from ‘HT/HTC’ interviews 
3.1.3.1 Interviewee transcript referencing structure 
All direct quotations within this report have been italicised and affixed with the interviewee 
reference identification number. The referencing structure is as follows: 
• ‘Pharmacist’ interviews 
Due to the small sample size, the referencing structure excludes identifiable elements such 
as gender, location, ownership status, etc., since assigning these characteristics to the 
coding structure may have compromised anonymity. Therefore, all comments made by 
pharmacists have been coded with a ‘PH’ and a numeric participant identifier (ranging from 
1 to 10), based on the order in which the interviews were conducted. 
• ‘HT/HTC interviews 
Every effort has been made to ensure interviewee anonymity. All comments referred to in 
this report have been coded with an ‘HT’ or ‘HTC’, followed by a numeric identifier (ranging 
from 1 to 10) which has been assigned on a random basis. The numeric identifiers do not 
correspond to the reference numbers allocated to comments made by pharmacist 
interviewees. The reason for using two distinct referencing sequences for both sets of 
interviewees (the HTCs/HTs and pharmacists) is to enable disassociation of the links 
between comments made by both sets, in order to prevent linking of HT/HTC comments to 
their respective employers and vice versa 
3.1.4 BACKGROUND INFORMATION ON HLPS 
3.1.4.1 Ownership status 
The study sample of ten HLPs comprised of nine independent pharmacist-owned pharmacies and 
one pharmacy, which was part of a multiple-outlet pharmacy company.  
3.1.4.2 Location of HLPs 
The majority of HLPs were located on busy roads or high streets in central Birmingham; three of 
which were located on the same road whilst another two were located on the same high street 
within close proximity of one another. One pharmacy was situated in a quiet shopping precinct.  
One HLP located close to the centre of Birmingham, benefited from both regular customers, as well 
as passing trade.  
3.2 RESULTS FROM THE PHARMACIST INTERVIEWS 
3.2.1 AWARENESS OF THE DEMOGRAPHIC PROFILE OF LOCAL COMMUNITIES SERVED BY HLPS 
All interviews commenced with preliminary questions to ease interviewees into the interview 
process and to gain an understanding of their awareness of the health needs of the local community 
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they served. This section therefore details interviewees’ perspectives on the demographic profile of 
the local population, the level of deprivation locally and the disease burden of the local population. 
3.2.1.1 Ethnicity 
All pharmacists mentioned having a highly ethnically diverse clientele base, with the majority of their 
patients being drawn from black and minority ethnic groups. A number of longer serving 
pharmacists stated having observed a change in the ethnic composition of the local populations 
from being predominantly White (English/Irish) to being predominantly Asian/Afro-Caribbean, with 
comparatively recent increases in people from Eastern European and Somalia. 
“Before it used to be a majority, English, Irish but now it is mainly Pakistani, Somalis, and 
Arabs but there is still white Irish, English, West Indians.” PH4 
“ [the community] ... is made up of mainly ethnic minorities, quite a high percentage of 
Asian, Afro Caribbean, also, in the last ten years, quite a few of the East Europeans have 
moved in as well, so quite a diverse culture.” PH6 
“ ... the community we serve is almost exclusively ethnic minority. Minority is the wrong word 
here because there is a majority here. It’s a very diverse ethnic mix, we’ve got quite a lot of 
the Somali community here, Pakistani, Indians, the remnants of the West Indians, and Irish so 
that’s the make-up of it. There’s a fair amount of Arab and Yemeni decent people. It’s a real 
mixture, it’s difficult to distinguish between some of the Iraqis and Kurdish people.” PH1  
One pharmacist reported to having maintained the custom of patients ‘from English backgrounds’ 
who although having moved out of the area had chosen to retain their General Practitioner (GP) – 
whose practice was in close proximity this HLP.  
“It is a predominantly Asian area but historically we have patients from English backgrounds 
as well who still come to the local doctor’s surgery because they used to live here but it’s a 
mix, we have some people from white backgrounds but mainly Asian which is mainly 
Pakistani and Bangladeshi and South Indian. We have a small amount of Polish community 
and a small amount from African, Somali community.” PH3 
3.2.1.2 Languages spoken 
Interviewees reported that a large number of languages were spoken in the local area. This, 
combined with low levels of literacy and poor fluency in English, resulted in some pharmacists 
employing staff members who were conversant in the dominant languages spoken in the HoB to 
overcome barriers to communication. 
“ ... there can be quite a few language problems because you’re dealing with people from so 
many backgrounds but we tried to capitalise on that, making sure that the staff we have can 
speak the languages of those people. We do have difficulties with the East Europeans 
because we don’t have staff from those countries.” PH6 
“ ... a large proportion of them [members of the community] are unable to read and write 
and come from a background where you know health has never been given priority ... ” PH5 
Note: Barriers to communication are explored further in this report. 
3.2.1.3 Deprivation 
There was a consensus of opinion that local communities experienced high levels of deprivation and 
high rates of unemployment.  
“It’s quite a deprived area ... ” PH7 
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“Mostly unemployed or long term unemployed in this area, most of our prescriptions - 97% of 
them would be unpaid certainly lower than the national average which gives you an 
indication of the deprivation in the area.” PH1 
3.2.1.4 Prevalent health conditions 
Pharmacists identified a range of prevalent conditions within the communities they served. The 
following diseases/health issues were reported by: 
• Alcohol addiction 
• Asthma, chronic obstructive airways disease 
• Cardiovascular/Coronary heart disease 
• Diabetes 
• Drug addiction 
• Eczema 
• Obesity (including childhood obesity) 
• Vitamin D deficiency  
3.2.2 PERCEPTIONS OF THE MAIN OBJECTIVES AN HLP 
When asked to consider the main objectives of an HLP, the responses were focussed on the role of 
HLPs in improving the health outcomes of the communities local to the pharmacy and the proactive 
supply of readily accessible health services and information. 
“To promote health awareness to the local community, the services that are available for 
them to use, the advice on medical health issues and generally this makes my staff more 
proactive in giving information of the services and the health issues, and obviously the Health 
Exchange monitors [the touch-screen kiosks] are excellent.” PH2 
“Again it’s just looking at health needs of a local population and making sure we can improve 
their physical, mental, and even social health, bring down mortalities, hospital admissions.” 
PH7 
“I think the main objective is to improve health of the community and accessibility and 
information ... ” PH9 
3.2.3 METHODS IMPLEMENTED BY THE PCT TO DISSEMINATE INFORMATION ON THE HLP PROGRAMME 
In March 2011, (prior to becoming part of the Birmingham and Solihull NHS Cluster), the PCT 
distributed the ‘Healthy Living Pharmacy Prospectus’ to pharmacies located within the geographical 
area covered by HoBtPCT.  
However, the two main forms of information dissemination recalled by pharmacists included; 
Protected Learning Time (PLT) meetings at which the HLP concept was gradually introduced over a 
period of time and an HLP programme launch event. 
3.2.3.1 PLT meetings 
The monthly PLT meetings (organised by the PCT) appeared to be the primary mode for knowledge 
transfer and information dissemination on new developments within community pharmacy locally. 
These meetings also provided pharmacists with learning opportunities and an opportunity to 
network with their professional colleagues.  
It was at the PLT meetings that the majority of pharmacists initially became aware of the HLP 
concept and the programme itself. A few pharmacists also mentioned acquiring knowledge of the 
HLP concept via PLT Newsletters, journals, literature on the Portsmouth HLP pilot and via the Local 
Pharmacy Committee (LPC). 
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“We have a very close relationship with the PCT, in particular the Medicines Management 
group. They are very supportive of pharmacists and through them we had monthly meetings 
which we’ve had for many years, again just looking at specific issues, whether it was 
developing services, negotiating new services and planning services in and it was out of that 
that this [the HLP concept] arrived. Initially it was muted there were national programmes 
and national talk about that [the HLP concept] but it was taken on by one of the champions- 
I think John Morrison at the PCT - and so it was presented at the PLT to all Heart of 
Birmingham pharmacists. It was also presented at the Local Pharmacy Committee to give a 
vision ... ” PH1 
“We go to all the PLT [meetings] and they’ve been talking about it [the HLP concept] for a 
while and it’s been in the journal [Pharmaceutical Journal (PJ)] so I’ve known about it for a 
long time.” PH3 
“Well I’ve been reading all about it [the HLP programme], how good it’s been in Portsmouth 
and then they started here ... Yes PLT meetings and a newsletter and also when you talk to 
your colleagues you hear things what’s happening but the PLT meetings yes.” PH4 
3.2.3.2 HLP programme launch event 
Following the distribution of the HLP prospectus in March 2011, the PCT launched the HLP 
programme at a PLT event. All those interested in submitting an ‘Expression of Interest’ with regards 
to participation in the HLP programme, were required to attend the HLP launch event.  
“Well we had to go to a meeting first which went through all the criteria and what you would 
have to do to be accredited so that was quite simple enough.” PH7 
3.2.4 VIEWS ON THE MODE AND CONTENT OF THE INFORMATION DISSEMINATED ON THE HLP 
PROGRAMME 
One pharmacist reflected that there was a lack of firm affirmation, from the PCT, regarding the 
benefits (of undertaking HLP accreditation) to the pharmacist, which was attributed to the 
embryonic state of the HLP programme.  
“ ... Because it [the HLP concept] is a new area it is very difficult to be specific about it so yes 
there was very good communication in terms of ‘this is what we would like to do’, ‘this is 
what the plan is’ but it was still very amorphous in that to get the exact tangible benefits was 
difficult. In many respects, it was good that there was a lot of engagement, a lot of 
communication ... it was still very amorphous in that to get the exact tangible benefits was 
difficult.” PH1 
The view stated above was shared by another pharmacist, who also questioned the effectiveness of 
the mode of information dissemination, which was likened to a ‘lecture’, and considered to impede 
full discussion.  
“I think the information given was a little bit, not very clear ... they [the PCT] need more 
experience and in the meetings they need to give the forms and say ‘if you have any 
questions to come back to us’. I suppose it is similar to lectures, you give a lecture, you have 
a workshop ... the workshop is where we sit down and digest what went on in the lecture. 
With the PCT, they give a lecture, you walk away, half of them [attendees] still didn’t 
understand what is going on here. I explained some of the points, so it wasn’t explained for 
people to understand, the pharmacists need more help in their understanding.” PH9 
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3.2.5 MOTIVATION TO PARTICIPATE IN THE HLP PROGRAMME 
Pharmacists’ motivations to participate in the HLP programme were based on a combination of 
factors; logical progression to enable development of a competitive advantage through 
differentiation from other pharmacies in the locality, and a genuine desire to improve health 
outcomes of the communities they served.  
3.2.5.1 Extrinsic motivation: natural progression 
As mentioned above, prior to engagement in the HLP programme, all pharmacies were already 
fulfilling a number of the HLP accreditation criteria e.g. most had a consultation room with IT 
facilities and provided some of the health services required for Level 1 accreditation. Therefore, 
engagement with the HLP programme was partially seen as a ‘natural progression’. 
“For us we were doing a lot of these things ... there was a list of criteria and we matched 
most of them and there was only a small amount of things to meet the criteria.” PH8  
“I found that we’d done everything required for qualification so I thought ‘Why should I not 
register myself for the programme?” PH10 
“It was natural, we’ve always participated in the sorts of activities that you need to be doing 
to be accredited to be an HLP. So it was a natural progression, we’ve been offering stop 
smoking for twelve years or more, we applied to take part in the weight management 
programme, the needle exchange, we’ve been doing those things anyway for many years, 
whenever they’ve come up ... ” PH3 
3.2.5.2 Extrinsic motivation: the desire to gain a competitive advantage 
Participating pharmacists also expressed strong levels of extrinsic motivation to secure long-term 
financial sustainability of their pharmacies in view of external factors that were cause for concern 
and potentially threatened the future viability of their pharmacies i.e.: 
• Instability within the NHS caused by the NHS reforms; pharmacists reported to being 
bewildered about how services would be commissioned following the introduction of the 
Health and Social Care Act 2012. 
• An anticipated tightening of healthcare budgets, which was expected to have a substantial 
impact on future revenues from dispensing.  
• Operating within a hypercompetitive environment; many HLPs were located in high street 
locations within walking distance from other pharmacies. 
• Demanding consumers, with high expectations for good standards of service and 
convenience.  
In view of these external threats, pharmacists were cognisant of the need to develop a competitive 
advantage to enable differentiation from non-HLPs. Therefore, the HLP programme provided 
pharmacists with an opportunity to enhance the skill sets of their pharmacy team and drive a 
cultural shift that embraced development of a health service-orientated pharmacy model, whilst still 
maintaining the core pharmaceutical services.  
“At the end of 2010 to January 2011, the White Paper had already come out and in that one 
there was a mention of how the community pharmacy can get involved. I got information 
from Portsmouth because they were the first ones and I took an interest, because there is a 
lot of competition in the area. I said I need to be something different from everybody else, so 
how can I be a different person, how can my pharmacy be different from other pharmacies 
and then these things came out.” PH2 
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“If some of the competition didn’t provide all the services we might see some added benefit 
but due to competition we’ve got to keep our standards really high, have some 
differentiating aspects that discriminate us from other pharmacies ... it’s only a matter of 
time. One of the pharmacies in the area has already obtained HLP accreditation, another one 
is on its way and the other two ... It’s due to competition you’re going to have to get 
accreditation achieved ... they [non-HLPs] don’t realise that the money that has been coming 
into pharmacy over the last few years has severely decreased and we’ve got to look at other 
revenues of other avenues of income. The way they see it is, ‘I’m still getting paid each 
month’ and they’re [non-HLPs] not looking to the future as well, like what the government 
might do, the profession is heavily dependent on the NHS and that if we don’t promote the 
profession, we don’t get behind what the government want to achieve then there might not 
be a profession here in five to ten years.” PH7 
“That’s the good message for the public that when it’s a Healthy Living Pharmacy they know 
that all the services are there, they don’t have to go to one chemist for the prescription, they 
go to our chemist for minor ailments, they go to another for stop smoking (we do have stop 
smoking here) so it’s very confusing for them. If they know there is an HLP they have a 
Champion who can explain to them about healthy living they, we have an information kiosk, 
they have all the services so they have one stop rather than three or four.” PH9 
Whilst pharmaceutical services continued to be the core activities, some pharmacists were acutely 
aware of the importance of ‘quality’ in terms of customer service, as a means of differentiation. 
Furthermore, since most pharmacies had an ethos of continuous development of their staff, the HLP 
programme served to reinforce the value of workforce development and the benefits of having 
qualified staff in terms of reducing the burden on the pharmacist and improving customer 
satisfaction.  
“It was good [the training provided by the PCT] but it’s all about time, having the time to 
provide that level of service and that is where pharmacy now is perhaps struggling and you 
see other retail stores as well, when you go into M&S or Tesco’s and want some help there’s 
never really anyone there to help you, you can see it on the shop floor when you go shopping, 
the number of employees has decreased over the years and I think customer service is not as 
good as it used to be but the biggest problem I think pharmacy is facing now is not just with 
remuneration but if we want to provide that level of service we have to have highly trained 
staff ... ” PH7 
“I have always tried to develop myself, by continuing professional development and I’ve 
always tried to do that with my staff because I think if we’ve got good staff and good 
customer service, if you’ve got good customer service you’ve got repeat business and the 
business will thrive. If we don’t, there’s no reason why someone should choose me over 
another pharmacy. We need to have a competitive advantage so that is the difference 
between us and the guy down the road ... the draw for them [customers] is that she knows 
she’s going to get a good level of service, it’s a quality service she can rely on, the 
information she is given is accurate ... and even if there’s situations when we can’t help them 
we can sign post them all or offer them something constructive to take away with them so 
it’s a good experience. The last thing someone wants to see is a sour face or chewing gum or 
having a chat with their friends, what you need to be is be attentive.” PH1 
“I put one of my staff there [through the HTC training course] because I thought it would be 
good because it gives you that extra prestige, if you have an HTC, you tell the customers 
we’ve got a HTC who can give good advice and they listen more.” PH3 
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Additionally, central to the goal of achieving differentiation from competitor pharmacies, was the 
need to build upon the trust between pharmacist and patient that had grown over a period of time 
(occasionally decades). By reinforcing the reputation of pharmacists and pharmacy staff as credible 
providers of a portfolio of health services/advice and information, it was hoped that repeat custom 
and customer loyalty would be generated and that this would help to secure future survival of the 
pharmacy as a business. Therefore, the HLP programme was a catalyst for change in that it was an 
impetus to maximise existing strengths to the best of their advantage.  
“I suppose the main thing is that it is a chance to connect with your customers/patients and 
it’s an opportunity to not just talk to them about their medication but also it’s a lifestyle and 
other things that they can do to improve their health. So when you have that connection with 
the customers they are more loyal to you which helps the business as well, the sustainability 
of the pharmacy. So for two reasons, one it’s a way to increase our standing in the local 
community, increase our profile and improve people’s health for example if somebody quit 
smoking or somebody loses weight and then the other thing the off-shoot of that is that we 
would become busier and then we become more sustainable as a pharmacy.” PH3 
“Well it promotes the pharmacy brand, it promotes pharmacy as a profession ... , it does 
improve turnover and profitability as well ... it improves your reputation.” PH7 
However, pharmacist PH7 highlighted the increasing pressure on pharmacists to maintain high 
standards with regards to pharmaceutical services, as well as health services. This combined with 
resource constraints (experienced by most community pharmacies) gave rise to the view that in the 
long-term, community pharmacists’ may struggle to maintain a focus on ‘quality’ in terms of health 
services.  
“We were ok because we are quite experienced in delivering services and maintaining 
standards but I think like a lot of pharmacies ... will struggle, trying to get their standards to 
what is expected by the society. A lot of pharmacists are finding it very, very difficult training 
staff so they can provide the professional services and the prescriptions at the same time as 
well ... “ PH7 
3.2.5.3 Intrinsic motivation 
The high prevalence of life-threatening diseases within the local communities was of significant 
concern to a number of pharmacists. These pharmacists were intrinsically motivated to tackle health 
issues and, in the absence of NHS funding for the delivery of certain services, decided to provide 
non-commissioned health services, free-of-charge to patients or at a nominal charge. 
“They [the PCT] need to be a lot faster, a lot faster in responding to the problems and sorting 
out the problems ... also more services, like I’m asking for cardio vascular, this community 
really, really needs that. I am worried about the cardio vascular in this area. ... cardio 
vascular risk needs to be done. I asked the PCT to allow me to do this, and do blood pressure 
free and cholesterol - because if it is free, they will go for it. To be honest, I waited and 
waited to be offered the free service but I started offering the free service blood pressure and 
everything because I thought that they will benefit if at least I can do a cardio vascular risk 
assessment for them. - Oh my God it is dangerous! I can’t just ignore it now ... I charge very 
low for diabetes because some of them are very uneducated and don’t know how to use the 
machine so sometimes it is best for me to check it ... ” PH9 
“ ... We do free blood pressure testing, it’s not an official service but we offer to measure 
peoples’ blood pressure for free.” PH3 
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“I do blood pressure monitoring on my own but I charge two pounds for the charity box. I do 
it free, then anybody walks in but if I say ‘give £2 put it in the box’, only genuine people come 
for it ... I’m going to advertise as well with charges for diabetes checking and put the money 
into the charity box, so it is worthwhile rather than just doing it for free.” PH4 
Personal satisfaction from being able to provide a good level of customer service and a broad range 
of services with a genuine desire to improve health outcomes of local communities were also 
motivational factors for some pharmacists. 
“I just liked the idea of being an HLP ... personal satisfaction from that - you can provide 
more services, quite a few little things that we do.” PH5 
“ ... it gives you a personal satisfaction more than anything else. I’m always keen on 
advancing, giving good quality service, we tend to chase prescriptions and that’s how we get 
remunerated and the same with services, but what I like to do is get the best out of myself 
and my staff for the patients that we have here ... ” PH1 
“To improve our services ... I want to give a good service to all the customers and we want to 
do the best that we can, this is one of the criteria that had to be met so I was willing to do 
that.” PH6 
3.2.6 DEMOTIVATING FACTORS LIKELY TO IMPEDE DEVELOPMENT OF THE HLP CONCEPT 
Interviewees identified three possible obstacles that may have inhibited widespread participation in 
the HLP programme: 
• Uncertainty about the potential benefits or return on investments of acquiring HLP status. 
“I think where people struggled to engage was that they couldn’t see the immediate 
benefit. They thought there was a lot of lag between them and would require a lot 
of effort before you see any benefits.” PH1 
• The risks and potential ramifications of ‘fitness to practise’ proceedings was considered to 
have placed substantial pressure on pharmacists to focus their attention on what they 
considered to be their primary role i.e. the safe dispensing of prescription only medicines. 
“I think that the problems are that a lot of people are under a lot of pressure from 
dispensing, there’s also problems like if you do make a mistake, people, particularly 
the Society [sic; the General Pharmaceutical Council – the statutory regulator for 
pharmacy], fitness to practise they’re coming down on you, people at the end of the 
day, there’s not much work out there and people are looking to protect their jobs 
and ensure that they’re doing their dispensing job properly and that’s why they are 
really reluctant to start providing services. I think like fitness to practice is one, time 
to provide the services, support staff, they’ve got to go to the accreditation meetings 
from the PCT and sometimes they’ve got to do their CPPE course from the 
Pharmaceutical Society and even now a lot of pharmacists are like ‘well why should I 
do it, I’m not getting anything out of it’ ... ” PH7 
• Resource constraints (i.e. small team of staff) and an increased burden of processing larger 
dispensing volumes were considered to be inhibitive factors likely to dissuade non-HLPs 
from undergoing the accreditation process.  
“I don’t know, I think most will say time, staff but the thing is if you don’t educate, 
your staff don’t do these courses you can’t really give good service ... ” PH4 
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3.2.7 PHARMACISTS’ EXPERIENCES OF THE ACCREDITATION  
3.2.7.1 Process 
To gain HLP Level 1 status, pharmacists were required to complete a form and work through an 
accreditation framework. 
The majority of pharmacists praised the PCT for their support and guidance concerning the 
accreditation process. 
“Oh I think so. They [the PCT] were very supportive. They supported all the leadership 
training for ourselves which wasn’t cheap. They set up meetings for us and the staff and they 
paid for all of those. It’s just a new area and it took time to do and in fact the support is still 
there now and they send people round to give that support. The support has been excellent.” 
PH1 
“I think there were one or two other things that we had to find out about that we needed a 
bit of help with but the PCT was more than willing to guide us through that and give us 
support as we needed it ... they were more than willing to help at the beginning so that 
wasn’t a problem.” PH3 
3.2.7.2 ‘Paperwork’ 
Some pharmacists considered the volume of paperwork, related to the accreditation process, to be 
daunting and the questions (asked on the form) to be repetitive and/or ambiguous.  
“To be honest it was quite overwhelming the actual paperwork that came with it, I think if 
you broke it down bit by bit and just worked through ... some of the things were a bit 
ambiguous on the accreditation, some of the things, for me anyway, when I was reading it, 
seemed to be asking the same things again and again. Some of the things were a bit vague, 
‘Like the pharmacy team is led by an effective leader to achieve an agreed vision’ that seems 
a bit fluffy. I suppose as pharmacists we need it to be succinct, do this, do that.” PH3 
Additionally, a number of pharmacists reported being uncertain about where and how to access 
credible sources of information in order to answer questions related to the prevalence of conditions 
and health needs within the communities they served.  
“Some of the questions, I think the first question was ‘do you know the setup of the area, 
what kind of medical conditions do they have’, I didn’t know about it so I said “you should 
put down where you should look for this information” when he [ a member of the PCT 
Medicines Management team] came here, he told me to look at the Birmingham Health ... 
but otherwise everything else was fine, there was no issues there.” PH2 
However, all pharmacists acknowledged and commended the level of support provided by the PCT 
with completion of the paperwork. 
“ ... if anything, the forms were very long winded- the application forms what have you and 
we did get good support from the PCT in that somebody came and helped go through the 
form.” PH8 
“ ... the forms were complicated so I had to keep phoning and asking and they were very 
helpful.” PH9 
3.2.7.3 Accreditation criteria 
Pharmacists provided insight into their experiences of working through a number of the HLP Level 1 
accreditation criteria: 
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• Physical environment i.e. consultation room and availability of IT facilities within the 
consultation room 
• Leadership training to be undertaken by pharmacists. 
• Recruitment and training of a HT/HTC to enhance uptake of services and/or signpost 
patients to relevant services available within the community. 
• Building relationships with other health professionals 
• Recording interventions 
• Pharmacy ‘mystery shopper’ audit (optional). 
• Installation of a touchscreen screen health kiosk. 
Note: The mandatory health services are discussed further into the report under ‘Health Services’. 
Most pharmacists had to some extent, fulfilled some of the HLP Level 1 accreditation criteria prior to 
engagement with the HLP programme, therefore, for these pharmacists the transition from non-HLP 
to HLP status was seamless. 
3.2.7.3.1 Consultation room and IT facilities 
The majority of HLPs were equipped with a consultation room with IT facilities. One pharmacist 
however was unconvinced about the need for committing financial resources to incorporate IT 
facilities within the consultation room, when IT facilities already existed in close proximity to the 
consultation room. 
“ ... Physically the pharmacy already has a consultation room ... we did have to get IT access 
into the consultation room which we didn’t have before ... generally the pharmacy is fairly 
new in that respect so we’ve got the consultation room, we’ve got the private areas, we were 
delivering a lot of the services, we already thought ourselves as an HLP ... ” PH1 
3.2.7.3.2 Leadership training 
Pharmacists were required to undertake Leadership training organised by the PCT. Most pharmacists 
considered the leadership training to be useful in highlighting deficiencies in their current leadership 
skills and providing them with a better understanding of the difference between ‘management’ and 
‘leadership’. Consequently, in some cases the Leadership training prompted pharmacists to reflect 
on their own style of leadership, which instigated action to redress areas of weakness. 
“The training was very good, we had training on leadership skills, on communication skills, 
customer service, a lot of the training we were doing anyway.” PH7 
“First of all I was invited to do the leaders course. That course really tells you that we don’t 
know much about our management skills. It really improved us and that was one of the 
conditions for us to be able to do the HLP programme ... I have had leadership training 
already, I have been a manager in different places so I have more experience than some 
other pharmacists but it opened my mind on how people do and it made me understand 
about myself. If you understand yourself, you can correct yourself and when you are doing 
something you can look how the people perceive it so it is that that the leadership gave me, 
which I think is useful.” PH10 
“It was Leadership training and giving you training on how to deal with people, how to be a 
leader effectively, trying to get you to find out what kind of person you are and what you 
have to be, to become a leader. I think it is important because when you’re providing a 
service like this, it’s not just about managing people it’s about being a leader of those people. 
Managing is one thing and leadership is a completely different thing. It has been quite useful. 
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I do go through the modules that we were given at that time and they are quite useful. I 
quite enjoyed that.” PH6 
“I thought it was excellent, it was a real eye opener for me, especially the Leadership training 
that we did. It was Leadership and Communication Skills - those were the two ones that we 
did. There was an assessment in there where you assess yourself and you reflect on what 
kind of leader you are and you don’t have to be the pharmacist, everybody can be a leader in 
their own right which was another important point to understand. I put myself down as one 
type of leader and then there was feedback from members of staff ... and I found out that 
what I thought I was, was something completely different to what the staff thought I was ... 
sometimes you just need to sit back and say ‘how can I manage this situation in a different 
way to get the best out of the staff that I have or myself?” PH1 
However, one pharmacist was sceptical about the value of the Leadership training which was 
considered to be ‘full of jargon’ and abstract in nature. This pharmacist stated a preference for a 
course that provided tangible solutions that could be easily transferred and implemented. 
“I found the leadership course not very useful. It was full of jargon about trying to work out 
which colour or which type of person you were and it was all very, very intellectual. He was 
going on and on about this particular philosopher and about different types of leadership 
and you had to try and work out which one you were. I’m quite a straightforward person. I 
found that not useful really. The Leadership training I honestly didn’t find useful.” PH3 
3.2.7.3.3 Recruitment of HTCs/HTs 
Most pharmacists alluded to having a small team of staff and in all cases recruitment of HTs/HTCs 
was from the existing pool of staff. Selection of an individual for the role of an HT/HTC was based 
either on staff seniority/experience or on an assessment of an individual’s ability to undertake 
training/willingness to progress their training to the next level. The number of staff recruited to 
HT/HTC level ranged from one to two. 
“To be honest we didn’t really [choose], I suppose like with most pharmacies you don’t have 
team of staff to choose, it will only literally be one person that might be able to attend the 
course or might do enough hours or who have enough experience and communication skills. 
For us it was, we had set people who were able to attend the training and who had enough 
experience and the skills to go on the course.” PH3 
“Well we have a pool of staff here, we’re not a large pharmacy so we’ve only got two or 
three staff so it wasn’t hard to recruit but everybody wanted to do it ... I would still like the 
others to continue doing it, I would like to offer it to all of them but at that time it was 
practicalities of releasing one person at a time – I put my most senior member of staff in for 
it – that I thought most capable.” PH1 
3.2.7.3.4 HTC/HT training 
Confusion regarding the differences between the HT/HTC training was evident from the responses 
given by interviewee’s to a question referring to the number of staff recruited at HT/HTC level. The 
responses were often vague, requiring the interviewer to enquire about the duration of the training 
in order to determine whether their staff had attended an HT or an HTC course (the HT course was 
longer in duration than the HTC course). This may be partly attributed to: 
• the absence of feedback from training providers, with regards to the HT/HTC course content 
and the attainable skills sets, and/or 
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• pharmacists not having received relevant communication from the PCT to explain the 
differences between both the HT/HTC training courses. 
Interviewer: “How long have the courses been that your staff have been on? Interviewee: 
Two days Interviewer: I think that is the HTCs, I think the longer one is HT ... Interviewee: 
which is the higher accreditation? Interviewer: HT Interviewee: They haven’t done the higher 
one, I thought the HTC was higher, that makes sense. Interviewer: “Did you just get a leaflet 
saying do your pharmacy staff want extra training, because a lot of people didn’t really know 
the difference between the different roles. Interviewee: I don’t either, that is why I was 
confused so yes we normally get a flier to say there’s a training course going on this date, do 
you wish to put forward any names and I always do that.” PH6 
“I’m not sure what the course entailed, whether there was any additional work for them to 
do or assessments or assignments that they had to do between days. I didn’t get any 
feedback from staff on that ... it was almost like we were releasing them, they were doing 
some training but there was no feedback, we weren’t closing the loop unless you asked.” PH1 
“I’m working on memory because it was such a long time because they went last year, 
August, September 2011 which is nearly a year ago, it covered communication, I don’t know 
what else it [HTC training] covered, you will have to ask [the staff member].” PH6 
Staff motivation to undertake training 
Staff that had been identified for the role of HT/HTC, were asked (by the pharmacist) to undertake 
either the HT or HTC course, which was provided by the PCT. All pharmacists stated that their staff 
were enthusiastic and motivated to undertake the necessary training. 
“We sent them on courses ... they were very excited to go on the courses.” PH5 
“I asked them to go to the meetings and to do the test ... they are both very enthusiastic and 
I’m very lucky because I’ve got very enthusiastic staff ... ” PH9 
Pharmacists’ views on HT/HTCs ease of undertaking training 
Some pharmacists were of the opinion that their staff did not experience difficulties with attending 
and completing the relevant courses on a day release basis, although others considered the courses 
to be onerous and an unwelcome addition to the already over-stretched workload of their staff.  
“It wasn’t a problem as long as, we obviously had to provide cover, give them adequate time 
to absorb information and to study but there was no problem.” PH8 
“Well it should have been fairly straightforward we released them for that day, we paid them 
for that day so there was no added burden on them ... ” PH1 
“it is very difficult, they do so many things in the pharmacy and then I tell them they have to 
do more, more requirements, they have to do more courses because they are involved in 
health and then on top of that they have to do extra courses for the CPD and they have to get 
involved in PCT courses.” PH9 
“They offered two levels of training. The first one that we did was a bit too intense, too 
much, 16 weeks I think and they narrowed it down later to two days. I thought the 16 weeks 
one was a bit too intensive and it took far too long and the member of staff who did that felt 
exhausted by the end of it.” PH8 
Furthermore, one pharmacist expressed frustration with having to contend with multiple training 
providers, which was believed to result in: 
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• Confusion as to which training staff were required (by the PCT) to undertake. 
• Difficulties for the PCT in maintaining records of all training undertaken by each  individual.  
“What I don’t like is that each company, each programme requires something different. If 
there was one company and they said this is what needs to be done and the education is 
controlled by one company ... before it used to be only CPD for example but now we have 
courses here, here and here and people are asking for updates ... we don’t know which one 
we’ve done ... but at the moment they [the PCT] don’t know, they [the PCT] say you’re not 
coming to the meeting ... ” PH9 
Issues with the HT/HTC training  
Whilst the HT/HTC courses were paid for by the PCT, the staff members attending the course were 
paid their usual wage for the day by the pharmacy contractor. In the absence of their usual 
complement of staff, pharmacists had to contend with an increased workload during the day(s) staff 
were attending training sessions.  
“You always miss a member of staff, especially with the HT course. I think the staff member 
had to go every Wednesday for so many months so you know, when that person is not there 
in the dispensary, it is difficult and obviously they didn’t charge us to send the people on the 
course but I had to pay them, they did not go in their own free time, so obviously there’s a 
cost, an outlay to the pharmacy.” PH3 
“ ... we have to give them the time [to attend training courses] as well and that’s one of the 
issues, is time to do all that when there’s other pressing things to do.” PH7 
“I think with the training I do struggle with that a little bit because, even now, sending out 
two girls for two days has an impact on my business because I’m lacking two staff for two 
days. So if there could be some provision for that or maybe on a weekend that would be 
more useful. It’s not the finance thing, it’s just that we haven’t got enough man power to do 
the services that we want to do. So, I think if they could do that at the weekend that would 
be useful. I know it’s probably difficult for the providers as they don’t work weekends but 
even the pharmacists it’s not always easy to get the locums on the days that the training is, 
again if you do it at the weekend ... ” PH6 
HT/HTC training considered to be useful 
Most pharmacists were of the view that their staff benefitted from attending the HT/HTC training 
course(s), which were considered useful in reinforcing knowledge acquired from on-the-job training 
provided by pharmacists. 
“Obviously the courses that the PCT do like the one day courses are more useful because I am 
there all the time with them, like sometimes what I say doesn’t click whereas an outsider 
saying something clicks better, it’s like when you tell your kids don’t do it but somebody from 
outside tells them it makes a lot of difference.” PH2 
“ ... The health champion and the health trainer [courses], they were very good, the staff 
benefited and they learnt some new things and it confirmed that the things that we were 
doing were right so that was good ... ” PH3 
Furthermore, the HT/HTC training (organised by the PCT) for all pharmacy staff was considered to be 
valuable in motivating staff to proactively promote health services and in equipping them with 
effective communication and customer service skills to enable them to approach customers with 
confidence and provide opportunistic health advice.  
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 [the training included]; “how to be interactive, how to talk to patients, how to listen to them 
and it was like what you say and what you hear can be two different things ... I always say 
this to my staff, ‘you must listen to what the patient is saying to you, not what you think you 
want to hear’ so things like that.” PH4 
“They [the PCT] provided the training for the healthcare assistants and myself for services, 
improving communication skills.” PH7 
Consequently, the perceived benefits of having trained staff were considered to be: 
• Greater levels of customer satisfaction as a result of having trained, confident staff, able to 
interact with patients in a professional manner and provide health 
advice/services/signposting to other services within the community. Customer satisfaction 
with a service encounter was considered to be of vital importance in generating positive 
word of mouth and in so doing facilitate development of pharmacists reputations and of 
their staff, as trusted and credible sources of health services/information.  
• Having appropriately trained staff, which also enabled pharmacists to readily delegate tasks 
to staff e.g. provision of services such as weight management, which helped to relieve 
pharmacists’ work burden.  
“ ... Everyone wants a return on their investment, it doesn’t have to be a financial return 
although that always helps, it can be a reward for training staff, they feel more empowered 
to give advice and stuff like that ... all of my staff are training to be technicians. I encouraged 
them to do that because staff are front of house. If you haven’t got decent staff, if they’re not 
trained and competent in what they’re doing, people will walk out not happy with the 
services that you give so that was the real kudos, the real driving force for me, having trained 
knowledgeable staff – it simplifies it for me as well because I’m not being asked every five 
minutes about ‘oh I need something for this cough’- a lot of them they will be able to deal 
with it themselves because they’ve had the training.” PH1 
“ ... if you don’t educate your staff, don’t do these courses, you can’t really give good service, 
they need to go through the motions even if they learn 50%, it is going to help you, you can 
delegate and the workload is increasing all the time and they [staff] can do things for me 
rather than I do it all the time, like smoking cessation, two of my staff are smoking advisors 
so we take it between the three of us.” PH4 
3.2.7.3.5 Other training undertaken by pharmacy staff 
In addition to the HT/HTC related training, pharmacists also reported having developed a culture of 
continuous development whereby their staff had undertaken other training in order to become 
accredited to provide services such as weight management and smoking cessation for example: 
“ ... all my staff are taken on the understanding that any course that we have to go and 
attend is part of their job.” PH4 
“I’m putting the girls on smoking cessation courses which is one of the criteria as well but 
they haven’t actually done that yet.” PH6 
“Any courses that have come our way they [staff] have tried to attend, all my staff are taken 
on, on the understanding that any course that we have to go and attend is part of their job.” 
PH4 
“ ... all of my staff are training to be technicians and I encouraged them to do.” PH1 
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“ ... they [staff] have to do the Medicines Management course then, we use NPA for the 
courses, accreditations.” PH2 
3.2.7.3.6 Building relationships with GPs 
Some pharmacists were better able to build relationships with GPs in their local area whilst others 
struggled to do so. Pharmacists, who had strong relationships with GPs in their local area, were 
explicit in describing their relationship as being supportive and trusting, benefitting from open 
channels of communication. These pharmacists stated having regular contact via either telephone or 
face-to-face meetings with GPs in their area, over a period of time. Open channels of communication 
between pharmacist and GP benefitted both parties; pharmacists from referral of patients for minor 
ailments and GPs from reduced workload and more time to allocate to patients presenting serious 
health problems. 
“Well, the surgery across the road, we have an open channel of communication. I go over 
there and have lunches with their medical students and we have an opportunity to talk about 
a subject. They send medical students over here for an afternoon so we will give them the 
information and part of their presentation is to go back and tell them ... we talk to them all 
the time. They’re [local GP practice] very supportive and I think when you get that support 
with the GP it really helps, that link really helps ... ” PH3 
“I do go and talk to them. I make an appointment with the GPs and talk to them and say look 
this is what we provide. Tomorrow I’m going to this surgery and I’m going to say to them ‘if 
there are any patients who want to stop smoking, please send them to us, it’s free of charge, 
it’s not going to cost you anything ... ” PH4 
“ ... We have a close working relationship with the GPs here anyway. We give them 
weekly/monthly updates of what is happening in the profession so yes, the GPs are happy, 
especially with minor ailments and blood pressure, it’s the things they don’t have to do.” PH7 
However, one pharmacist described his relationship with local GPs as ‘working professional’, whilst 
some pharmacists alluded to difficulties with forming relationships, which were attributed to the 
impracticality of maintaining regular contact with GPs, especially those based in multi-partner 
practices/health centres.  
“I think, I suppose it’s how you define ‘good’. We have a good working professional 
relationship, they’re quite happy on the end of a phone call, we don’t sit down and have 
meetings together which we perhaps ought to have but it’s a good working relationship. If 
there’s ever an issue on a script or if I have an issue about a patient or a product I’m usually 
on the phone and they will take the call or vice versa if they’ve got an issue they call me.” 
PH1 
“ ... we haven’t met face to face or haven’t attempted to, I wanted to talk to them once many 
years back but they haven’t come to me ... the manager hasn’t been able to contact me, 
although I have done the contact so these are difficulties, I think it is human relations rather 
than work.” PH10 
3.2.7.3.7 Recording interventions and signposting 
This accreditation criterion entailed the recording of information related to interventions and 
signposting activities. However, pharmacists were generally unable to fulfil this criterion i.e. 
recording of activities was not commonplace and this was attributed to forgetfulness, time 
constraints and work-pressures experienced by pharmacists and their staff, especially for those 
pharmacies located on busy high streets. 
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“We do and I’ll be honest, when I remember we try and put it on the PMR and I don’t 
remember very often- on the PMR really, so I’ll just go in there and log in on there that we 
sign posted or offered them a service.” PH3 
“You need time and time is not there, the amount of paperwork I have to go through every 
day, I need another twelve hours in a day I think to be able to record those things.” PH4 
One pharmacist had implemented a ‘recording’ system, which was considered to be beneficial in 
enabling a review of intervention/signposting activities. However, difficulties were experienced with 
embedding a data capturing orientation within a work culture that was characteristically orientated 
towards the performance of practical tasks. 
“ ... we’ve devised this template for the health trainer, where she records specifically and we 
have a debrief every week, what kind of issues were raised this week, what was the issue, 
who was it from, what did we do about it, was it resolved in house, did we have to get more 
information, did we signpost them elsewhere so then there’s a record for us and then we 
share the learning with the other staff. We have also asked the other staff to input onto that 
template ... admittedly it’s been a struggle because it’s been a change of work practices as 
well, we’re very much doers rather than recorders if you know what I mean, our work is 
practical ... ” PH1 
3.2.7.3.8 Mystery shopper 
For all pharmacists, maintaining good standards of service was of prime importance and the mystery 
shopper feedback reports were generally considered valuable in highlighting potential areas of 
improvement.  
“The PCT one [mystery shopper audit] was some time ago. It was good but I always think 
things can be better ... there are pharmacies that came 100% and there are pharmacies that 
came 96% and I was in that category so ... my staff and I discussed it and asked what things 
are we missing and we started working on it ... ” PH4 
“Yes we did [find the mystery shopper feedback report useful]. There were a few things that 
we had to change, the way we answer the phone, a few bits and pieces but overall we got a 
positive feedback.” PH5 
“We had to do a shop front audit, a customer service audit. I suppose [the audit was 
beneficial] because I suppose you get a bit complacent because in the past we’ve won 
awards so you become complacent but you don’t realise that you’re lacking on things so it 
was good to have somebody else look at it.” PH3 
3.2.7.3.9 Health kiosk 
All HLPs (and a small number of non-HLPs) were fitted with a touchscreen health kiosk to facilitate 
ease of access to health related information (displayed on screen or in print format). However, 
whilst literate patients who were not fearful of using a computer, were able to access information 
independently, patients who were unfamiliar with computers or those with poor literacy skills 
required assistance from a member of the pharmacy team. 
“ ... we have the kiosk which is a good source of information ... if they can read and write 
then it is not a problem, I take them to the kiosk and I show them ... on the kiosk, they can 
read more and if they have any questions they come back, or print it or email it to themselves 
and so I think the kiosk really helped me to cut down me explaining ... I might explain 
everything but I might miss an important point whereas if they read, they can come back and 
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they can tell me what they didn’t understand rather than me explaining the whole thing. It 
saves time.” PH9 
“ ... I think one of the problems we’ve had, since that kiosk has gone up, a lot of the people 
who walk in, they see a computer and they get scared ... they think it’s part of the shop and 
they’re not supposed to touch it. Secondly when they try to access it it’s not always easy, we 
have a lot of ethnic minorities here and their computer skills are not good so it always needs 
intervention by one of the girls here.” PH6  
Additionally, two pharmacists reported that technical issues resulted in kiosk malfunction on a 
regular basis. 
“ ... we had the Health Exchange screen already, before it was not working very well because 
of the signal but now they have put us a router and now it works very well so if any 
pharmacy has got a problem with the signal because the signal in this area is not very good 
so hence they put a router.” PH2 
“We had many problems with that [health kiosk] right from day one, it just wasn’t working.” 
PH6 
3.2.7.4 Expected benefits of undertaking accreditation 
Unsurprisingly, pharmacists expected: 
• That commitment to the HLP programme would secure the position of HLPs as the PCT’s 
preferred providers of future services commissioned through pharmacy. 
“What would be really useful is if there were service elements attached to the Healthy Living 
Pharmacy from the outset so that if you managed to get this accreditation you would be 
entitled to provide X, Y and Z services or you would be the first port of call for these services, 
which is what we have been told already but clearly what they might have done is say that if 
you are going to invest this time and effort in terms of yourself and your staff, what you need 
to do is say OK there’s elements involved with that that you need to do.” PH1 
“There’s trust between us and the PCT because they know that we are working very hard. 
They reward you for it as well because, if the PCT see you are a leading pharmacy so 
therefore they will allow you to do these services so it’s actually a good thing ... One of the 
reasons [for participating in the HLP programme] was that we can provide more services and 
involve the PCT more, to increase more customers and increasing business, that’s one point.” 
PH9 
• A financial return on their investment (associated with the cost of meeting accreditation 
criteria such as installing computers, paid day-release of staff (to enable them to attend 
training sessions etc.) in the form of realisable benefits that would ensure that their 
pharmacy remained financially viable going into the future. 
“ ... Now we’ve done all the exercises, we’ve become accredited ... you do want to see some 
reward for that and it has to be in terms of services or financial gain to yourself because 
otherwise, you can do a lot of things to the nth degree but, at the end of the day, you’ve still 
got to pay the bills and the staff and yourself.” PH1 
“ ... If we spend £2,000 on a computer or a laptop for the consultation room, if I pay a builder 
to knock through a toilet in our consultation room is it going to be worth it or it is just 
spending money hoping that you have a few more customers through the door? I suppose 
traditionally pharmacies and pharmacists do work for free whereas doctors and dentist and 
other professions wouldn’t. Pharmacists have done a lot of things for free in the past.” PH3 
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• That HLPs would continue to be supported and promoted by the PCT to increase awareness 
of the HLP logo and concept within the local population, to enable differentiation between 
an HLP and a non-HLP, which it was hoped would drive footfall into the premises. 
“ ... I would expect when services are offered, whether the PCT are there anymore I don’t 
know but when services are offered, for us obviously to be considered and perhaps involved 
in pilots with the PCT where they can guarantee that the HLP, can hopefully guarantee a 
better uptake of a service as opposed to a non HLP pharmacy so that is the support I would 
expect ... For us, we were doing a lot of these things already but to have that title perhaps 
could be beneficial for us in the future to have services offered so for that reason - Obviously 
whether you’re called HLP or not doesn’t really make any difference to the service you give 
because you’d expect to be doing that anyway, that’s the standard that I would expect 
anyway, however for future funding or support from the PCT for advertising that would come 
from the PCT if you are an HLP so that we stand better ground as opposed to a non HLP.” 
PH8 
3.2.8 REALISED BENEFITS OF UNDERTAKING HLP ACCREDITATION 
Some pharmacists reported a number of benefits as a consequence of the accreditation process i.e.: 
• a greater awareness of prevailing health issues, 
• ability to attract ‘new customers’ (PH9) stemming from the training organised by the PCT for 
both pharmacists and HTs/HTCs, and  
• improved staff motivation to deliver a high quality of service. 
“Yes the benefits are that I have become more aware of the health issues. I tend to read up 
more, I get my staff to read up more and take interest in the services.” PH2 
“The customers are the same but the quality [of health advice provided] has improved.” PH5 
“We had to look at our leadership skills and communication skills, the staff makeup and how, 
again the communication skills for staff and the training for staff, and their understanding of 
the health environment so it was up-skilling staff really, those are the main changes.” PH1  
Consequently, an increase in custom was reported by a few pharmacists, although this may have 
been attributed to the one-off promotional activity organised by the PCT to launch newly accredited 
pharmacies. 
“The benefit we have got in terms of the prescriptions have gone up because obviously they 
come for advice and then they bring their prescriptions, the services that we do have 
increased ... We’re getting a lot of different types of customers coming about their health 
problems. The thing in this area is that if you are a good pharmacist or your staff are good 
and they give good advice the word goes round, it’s a lot of word of mouth in this area, they 
say “you know what I went there and I got really good information, a printout of my diabetes 
problem in a language which I could understand” so then that passes round a lot and then it 
is beneficial.” PH2 
“It sounds better and also when we tell people we are an HLP they get impressed and we tell 
them what we can do and I have seen an increase in people coming through the door ... I 
think more people are coming in for advice then before, I’ve seen an increase, I’m spending 
more time in here [in the consulting room]. I used to spend time before but now I think 
there’s an increase and people will say “can I talk to you in there” whereas before they used 
to have a quick chat with me.” PH4 
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“Yes definitely I think the week we had the HLP up and we got advertising, people came in 
and started asking questions, we had a lot of new customers which showed that they had 
advertised our pharmacy and that was really, really good, it really increased the attention of 
the community.” PH9 
There were however, some pharmacists who had not noticed any significant, sustained 
improvement in terms of an increased uptake of health services or an increase in footfall as a result 
of having acquired HLP status. This was attributed to high levels of competition and patients being 
oblivious of any changes between pre and post accreditation periods since: 
• Patients in HoB were accustomed to accessing health services via pharmacies - prior to the 
rollout of the HLP programme.  
• The level of health service provision remained constant between pre and post accreditation 
periods.  
“ ... I suppose that pharmacies that haven’t traditionally done these things [HLP related 
activities] and have just started doing them more recently to become accredited will have a 
bigger improvement than pharmacies like us that have done these services for years and 
have always pushed them, so maybe the increase that our pharmacy shows, might not be as 
great as somebody who has only just started doing the services ... ” PH3 
“I picked up on it before - is there a difference between the before and now, what’s the 
difference? How do you see an increase in business? Is it an increase in foot fall or the 
number of referrals or the interventions, not necessarily, we’re recording them a bit better 
now so there’s not going to be a magic jump in the number of stop smoking people just 
because we are an HLP or the number of minor ailment schemes we’re seeing because these 
were long established disciplines, so you’re not going to see the quantitative increase. If you 
went into an area in south Birmingham where the services aren’t available and you put a 
healthy living pharmacy and you promoted it in the way that HoB did here I think you would 
see a completely different picture because people aren’t used to having those services there, 
whether it’s a minor ailment scheme or stop smoking so that would be a completely new way 
of looking in those sorts of areas – you would see a big difference in those sort of areas ... but 
hopefully it’s going to be a changing culture of people and customers will find that this is the 
first point of call for their health needs.” PH1 
“As for the benefits I haven’t really seen the benefits and to be quite honest I don’t think 
we’re going to see a massive increase in business because of the competition in the area but 
it’s only because we’ve got standards and because we offer all the services we’ve been able 
to survive as a business because over the last three years we’ve seen like four new contracts, 
there’s a lot of GP direction that goes on here and there’s a lot of 100 hour contracts, HOB 
PCT have had the second highest number of 100 hour contracts in the whole of the country, 
second behind Westminster PCT so it’s just about survival really.” PH7 
3.2.9 PERCEIVED DIFFERENCES BETWEEN HLPS AND NON-HLPS 
Interviewees were asked what they perceived to be the differences between an HLP and a non-HLP 
to be. Some of these beliefs are highlighted below: 
“The pharmacies that are HLP become more active and more conscientious of the health 
problems, health issues for the community because, initially, before we became an HLP, I had 
to do some research, strategic joint health problems in the area so from the survey of 2010 I 
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got information and this year there was a high prevalence of certain kind of medical 
conditions in comparison to Birmingham City.” PH2 
“I suppose the main thing would be the enthusiasm for promoting public health that would 
be a main difference. Maybe a pharmacy that is not an HLP will still offer some of the 
services but I think the HLP pharmacies have to demonstrate and have to provide those 
services more enthusiastically. I think that is the difference.” PH3 
“It’s basically health promotion, prevention is better than cure, providing services, trying to 
tailor individual health needs to each patient and being their local health authority.” PH7 
“I think the staff are more highly trained, they can provide more advice better advice.” PH5 
“ ... We would be a base for people to be signposted to as well as us signpost from this 
pharmacy ... provide information [such as] whether it’s ‘I don’t have a doctor’, ‘I need to find 
a doctor’ or ‘where is my local gum clinic’ or ‘what do I do about drugs’ or ‘I’m concerned I 
may have diabetes’ – the whole range. We’re an information zone or point that is the 
difference ... [HLPs] have that depth of knowledge from their staff who can then signpost 
other people to the appropriate areas of advice. I think that’s what the difference is.” PH1 
3.2.10 HEALTH SERVICES 
3.2.10.1 Mandatory health services 
To achieve HLP Level 1 status, pharmacies were required to provide five ‘core’ health services and a 
minimum of one ‘extra’ health service. At the time of embarking upon HLP accreditation, most 
pharmacies were already delivering a wide range of health services including the mandatory services 
(listed in Table 25), with the exception of two pharmacies, which at the time the interviews were 
conducted, did not provide SC and EHC/EPT services. 
“ ... we were doing the services anyway and the rest of it was just basically looking at the 
standards within your pharmacy, making sure you had proper standards so for us it was just 
basically filling out a form because we’ve been doing this for a number of years now.” PH7 
Table 25: List of ‘core’ and ‘extra’ services as defined in HoBtPCT’s HLP Prospectus 
CORE SERVICES 
(MANDATORY) 
EXTRA SERVICES 
(MINIMUM OF ONE TO BE SUPPLIED) 
• Smoking Cessation (SC) • Weight Management 
• Sexual Health • Substance Misuse and Harm Reduction 
o Emergency Hormonal 
Contraception (EHC) service  
• Men’s Health 
o Chlamydia screening • Alcohol Screen and Brief interventions  
• Minor Ailments Scheme (MAS)  
• Long-term conditions 
• Early Pregnancy Testing (EPT) Local 
service 
3.2.10.2 Most accessed health service 
Most pharmacists were of the view that the MAS was the most accessed service and according to 
some pharmacists, young mothers benefitted the most from convenience of access to expert advice. 
“The minor ailment scheme because it’s so convenient and a useful service. The demographic 
of our area is low income and a lot of unemployment so what they do have is time on their 
hands and they don’t have money and also they don’t have the self-knowledge or 
information for themselves to differentiate between something that is minor that they can 
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treat themselves and something that is a bit more serious and they need to see a doctor, so 
they may visit a doctor for every eventuality so with the minor ailment scheme, that’s been a 
tremendous thing for a cough or a cold and also get advice if it continues and they need to 
see a GP so that’s been one of the most valuable ones I think.” PH1  
“Minor ailment because it is free for the patient and they don’t have to wait at the doctors, 
for the children they keep coming in for the paracetamol, nasal drops, they don’t have to 
wait at the doctors. They love it, they think it is a good service.” PH4 
“Most frequently, minor ailments is very popular, one reason- that’s been running for a long 
while, since 2005 so people are used coming to the pharmacy instead of the GP so that’s very 
popular.” PH6 
Success of the MAS was attributed to: 
1. Convenience of access to professional health advice/treatments at a time, date, and location 
of choice, thereby bypassing the need to make GP appointments. 
2. Access to free medicines – for patients exempt from prescription charges. 
3. Good awareness of the service (locally), as MAS has been running in the Heart of 
Birmingham since 2005. Consequently, members of the public in HoB are accustomed to 
accessing this service (and other services) from pharmacies. 
“Yes they trust, usually for minor ailments you find they have gone to the doctor and get 
possibly the same thing so we are only supplementing or cutting short so they don’t go to the 
doctor again, it’s not really new- what we do.” PH10 
3.2.10.3 Least accessed health services 
There was general agreement that EHC and Chlamydia testing services were the least accessed, 
which was attributed to the stigma of accessing services for culturally sensitive health issues 
considered as ‘taboo’ topics within the Asian community. However, one pharmacist reported an 
improvement in the uptake of EHC.  
“Because of the area, the morning after pill and the stigma that is associated with it, that is 
probably the least frequently accessed because of the stigma of someone coming to ask for 
the morning after pill and Asian communities and stuff like that.” PH5 
One pharmacist contended that EPT was the least accessed service and attributed this to availability 
of inexpensive testing kits that enabled patients to conduct the test in the comfort and privacy of the 
home environment. 
“I think the least would be, I’m not sure if it’s pregnancy testing or weight management, 
pregnancy testing is obviously supply and demand, whether somebody wants to come into a 
pharmacy and have it done or do it in the comfort of their own home, pregnancy tests are 
relatively cheap to purchase so that’s probably the least really even though locals are aware 
of that, to buy a pregnancy test kit for £2 and then do it at their own convenience, and it 
waives the need for filling in forms and spending twenty minutes at the pharmacy.” PH8 
3.2.10.4 Difference in opinion regarding the popularity of Smoking Cessation 
There were mixed views with regards to the popularity of the SC service. Some pharmacists reported 
a good uptake and attributed this to patients noticing the outcomes in a short period of time. 
However, one pharmacist noticed a decrease in comparison to the previous year’s figures and 
attributed the drop in uptake to difficulties experienced with engaging male patients, whilst another 
highlighted that during Ramadan, uptake of the SC service was generally low. 
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“ ... stop smoking - this is harder and harder to come by because it’s become less prevalent in 
that respect but it’s still high among the local community and especially the males, they’re 
much harder to reach, to engage with.” PH1 
3.2.11 MULTI-SKILLED PHARMACY TEAM 
In some instances, pharmacists often delegated some tasks related to the provision of health 
services, such as smoking cessation, to appropriately trained members of staff. 
“With the smoking and the weight checking and height checking and healthy life, they 
[pharmacy staff] are involved ... ” PH5 
“They [pharmacy staff] are obviously involved in pregnancy testing, I get them to do the EHC 
as well to a point so they can go through the questionnaire, if they get stuck I obviously 
intervene, ... so that’s how they are involved.” PH6 
“ ... [with regards to] smoking it will generally be me but I don’t do all the mechanical stuff, 
so maybe I’ll get one of the other staff members to measure the carbon monoxide and 
maybe fill in the form but I will run it ... if I’m running a scheme by myself I definitely delegate 
little bits of it to other people.” PH3 
“ ... if it’s a minor ailment, the healthcare assistants will load all the information up onto the 
computer. For EHC, they’ll fill out the forms and then I’ll go in there and do the clinical bit.” 
PH7 
3.2.12 BARRIERS TO HEALTH SERVICE DELIVERY: RESOURCE CONSTRAINTS 
In addition to managing dispensing workloads, pharmacists also oversee the commercial aspects 
related to running a business.  
“One of the things that I struggle with as an independent pharmacist, becoming an HLP is 
great, it looks fantastic, obviously we’re carrying out lots of services, I think it becomes 
increasingly difficult for an independent person to cope with everything because don’t forget 
we’re still running the business, dispensing, giving advice over the counter and in addition to 
that, we’re having to carry out these additional services as well, MURs, MAS, smoking 
cessation, EHC, pregnancy testing, weight management, chlamydia, there’s a whole list of 
services that we have to provide as part of the criteria. I think for an independent to do that, 
because it’s very difficult to time manage that, for one person to do that in one day’s work, 
especially when you’ve got a very busy pharmacy, we are quite busy with prescriptions, we 
have a high number, I think to do this in addition is difficult to do” PH6 
Consequently, during peak periods, when dispensing workloads peaked, most pharmacists 
highlighted experiencing a strain on capacity (arising from the limited number of staff at any given 
point in time) necessitating prioritisation of the core pharmaceutical activities, which sustained the 
financial stability of the pharmacy.  
“As I mentioned before I think HLP is a good idea but there is a lot of pressure on 
independent pharmacies. I think one of the drawbacks is going to be that we don’t have the 
time to do these services. It’s not that we don’t want to do them, it’s just that you don’t have 
enough time in the day to do it and not enough manpower ... I think the only way to go 
forward is to increase your number of members working in the pharmacy, whether it’s 
pharmacist or pharmacist technician or health trainers but we need some financial support 
from the PCT in order to provide those services, that’s where I struggle and that’s one of the 
reasons why the numbers may not stack up, when you come to independent pharmacy, the 
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number of new medicine services or MURs won’t be as high as say someone like Lloyds or 
Boots, they have the additional members there so they have more financial powers.” PH6 
“If you’ve got a couple of staff in the pharmacy then it’s quite easy but on their own it’s 
difficult. The problem in this area is that there is no such thing as a busy period and a quiet 
period, like this morning every day in the morning has been very quiet because of the fasting 
but today we were so busy in the morning, I just couldn’t believe it that we had so many 
customers come through so there is no fixed time. The thing here is that when they come 
they want information quickly so we are always rushing so sometimes you have to step aside 
but normally we have two staff here so it’s quite good that way but you definitely need two 
staff to do this service.” PH2 
3.2.13 BARRIERS TO HEALTH SERVICE UPTAKE 
3.2.13.1 Challenges of serving a socioeconomically deprived clientele 
Pharmacists identified a number of challenges associated with engaging and attracting specific 
groups within the community and described the challenges faced with serving socioeconomic 
deprived clientele. 
3.2.13.1.1 Patients averse to change 
One pharmacist highlighted the issues presented by elderly patients and those with learning 
difficulties who preferred to maintain the status quo with regards to lifestyle choices and were 
resolutely opposed to any suggestions that might require them to make changes. Consequently, 
pharmacists erred on the side of caution to avoid causing offence and the likely loss of custom as a 
consequence of providing unwelcome information. 
“People that are in a rush, people that are elderly and having learning difficulties, sometimes 
you see people who don’t want to change their ways, they like smoking, they like eating, 
drinking and some of these people, because it’s a poor area have few pleasures in life and 
they see it like you’re taking the one thing that they do enjoy doing, and you’ve got to be 
careful, you should be providing health information and promoting health as well but you 
certainly don’t want to lose patients over it so you have to balance that.” PH7 
3.2.13.1.2 Patient apathy 
A number of pharmacists experienced difficulties with generating uptake of specific health services 
within the Asian community and particularly Asian males.  
 “ ... the males, they’re much harder to reach, to engage with.” PH1 
“I suppose young Asian lads, we find that they don’t really come into the pharmacy that 
much and when they access services, predominantly the stop smoking we find them hard to 
keep them going on the service so we struggle with that group, young lads, they don’t really 
engage with services very easily.” PH3 
One pharmacist, with in-depth knowledge of the local community also noted a propensity for Asian 
men to disregard health issues and wait until escalation of the symptoms before seeking advice.  
“The males don’t look after themselves and I try to push them to see the doctor, their blood 
pressure is high but they’re not interested and I am worried about the cardio vascular in this 
area ... I think mostly the problem is the males are not into looking after themselves so the 
Asian community always wait for them to be very old ... ” PH9 
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3.2.13.1.3 Language difficulties 
Although pharmacists employed multilingual staff (conversant in the dominant languages spoken in 
the local area), it was not feasible to cater for the diversity of languages spoken in central 
Birmingham. Consequently, difficulties were experienced with communication of information on 
prescriptions or encouraging uptake of services. This was especially the case with new migrant 
communities such as Eastern European and Somali communities. 
“ ... the ones who don’t understand English at all, because I’ve got three staff who can speak 
different dialects and most of the time I understand what they are saying. For example, there 
is a Somali family, if he speaks anything, you don’t understand what he is saying, he’s got 
problems and he’s got four or five kids and all of them have got incontinence problems, 
health problems and he came here and I took time out and I figured out what he was trying 
to say and I sorted out his problem, so now he comes here because nobody would get him 
the pads he wanted and because of my experience I knew what he was looking for and I 
sorted him out but you have to be patient and you try and figure out what he is trying to say 
but it is hard. If I am busy, I tend to say come back in 15 minutes and I will see him or I will 
tell him to come back in the afternoon.” PH2 
“ ... I think language is the biggest barrier. Like I said we tend to cover the majority of 
languages but we do struggle with the East European ones because they are fairly new and 
their grasp of the English language is not as good as other ethnic minorities. We do struggle 
a lot and it does cause a big problem because they do come in for prescriptions and you try 
to explain things to them, it’s almost impossible ... ” PH6 
3.2.13.2 Cultural norms 
Pharmacist PH9 provided an insight into cultural sensitivities within Islamic communities, which 
were considered to impede access to health services such as Alcohol Interventions since 
consumption of alcohol, is prohibited. Consequently, uptake of such a service would result in 
disclosure of engaging in activities considered to be taboo and the associated stigma. 
“In this community drinking is taboo ... Alcohol is an issue because most people would not 
admit to drinking alcohol, so we can’t give advice on alcohol and it’s [drinking alcohol] very 
discreet. I worry about that because I know for a fact that there are people drinking but we 
cannot give advice at all, it’s forbidden. It’s very difficult and I think it is an issue with other 
communities as well. It is not possible to get involved with alcohol consumption. Even with 
weight management, it is very difficult. Usually I wait for people to say they have a problem 
and then I get involved. Those two issues are very difficult to talk about, the alcohol and 
weight management. Sexual health is also very difficult ... ” PH9 
Furthermore, pharmacist PH9 also highlighted that the stereotyping of gender roles within Asian 
communities: 
• Results in reluctance by Asian males to seek health information from female members of the 
pharmacy team. 
“I employed a male [member of the team] because some of them [male patients] are shy to 
come and talk to [female members of staff] ... “ PH9 
• Impacts upon the health of Asian women in terms of diet control. 
“The ladies have so many duties that they have to perform ... they are looking after the 
whole family and the in-laws ... There’s a lot of young ladies in the Asian community having 
diabetes ... It’s not controlled because when they cook they don’t think ‘I can’t have sugary, I 
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can’t have this, I can’t have that’ because they have to sit and eat together. Diet control is 
the problem.” PH9 
3.2.14 PROMOTIONAL ACTIVITIES TO RAISE AWARENESS OF HLPS 
3.2.14.1 PCT-led promotional activities 
Interviewees were in agreement that the PCT had assured HLPs that they would undertake 
responsibility for raising awareness of the HLP concept and the HLP brand. Generally, pharmacists 
recalled a range of components of the marketing strategy implemented by the PCT to raise 
awareness of the HLP concept, which were as follows: 
• Posters 
• Leaflets 
• Badges (for staff) 
• T-shirts 
• HLP signage 
“Yes they’ve [local residents] been given lots of leaflets. We’ve got in store promotion 
material ... a few badges for staff to wear. There’s been quite a bit of support ... ” PH1 
“They started with giving us the posters in our shops, so people can’t miss it ... This is the best 
thing that has come out because we can give them leaflets and we can say this is what we 
do.” PH2 
The majority of pharmacists were of the view that the leaflet-drops, which had been promised by 
the PCT, may not have materialised in some areas, although one pharmacist noticed an increase in 
uptake of health services and attributed this to leaflet-drops within the surrounding area.  
“ ... . Leaflet drops although I haven’t seen the fruition of that ... ” PH1 
“ ... . The other thing is the leaflet that I gave, they were going to do a door-to-door drop but 
I’m not sure if they’ve done it or not.” PH2 
“ ... They [the PCT] said that they would do a leaflet drop, which hasn’t happened yet.” PH3 
“I’ve spoken to [a member of the PCT Medicines Management team] about this as well 
about giving out A5 leaflets which they said would be distributed around all the houses in 
[the locality]. They did say it would happen within two weeks but there hasn’t been any 
distribution yet. That was about four months. So I’m disappointed about that ... ” PH6 
3.2.14.2 Publications relations (PR) activities 
The PCT held a one-day launch event for each newly accredited HLP. Pharmacists mentioned that 
this PR activity featured: 
• A large inflatable ‘Mr Pharm’ (a virtual pharmacist icon used to convey health related 
information to patients via touchscreen health kiosks) positioned outside their HLPs to 
attract local attention, 
• Employees of a local radio station handing out cards to passers-by, 
• A mobile HLP billboard in the form of an ad-van, which paraded up and down the High 
Street/road or within the vicinity of newly, accredited HLPs. 
“ ... .there was a lot of promotion with Mr Pharm ... ” PH1 
“The only thing they have done was on the day that I was accredited. I’m not sure if you are 
aware of this but they had people giving out cards and big blown up Mr Pharm. So they 
made a lot of noise on the day for three or four hours and they had a van driving up and 
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down Soho Road, even around the area. ... Only a certain number of people will have seen 
that on the day ... ” PH6 
“ ... we did have a promotional day when we had our launch day, about three weeks ago, 
when. they handed out leaflets and told people about the services that they could obtain 
from [name excised] pharmacy which you probably couldn’t get from anyway else ... ” PH7 
3.2.14.3 Perceptions of the effectiveness of the PCT’s marketing/PR strategy 
There was a consensus of opinion that the PCT-led marketing/PR strategy was of insufficient length 
and intensity to effectively promote the HLP concept (at a local level) and unsuccessful in 
engendering; public recognition of the HLP brand and understanding of the differences between an 
HLP and a non-HLP. 
“I don’t think they [members of the public] really understand it [the HLP concept] to tell you 
the truth.” PH5 
“I don’t think the public itself are aware of the fact of what an HLP is and what that actually 
means so they don’t know what the difference is between a normal pharmacy and an HLP. I 
think it needs to be marketed more, either by the PCT or by ourselves, so I think there needs 
to be awareness that we provide more services as a result of accreditation whereas a non 
HLP wouldn’t. I think marketing is required at the moment ... nobody has come in and said 
they’ve seen us on the website or seen our sign to say we’re an HLP or come in as a result. So 
at the moment there’s no statistic to show there’s an increase in number of people using the 
services. The services that we do are the same ... ” PH6 
“ ... The promotion around the HLP kudos is critical ... It can’t just be a snap shot of when you 
get accredited, it needs to be on-going and then you need to establish the difference 
between an HLP, where you can go for x, y and z services or information, and a pharmacy 
that is not accredited ... ” PH1 
“I think the actual branding hasn’t really caught anybody’s imagination publicly yet so our 
customers don’t really understand the HLP banner and I don’t know if those badges or T-
shirts and signage have helped. They [the PCT] were saying that they will start doing radio 
adverts, newspaper, magazines and leaflet drops. Once that starts maybe people will 
recognise the branding ‘oh this is a Healthy Living Pharmacy, this particular pharmacy must 
do this, this and this because it is a Healthy Living Pharmacy’, but that hasn’t really happened 
as yet.” PH3 
“As an HLP, we’ve actually promoted ourselves. They [the PCT] did bring the HLP banner but 
the advertisement is still missing. I think they’re not fast moving, I guess they have a huge 
amount of work -that could be the reason.” PH9 
“I’m not sure how much of the community realise we are an HLP because a lot of the 
community round here is illiterate ... The problem is a lot of the area is Asian and elderly 
West Indian people as well so I don’t think they understand the concept of HLP.” PH7 
“ ... they [members of the public] wouldn’t have a clue [about the HLP concept]. I don’t think 
anyone would. I don’t think many pharmacists know. It’s [HLP] not really an official title, it’s 
something that has been loosely, used in PCT language.” PH8 
A few pharmacists also highlighted that printed promotional materials were not designed to meet 
the need of audiences with poor literacy skills or for those for whom English is not their first 
language.  
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“ ... a lot of the patients are illiterate and it’s difficult for them to read pamphlets ... “ PH7 
One pharmacist was of the view that information in print format required simplification to initiate 
interest and suggested that communiqué only include just the top-level, brief outlines of the key 
messages rather than providing in-depth explanations. Once the interest has been initiated, the 
pharmacist would then be able to provide additional information as required. 
“ ... There’s too much reading, a few points that’s enough ... if you give them more 
information then they will read and forget about it but if you give them some points then 
they will come back and you can you give me more information ... If you get a leaflet at 
home, half of the time you don’t read it ... the best thing is a one sided [leaflet] to highlight 
something ... and then they might take interest in it.” PH2 
3.2.15 HLP-LED PROMOTIONAL ACTIVITIES 
3.2.15.1 To raise patients’ awareness of the health services offered by HLPs 
Promotion of health services, (including provision of opportunistic health advice and signposting) to 
raise patients’ awareness of the health services offered by HLPs, seemed to be considered the 
responsibility primarily of HTs and HTCs.  
Most HLPs employed in-house promotion to raise awareness of the services on offer and about the 
HLP concept by, for example: 
• Talking to customers and informing them of their HLP status. 
• Displaying posters/stickers in pharmacy windows and surgeries. 
• Displaying posters on ‘A’ boards. 
• Displaying leaflets within the pharmacy 
• Proactive promotion of services to individual patients by pharmacy staff 
“ ... . As a team we all promote the service but I suppose with the HT and HTC they are more 
focussed on it, so they would do their day-to-day duties, which is dispensary assistant but 
then make sure that they promote the services when they need to so.” PH3 
“ ... We’ve got A boards that you put outside when you want to advertise something in 
particular. So when smoking cessation have a new campaign, we’ll put that out so people 
can be aware. I would say that everyone knows about it but if it’s in your face you’re more 
likely to take it up and you’re reminded of it. We also do bag stuffers telling them what we 
do. The staff are encouraged to, with tact, if they feel that somebody would benefit from a 
service, to mention a service we offer ... ” PH8 
“We try and print leaflets ourselves. So, for the minor ailment, we always only use our own 
leaflets, so we’ve got a flyer that we hand out so say somebody who has joined the surgery 
or moved into the area and who is exempt from prescription charges and whose GP is in the 
Heart of Birmingham, so they can access the minor ailment scheme. The weight 
management, again the Your Choice posters are a little bit vague; they didn’t seem to 
capture anybody’s imagination. So again, we made our own and they were quite straight 
forward and they worked, so we make our own when we can. Sometimes when you do your 
own in black and white they sort of catch people’s eyes, whereas posh posters seem to blend 
in with the other posh posters.” PH3 
“When they [patients] come here, the staff will mention services to them, if they ask for 
cough mixtures or they take some medications for the asthma. They [staff] will ask if they 
[patients] smoke and if patients have ever thought about giving up - so we promote it that 
way ... The pregnancy testing is [promoted] if they [patients] ask for folic acid tablets, so 
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staff ask if the patient is expecting or trying to conceive. We advise patients that they can 
have a test [pregnancy] done anytime provided they bring their medical card ... weight 
management we do if somebody comes here and asks for weight loss tablets, which will 
prompt staff to suggest alternatives-so that’s how we promote it.” PH2 
“I suppose like they’ve [pharmacy staff] always have done [promoted services] because in 
terms of promoting, we promote our services quite a lot. Whenever anyone comes in, a 
member of staff will be responsible to tell them about a service, whether it’s a minor ailment, 
about the Healthy Start vitamins, ... So whoever hands out a prescription or whoever is 
working on the front, I’ve always said ‘try and leave them with one bit of information, don’t 
bombard them'. So we’ve always done that ... we just promote it when we have the 
opportunity ... ” PH3 
“Again you have to individualise that [promotion of a health service] to the patient who is in 
front of you. Maybe visually look at them, see if they smoke, see if they drink, see what 
medication they are on, maybe do a MUR, see if they’re having any problems with their 
tablets, see if you can help them. We do asthma review as well. If they are asthmatic, see if 
they know the difference between the inhalers, how to prevent side effects of the inhalers 
and give them a patient care plan and also give them non-pharmacological advice as well 
about allergies, house dust mites so it’s all tailored to individual needs of the patients ... ” 
PH7 
3.2.15.2 To raise GPs’ awareness of the health services offered by HLPs 
Generally, most interviewees reported having contacted GPs based in neighbouring health centres 
or GP practices to inform them of their HLP status and in some cases invited key members of the 
local surgery staff to the launch event. 
“ ... I’ve told all the managers and the GPs ... When the launch was there I invited the GP 
managers [to the HLP launch event]. They came and took these cards and gave them to all 
the GPs ... We were getting in touch with surgeries and things like that and going to their 
meetings but we were doing that anyway. In fact the surgeries were inviting us to meetings 
so we didn’t have to make an effort.” PH4 
However, one pharmacist highlighted the difficulty experienced with disseminating information to 
GPs attached to multi-partner practices, since time constraints prevented the pharmacist from 
informing each GP on an individual basis.  
“I mean I can deal with one GP but there’s five or six GPs in the health centre across the road. 
I will speak to one but it’s very difficult to speak to each one because it takes time.” PH6 
3.2.15.3 Word of mouth promotion to raise awareness of the health services offered by 
HLPs 
Customer satisfaction and trust were believed to generate positive ‘word of mouth’ 
recommendations by patients. However, pharmacists were equally wary of customer dissatisfaction 
that could give rise to negative ‘word of mouth’, which, within the tight-knit communities they 
served, had the potential for widespread and rapid dissemination.  
“ ... Once someone has accessed it [a health service], then word of mouth - that is a big 
factor in this area. If you are a bad pharmacist the word will go round.” PH2 
“[We promote services] through word of mouth, we can probably put up posters in the GP’s 
surgery in the waiting areas but besides that through word of mouth plus the posters in the 
windows here.” PH6 
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“ ... Word of mouth is very important so if you give good advice to one person more will come 
and it is working. I give advice and I’ve seen more people come because of that.” PH4 
“ ... We find that word of mouth is the best ... ” PH3 
“ ... A lot of it is word of mouth is because of staff telling patients [about the services being 
offered etc.] who then tell others that could benefit from it [health service].” PH8 
3.2.16 THE EXTENDED ROLE PHARMACISTS AS HEALTHCARE PROVIDERS 
3.2.16.1 Extent of patients’ awareness of the extended role of pharmacists 
Pharmacists interviewed believed that awareness within the local population of pharmacists and 
pharmacy staff as providers of health services and healthcare advisors was high. This was attributed 
mainly to pharmacists having established reputations (that spanned decades) and having built 
relationships with members of the local community and also to having been involved in the 
provision of such services for several years. A reputation for reliable delivery of high quality services 
had also led to GP referral into such services. 
“ ... From 2005 we’ve been providing all the services that are done in the area by the PCT. We 
took part in them so we were all ready to provide all these services ... Awareness for our 
pharmacy I would say about 80%, the general public who go to any pharmacy I would say 30 
to 40%, in this area there is a lot of awareness because a lot of services have been going on 
for quite a few years. In south Birmingham there isn’t much awareness because the PCT did 
nothing because they did everything for the GPs and never took interest in the pharmacy, we 
never had meetings for two or three years, there was nothing proactive at all.” PH2 
“I think it’s fairly high [awareness of the extended role of the pharmacist], they don’t always 
know everything you can do which is down to us to market the terms in general. I’m talking 
about specific services, in terms of general advice. I think most of our patients are aware 
that, we’re a community pharmacy. We’ve been established for some time and I myself am 
quite established, so I think the pharmacist also makes a difference. So if I’ve got locums or 
somebody who is changing all the time, the patients, even though the locum will still have 
the same title, they [patients] may not feel that they can relate to a locum in the same way, 
locums won’t understand the problems they [patients] had four years ago. I think most of 
ours [patients] because it is a community pharmacy in the heart of this community I think it’s 
fairly well known the pharmacist’s role in terms of health advice.” PH8 
“The other services, because they’ve been running for a long time they might be signposted 
from GPs or friends but we have been doing them for a long time. A lot of them are 
signposted from GPs, particularly EHC, early pregnancy testing, diabetes testing, blood 
pressure testing and minor ailments.” PH7 
Furthermore, some pharmacists held the view that patients in HoB were inclined to make 
pharmacies the first port of call for certain conditions, rather than a visit to the GP.  
“ ... Initially they all used to go to their GP and slowly they’ve learnt that for certain 
conditions they could come here and for other conditions they would have to go to the GP ... . 
and over a period of time, they are changing their way of thinking ... they need to know they 
can come to a pharmacy instead of going to the GP and that’s happened over the last seven 
years ... ” PH1 
“They will come to me first and then they will go to the GP and tell them my advice and they 
will also ask me what questions they can ask the GP, so they can get the best possible advice. 
Most times I talk to them, ‘this is your problem, these are the questions you must ask’ ... . If 
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there is some advice I have given and they have been to the GP they will come back to me 
and they’ll say ‘what do you think about this, about the medication prescribed etc.” PH4 
3.2.16.2 Extent of GPs awareness of the extended role of pharmacists 
There was a mixed picture in terms of perceived levels of awareness of the HLP concept and the 
delivery of services via community pharmacy amongst GPs. A number of pharmacists reported that 
GPs in their local area were kept well informed of health services supplied by pharmacists and those 
pharmacies benefitted from GP referrals to such services. 
However, a small number of pharmacists were of the view that the GPs they had spoken to were 
unfamiliar with the HLP concept and had little knowledge of the health services provided by 
pharmacies. These pharmacists expected the PCT to promote HLPs within the GP population in their 
local area and heighten awareness of services being offered by HLPs. 
“Yes they [GPs] know that we are an HLP but I don’t think it’s really taken off because the 
GPs don’t really understand what we are here for ... I think the PCT could write to them and 
say what we do in the area and that we can provide them with this, this this and this; that 
would help.” PH5 
“ ... in HoB there’s a whole bunch of GPs in the area who should all know what’s going on ... 
That’s one of the things that always comes out of the PLTs, GPs do not know what’s 
happening in pharmacies, they think that the pharmacy is still just a place where you pick up 
your medication, that’s it, nothing else. Even with the minor ailment scheme, they [GPs] did 
not do very well with that. The PCT did not tell GPs, maybe that’s not correct, I think they did 
tell GPs that we do a minor ailment scheme but the GPs and the receptionists were not 
aware exactly of which conditions were covered. So they [GPs] were saying ‘go to the 
pharmacy’ whereas certain conditions are not covered, so they should have the knowledge as 
to what they can refer the patients for. They [GPs] were referring patients for conditions that 
are not covered at all, so yet again, a lack of knowledge and it is wasting the patient’s time 
because they go to the GP and then they come to the pharmacy and find out that they can’t 
actually have something for that particular condition, so they go back to the GP again, it’s 
time wasting. What I’m trying to say is that GPs need to know a bit more about what a 
pharmacy does.” PH6  
3.2.16.3 Benefits of the extended role of pharmacists 
All pharmacists were cognisant of their contribution towards improving access to health services and 
they believed that this improved health outcomes within the local population as a result of: 
• Trusting relationships established over many years, which enabled continuity care. 
• Extended opening hours facilitating convenience of access to a range of free health 
services (eligibility criteria dependent), mostly provided on a walk-in basis by trained 
members of the pharmacy team.  
• A friendly welcoming atmosphere.  
“ ... If you deliver, then people will trust you, the GPs will send them [patients] here 
because once every two or three months I send them a newsletter and remind them of 
the things that we do ... “ PH2 
“They trust me, I’ve been here twenty-seven years and I’m part of the furniture so they 
know anything I say will be for their benefit ... “ PH4 
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“ ... Access is really important to people who are working or not working, different shifts 
on the High Street as opposed to fixed appointment times. ... access is key, we tend to be 
open for six days a week and open late hours as well.” PH1 
“It’s convenient, it’s free and they don’t have to go to the doctors ... blood pressure 
testing and diabetes testing, again it’s free, it’s convenient and if people have got 
concerns about their health, not only do we tell them what their blood pressure is and 
whether they might be diabetic or not but they also get health promotion advice as 
well.” PH7 
“Just walk straight in, it’s just so convenient to walk in, to be able to see somebody 
straight away, to not be pressurised for time, to have friendly faces as opposed to 
sometimes a receptionist and not having to go through two or three people to book in 
[GP appointment], and sit there [in the surgery]. It’s very convenient to walk into a 
pharmacy, have a person on the front, you may have to wait a minute, to be brought into 
a room. The accessibility and the ease for patients is second to none I believe.” PH8 
A number of interviewees were of the view that GP referral of patients to pharmacies for health 
services has facilitated a reduction in the number of GP consultations for minor ailments and 
enabled GPs to concentrate on more serious conditions. Furthermore, a number of pharmacists 
mentioned that GPs are able to score Quality of Framework (QoFg) points as a result of positive 
patient outcomes from health services (e.g. SC) provided by pharmacies. 
“It’s saving doctors’ time and all the hassle for the patient ... The public have started to 
know that pharmacists give advice on most of the problems and we can identify whether 
they need to go to the doctors, whether they can wait till tomorrow to see the doctor or 
whether they need to go to hospital. First point of contact, information free, no waiting 
etc.” PH9 
“Because it’s a poor area, people make appointments to see GPs for paracetamol, Calpol 
suspension, so the GPs, particularly with minor ailments, they like that service ... ” PH7 
“ ... they [local GPs] were quite happy [to hear about PH4’s HLP status]. Anything to 
decrease their workload, they are happy as long as I don’t take the money off them. It is 
a very big balancing act because they want to meet their QoF and they want to earn 
their money.” PH4 
“It’s a brilliant service [minor ailments scheme], it’s really good, it takes the pressure off 
the GP for minor things. Hopefully the doctors will be noticing that their, patients are 
coming in less for things like simple coughs and colds, hopefully the GP will be noticing 
that. Then they’ll obviously have more appointments available for more serious 
conditions where the GP does need to get involved such as heart conditions, asthma 
these kind of things, so the doctor can concentrate on those patients that he needs to 
deal with and less on the minor things ... They can see if one of their patients has gone in 
and quit it helps them and they get QoF points.” PH3 
                                                            
 
 
g “QoF is a voluntary incentive scheme for GP practices in the UK, rewarding them for how well they care for patients. The 
QOF gives an indication of the overall achievement of a practice through a points system. Practices aim to deliver high 
quality care across a range of areas, for which they score points. Put simply, the higher the score, the higher the financial 
reward for the practice. The final payment is adjusted to take account of the practice list size and prevalence.” 
[http://www.nice.org.uk/aboutnice/qof/] 
 
 77 | P a g e  
 
Aston University HLP Study 
One pharmacist also expressed the belief that the PCT benefitted from being able to optimise 
available resources in order to generate maximum benefit for patients in the Heart of Birmingham. 
“I’m sure they’ll [PCT] will be getting the results, they must be saving lots of GP 
appointments with the minor ailments scheme. In terms of the stop smoking, I know 
from talking to the Stop Smoking team that they get massive of numbers of quits from 
pharmacies. I know that it’s worth it but I hope that they can see that and keep these 
services going.” PH3 
3.2.16.4 Pharmacists’ perceptions of the value placed by patients on the extended role 
of pharmacists  
Interviewees believed that positive patient feedback and patient initiated referrals (via word of 
mouth) were indicative of patients’ appreciation of the value of the services provided by 
pharmacists. It was mentioned that patients were especially appreciative of services when advised 
about the financial savings patients could make by accessing treatments such as Nicotine 
Replacement Therapy (NRT) via the SC scheme as opposed to purchasing NRT directly over the 
counter. 
“When somebody comes and says this person said go to this pharmacy because they gave 
good advice it makes you feel happy ... ” PH4 
“All the services that we provide, they [patients] are quite happy with. We’ve had no 
negative feedback from anyone so I think it goes down quite well especially as we never used 
to do this before ... ” PH6 
“With the services they [patients] do appreciate it because sometimes with the smoking 
cessation they come in if they want to buy something and they only pay one price for the 
whole [treatment] whereas each of the patch is £22 or £15 or £18, yet [patients] only pay 
£60 for the whole eight weeks ... Minor ailments again ... it’s helping them to see the costs 
and they [patients] actually don’t have to pay ... they [patients] appreciate it.” PH9 
3.2.16.5 Pharmacists’ perceptions of the value placed by GPs on the extended role of 
pharmacists  
Pharmacists expressed mixed views on whether GPs valued the contributions made by pharmacists 
as health service providers. The variation in opinions appeared to be routed in the apparent absence 
of formal recognition, from the PCT or GPs, with regards to the contributions made by pharmacists 
in improving health outcomes of local communities within HoB. One pharmacist attributed this lack 
of recognition to the absence of quantifiable proof i.e. ‘we will be valued if we [HLPs] succeed’ PH10. 
“Yes they [GPs] value it, the receptionists value it because when somebody stumps up at half 
five because little Johnny has got a cough, well ‘why don’t you go across the road because 
there’s no appointments left’ ... If they’ve just gone in and sat for an hour to see the doctor 
for a bottle of paracetamol the doctor can say ‘next time you can just go in and see the 
pharmacist and they can give it for free’ ... ” PH3 
“ ... In fact only the day before yesterday a lady brought a letter from the GP and saying they 
[GP] want me to do the smoking cessation with this lady. So we had a thorough discussion, I 
said ‘see the GP, see what they want and then come back and we will put you through the 
smoking cessation’.” PH4 
“It’s difficult to say, we don’t have any joint meetings [between pharmacists and GPs] as 
such. There’s always room for improvement and knowledge of other professionals i.e. the 
services we do do, what we can offer and having a level playing field with them ... ” PH1 
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“I couldn’t say. I think they’ve [GPs] got used to the idea like pregnancy testing and minor 
ailments and any additional services like new medicines services and MURs. I really don’t 
think they value that at all. The number of times you see it in the press that they think it’s a 
waste of time because they say they do it anyway. So what’s the point? They just see it 
[communications sent to GPs by the pharmacist] as additional paperwork coming from the 
pharmacy; it goes straight in the bin.” PH6 
3.2.16.6 Pharmacists’ perceptions of the value placed by the PCT on the extended role 
of pharmacists  
In a similar fashion, most pharmacists were uncertain as to whether the PCT valued the 
contributions made by pharmacists in helping to improve health outcomes of the local communities 
they served. 
“Certainly the PCT value us, the current incumbents from the Heart of Birmingham, which is 
now the Cluster, they’ve always been supportive and they value the services that’s why they 
have promoted a lot of the services through us and we’ve delivered those services quite well 
so I think they are valued in that respect ... ” PH1 
“I don’t know. They [the PCT] don’t tell me anything like that but I am sure they value it 
because I think they value us highly. That’s why they made us the first HLP. I think it’s the 
trust.” PH2 
“I don’t know about PCT, ... I’d probably say not- I’d say semi valued in terms of helping us 
getting along to this position but the proof is what they do now to show the value. The 
support they’ve given us yes, that was valuable but to date I don’t feel any difference to six 
months ago.” PH8 
“I should hope so yes, the results will tell, I should think they will want to have some sort of 
feedback from me after six months or something to see what we’ve been doing since we’ve 
been accredited, so we will find out then.” PH6 
3.2.17 GOING FORWARD 
3.2.17.1 Services pharmacists would like to supply 
Some pharmacists praised the PCT for being pro-active with the commissioning of health services 
and most were keen to supply additional services that would be of benefit to the local community to 
enable targeted provision of services.  
“ ... This PCT is very active compared to some PCTs around the country are not offering half 
the services that Birmingham and Solihull are providing and a lot of them are now cutting 
back on services as well.” PH7 
Services pharmacists would like to provide in the future included: 
“ ... Flu vaccination or travel vaccination is a really key one in the area. So I’d like to offer 
those kinds of services as well and become accredited to offer that. Travel advice, with the 
ethnicity, there’s a lot of international travel occurring and the health needs and the 
potential risks of travelling abroad without proper cover are quite considerable.” PH1 
“We would like to provide blood pressure monitoring if we could and diabetes obviously but 
because that is to do with blood, how we can do it may be difficult but blood pressure 
monitoring would be useful in this area.” PH2 
“ ... Maybe cholesterol, I’ve got everything here but someone has to say ‘go ahead, here is 
the machine for checking the cholesterol’.” PH4 
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“There’s a weight management service out there that I would like to get on to but I’ve heard 
that it’s been stopped ... I think that would be a good service to have.” PH5 
“ ... Maybe running a warfarin clinic but I think for the time being we do quite a few services 
and I’m not sure we want to add to anymore.” PH7 
“Cardio vascular is definitely needed in this community ... I think the services need to 
increase, the cardio vascular risk has to be one of the services I think, most communities 
need that for definite.” PH9 
3.2.17.2 Threat to role extension 
3.2.17.2.1 Due to insufficient funding 
The pharmacists interviewed were confident about the ability of HLPs to improve health outcomes 
given their local presence and in-depth knowledge of the local communities whom they served and 
with whom they had developed trusting relationships. However, many raised their concerns that 
pharmacists were increasingly coerced into increasing their workloads without fair remuneration for 
the additional services provided. Therefore, a number of interviewees questioned the financial 
viability of continued expansion of services in view of current levels of reimbursement for the 
services provided by pharmacists which were considered to be insufficient to maintain current 
standards for the provision of health services. Consequently, most interviewed pharmacists stated a 
need for financial support to enable expansion of their workforce, the need for remuneration for 
services provided in a timely manner, and incentives to encourage patient-facing staff to take on 
additional HT/HTC responsibilities. 
Furthermore, the discrepancy in funding available to GPs as opposed to pharmacists and the greatly 
enhanced ability of multiple pharmacy chains to absorb the costs of such services when compared to 
independent pharmacies was keenly felt.  
“It’s whether the PCT see the cost to benefit ratio. I would like to offer as much as possible 
because I think we’ve performed where we can ... ” PH10 
“I think the way the PCT can help us is to have two pharmacists, so if there can be some 
additional support, financial support from the PCT, like the GPs have; GPs get funded for 70% 
of their staff, they get funded for the computers, they get funded for electric, gas, council tax, 
... we don’t get funded for anything at all and at the same time the PCT wants us to do the 
services that the GPs have traditionally been providing. So they want us to do it through our 
own resources ... but the fact is that we need the money initially to invest in to our premises 
in order to carry the services so unless they can change that I think it’s going to be very 
difficult. ... A lot of people come in for blood pressure, diabetes, cholesterol, I would like to 
provide that but we’ve got no funding. The bigger boys like Lloyds and Boots do it free of 
charge because they’ve got the finance behind them but unfortunately we’re not in a 
position to do that, so that is something I would like to see.” PH6 
“I’d like to be able to offer services where we get fair remuneration, I’m sure everyone says 
the same thing because at the end of the day you can’t do something for nothing, it takes 
time, pharmacist, a member of staff, everything has to be paid for, we’ve all had cutbacks, 
staff, the cost of living is greater, you’ve got to increase people’s salaries but from your side 
you’re not getting any more money so it’s a difficult one but in reality will you ever get that- I 
don’t know but fair remuneration for some of the services.” PH8 
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3.2.17.2.2 Due to instability within the NHS 
A number of pharmacists raised their concerns about the perceived turmoil within the NHS. 
Although there was awareness of the impending (at the time of the interviews) disbanding of PCTs, 
there appeared to a lack of comprehensive information on the impact of the changes taking place 
within the NHS. Consequently, there was a high degree of uncertainty as to which of the nascent 
organisations (Clinical Commissioning Groups, Health and Wellbeing Boards, Local Area Teams etc.) 
would assume the responsibility for the future commissioning of services from community 
pharmacy. Therefore, a number of pharmacists were reticent about committing any further 
resources into developing their HLPs further in view of the uncertainty about the impact of the 
structural changes within the NHS on the viability of HLPs. 
“I suppose the other thing is just the money situation, we’re being ask to invest in extra 
services and then we keep hearing that there might be cuts, so do you invest loads of money 
in training a member of staff, hiring extra people, possibly thinking that next year there’s no 
PCTs, that this is all going to shut? We read it in the C+D [Chemist and Druggist] that the PCT 
somewhere has to cut their services so that’s difficult. We’re not being paid to be an HLP and 
that’s something you work out straight away.” PH3 
“I think it’s quite political, it [further development of service provision] all depends on what 
happens with politics. I try not to think too far ahead ... I have my thoughts but I tend not to 
dwell too much on them because of things that are out of your control. It depends on who is 
in parliament, and what is happening with PCTs, GP commissioning, the whole structure. 
Everything is changing ... It’s difficult because I’m aware of the economic climate, I’m also 
aware of the fact that PCTs are finished and you’ve got your Health and Wellbeing Boards 
being brought in and nobody really knows what is going to happen in the future.” PH8 
“We would hope that the PCTs, while we’ve got them, or whoever is going to take over that 
particular role will support because it needs to be supported with new services; 
commissioning new services and protecting the existing ones ... I know that for certain 
services, in terms of public health, it’s going over to the Public Health Commissioning Boards 
which is more aligned with the council. At the moment it’s sort of under the health umbrella 
but it’s going to be going over to the commissioning but I’m not very clear on the specifics of 
it. There’s a lot of jargon. I think that at the last PLT we went to, even some of the presenters 
were not clear about what is happening, who is going to be doing what; that’s my perception 
... It would be nice to know that it is going to be carried on and who is going to be well not in 
charge but looking after this HLP project ... I know that one of the reasons for the PCT to get 
involved in this project [piloting the HLP programme] was to safeguard some of the services 
through pharmacy because they thought if they could start this HLP concept, it would protect 
services once the PCT had gone ... ” PH3 
However, one pharmacist was “optimistic” that the Government would support further 
development of HLPs. 
“The PCT is not going to be there ... it is my hope and this is my own personal opinion, it will 
be one of the things that the Government will say that all pharmacies must provide these 
services and I think it will come. I am very optimistic about it. I think it is a good thing for 
pharmacy.” PH4 
3.2.17.3 Motivation to progress to HLP Level 2/Level3 
Most pharmacists stated a desire to undertake HLP Level 2/Level 3 accreditation and motivation to 
do so appears to stem from the need to maintain a competitive advantage in view of the changing 
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focus of community pharmacies from being primarily focused on supply of pharmaceutical services 
to one that embraced the supply of clinical services, health advice, and signposting.  
“I don’t like to get left behind so if there is one, we will go for it.” PH4 
“Yes I would love to be involved, I think it’s going to be the way forward. I think pharmacy 
isn’t just there to provide medicine, I think it’s there to provide help and advice.” PH5 
“I’d like to be able to do everything, a mini hospital here, my drive is service and this is how I 
see pharmacy in the future.” PH5 
It is noteworthy however, that some interviewees expressed reservations about rapidly progressing 
onto subsequent levels of HLP accreditation:  
“I don’t know, I am a bit reluctant [to move onto Level 2/Level 3 accreditation] because I 
want to stabilise myself for a year or two years because I find that when you start jumping 
too quickly you tend to fall and then you lose interest. I always find that when I do things I 
like to do it properly, take my time, make sure that everyone is comfortable and I know there 
are some people who like to see quick results but I don’t believe in quick results, in health it is 
different.” PH2 
“Ideally what we need to do is, there needs to be a ground swell on the idea of a healthy 
living pharmacy as a [quality] kite mark, which is important. Then going onto the higher 
levels, to prove that you’ve got the infrastructure in the business and that you’re promoting 
those services. That’s always been my way of working ... ” PH1 
“Pharmacy has to wear a number of hats unfortunately, which is quite frustrating and lack of 
manpower - the only big hurdle in terms of the growth of the HLPs. If you can increase that I 
think we can basically carry out most services, whatever is required through level one, level 
two and level three. So I think we can do well but we need more manpower.” PH6 
3.2.18 PHARMACISTS’ RECOMMENDATIONS 
3.2.18.1 Training: HLP course for pharmacy staff 
Two pharmacists highlighted the need for a course specifically designed to improve pharmacy staff’s 
knowledge and understanding of the HLP concept, perhaps delivered via PLT sessions to facilitate 
exchange of ideas.  
“I think they [staff] need more training, even the HLP model, they [staff] need more 
knowledge about that. I can do a training course for them about what an HLP means but I 
don’t think they know as much as they should do and I think the PCT should recognise that 
fact and do another training course based on HLP and the criteria of an HLP just to increase 
their knowledge.” PH6 
“The PLT evenings are very informative, they come and give us a lecture which is fairly good 
but they are short and concise. So I suppose if there are any courses to do with the HLP. 
Rather than having one hour have a bigger discussion. There are, ten of us now, if all ten 
[HLPs] are there we can exchange ideas about something.” PH4 
3.2.18.2 Involve pharmacists in health promotion outside of the pharmacy 
Two pharmacists iterated a belief that pharmacists, as trusted members of the local community, can 
play an effective role in health promotion in venues outside of the pharmacy premises. Potential 
venues suggested included schools and homes:  
“In future if the adults are not changing what they eat it’s going to be a problem for the 
youngsters. I’m trying to get involved in homes and schools, to try and teach healthy eating 
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from the beginning in order to change behaviour, by telling them they have to cook more 
healthily. Maybe, in the future that will change some of the health problems in this 
community.” PH9 
“ ... There are a lot of young boys and girls smoking around school. I know this community, I 
have lived here for twenty years and I notice them hanging round the church and other 
places and smoking. They’re hiding from their elders ... I see them because I know them, I 
know the families and the families don’t know that they are smoking ... So I’m trying to get 
involved ... and tell them the dangers of smoking, of cancer and to get them to see what the 
danger is and to avoid new people smoking ... The problem with the smoking cessation is 
you’re not allowed to give to under sixteen ... I think it should start from primary school, it 
shouldn’t be secondary school because in primary school they have the message that 
smoking is really bad but in secondary school they are drawn to these things and the problem 
is, there is no help for the youngsters and they are ignored ... ” PH9 
“The community know that I am a pharmacist, we have to get involved by organising 
meetings for Asian ladies for example, to encourage them to provide healthy eating for the 
family or something like that. If you get information into one family it can change everything 
in a generation; one family, one mother decides I have to do this then the attitudes are 
automatically changing and you are protecting them for the future ... if one family changes 
or two families changes, they are in competition with each other, slowly the community will 
change. They [PCT] need to find a place where we can make big changes in families and if we 
get pharmacy involved with the community then I think it is a good thing. The PCT 
themselves should advertise in the community, lectures for mums or for the men to look after 
themselves.” PH9 
“I think every community has a website which they list their problems so we look at that and 
we have to sit down and see what we target. The idea of going into a school and talk is one, 
the idea of people coming to talk about their illness is another. I don’t know if I’ll stand out 
there [outside the pharmacy] and tell them [passers-by] to come into [the pharmacy] to talk 
about something. What I will do is go to a specific group people and talk about a small 
subject, which has nothing to do with pharmacy but may be of help; like if you tell children 
about the dangers of smoking, I think that is worth talking about ... ” PH10 
3.2.18.3 Potential improvements to facilitate development of the HLP programme 
3.2.18.3.1 Continuous promotion via TV, radio, leaflet drops etc. 
Most interviewees were in agreement that the PCT-led marketing of HLPs needed to have been an 
on-going stream of a variety of PR and marketing (e.g. radio, TV, posters in GP surgeries, leaflets) 
activities to highlight the differences between HLPs and non-HLPs. 
“ ... I think it’s a case of plugging away because there’s not a huge differential between them 
[HLPs and non-HLPs] in terms of the service we offer but hopefully when they [the public] 
engage with our services, word of mouth should get out and they’ll say ‘well actually go to 
that pharmacy they’ll be able to help you with x y or z’, so you need to establish that ... and 
that would come through bits of radio, leaflets, promotion, little and often all the while 
because that’s how you make the differential, because then people engage and say ‘when I 
went in there I was able to do this, this and this.” PH1 
“You have to go back to education, educating people, maybe improve the adverts on the TV 
or on the radio.” PH5 
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“To do the leaflet distribution first, that’s the most important thing maybe have something in 
surgeries, a poster in the surgery to say who is an accredited pharmacy.” PH6 
3.2.18.3.2 HLP Brand development 
Some pharmacists highlighted the need for a concerted effort to develop the HLP brand to enable 
further development of HLPs. 
“I suppose it’s a banner, it’s a heading to build on and I suppose it’s a branding that hopefully 
the PCTs while they are around can use that branding to build on more services and to 
promote the existing services more so we’re hoping that it will grow, this is just the start.” 
PH3 
“I suppose like the brand I hope they grow that brand, I know that the PCT have invested 
heavily but we have as well, we’ve invested in our time and our staff and we want to hope 
that we don’t waste that investment and we want to expand any HLP role within the 
pharmacy we would be actively looking to do that.” PH3 
“One word Healthy Living Pharmacy automatically gives you so much behind it for example if 
somebody says is this halal, it’s very difficult, but actually you know what halal food is, it’s 
one word explaining so much behind it and I think it’s a very good idea because if they keep 
advertising HLP automatically if people will start knowing what an HLP is, one word explains 
all the processes. We do smoking cessation, we do weight management but if it is called HLP 
it automatically clicks in every head, ok we’ve got everything that I need.” PH9 
3.3 RESULTS FROM THE HT/HTC INTERVIEWS 
3.3.1 BACKGROUND INFORMATION ON HT/HTC QUALIFICATIONS 
The Level 2 HTC qualification precedes the Level 3 HT qualification within the National Qualification 
Framework and according to the NPA guidelines; both roles are distinct in terms of their remit, in 
that the HTC role is limited in its remit as a supportive role compared to the HT. The role descriptor 
for an HTC according to NPA guidelines is: 
 ‘[the HTC role] facilitates the uptake of Health Trainer services and other interventions, as 
appropriate. This is often referred to as ‘signposting and improving access to services 
achieved by peer support and information giving ... Health Trainer Champions (sometimes 
called Level 2 Health Trainers, Associate Health Trainers or Health Champions) do not provide 
one-to-one behaviour change programmes.’49 
3.3.2 AWARENESS OF THE DEMOGRAPHIC PROFILE OF LOCAL COMMUNITIES SERVED BY HLPS 
As with the ‘pharmacist’ interviews, all HTC and HT interviews commenced with preliminary 
questions to ease interviewees into the interview process and to gain an understanding of their 
awareness of the prevalent conditions, socio-economic and demographic profiles of the local 
population. The majority of interviewees demonstrated good awareness of the prevalent conditions 
and demographic profiles and responses to these questions, were generally in alignment with 
statements made by pharmacists on the respective topics. 
However, most interviewees differed in their view with regards to the most predominant 
communities within the locality, which may be reflective of the geographical location of the HLP at 
which participants were employed. That is, whilst HTC10, HTC1 and HTC3 shared the view that 
communities within the vicinity of their HLPs, were ‘mainly Asian’, HT9 and HTC8 maintained that 
the local community comprised of ‘mainly Somalian people’. Additionally, both HT7 and HTC8 had 
observed migration of the original communities and inflow of new communities i.e. Somali and 
Arabic, which HT7 believed to transient. 
 84 | P a g e  
 
Aston University HLP Study 
“To be quite honest there’s quite a lot of different people round here. Over a period of time, 
the community has changed from what it was, to what it is now. Whereas before you had a 
lot of Asians, Pakistani, Indian, Bangladeshis and English, now you’ve got Somalians and 
Arabics ... most of them are from out of town, but come to visit. When they come in [to the 
HLP] obviously you talk to them and ask where they’re from because they’re not faces that 
you see all the time, so when you talk to them they say they’ve come from London ... ” HT7 
“It’s mostly a mixed community. Here, the local area is Asian, Bengali, Pakistani, Indian, 
African but because of the surgery we are next to, we get a lot of British white citizens as 
well, we’ve got a good mixture of customers ... ” HTC4 
3.3.3 PERCEPTIONS OF THE MAIN OBJECTIVE OF AN HLP 
Interviewees’ comments indicated an understanding of the general purpose of an HLP i.e. the 
proactive promotion of healthy living and the provision of a range of easily accessible services 
designed to prevent ill health or promote good health. 
“ ... We’re going to be promoting healthy living, that is what our accreditation is, so that 
patients can walk in here and benefit. They can’t always get to their doctors can they? They 
need to make an appointment or for whatever reason they haven’t got the time and there 
are these pharmacies that are available that will benefit the patient. We are there to try and 
provide some of the services, that is what I understand of it [objectives of an HLP].” HTC3 
“Just to make sure of the health and wellbeing of the local community, try and find things 
that could be happening with a particular group of people before it actually gets any worse- 
identify problems at the beginning.” HTC8 
However, HTC3 further explained that the desired outcome of an HLP was to encourage the local 
community to make HLPs the ‘first port of call’, to reduce the burden on the GP’s time. HT7 also 
agreed and was optimistic that in time, the public would come to view HLPs as an alternative source 
of health-related services.  
“ ... Their first port of call does not have to be their GP basically, they can come into a 
pharmacy and discuss with either the pharmacist or the health care trainers and depending 
on their requirements if we can help them we should be able to do so then that eliminates 
the GP having to intervene and he can concentrate on other matters which are more 
important.” HTC3 
“I think they could be quite vital in the long run, they could save the NHS a lot of money and I 
think it’s good because people can know that they can go to a pharmacy for this this and this 
but it’s going to take a little while, because people are so used to doctors ... most of the 
people who come here are through the doctors ... the first port of call is the doctor’s so once 
that trust between them and us grows then it will help quite a lot ... ” HT7 
3.3.3.1.1 Health improvement 
When asked to identify which patient groups would gain most benefit from the HLP programme, 
many interviewees referred to patient groups such as the elderly, children/teenagers, the 
overweight/obese, people with diabetes and those with poor levels of English literacy.  
Interviewee: “I think elderly people, to make them understand and to improve their health. 
Interviewer: Do you have many elderly people? Interviewee: Yes, we do, we have plenty of 
elderly, we’ve got children as well and their parents will come and ask for advice and stuff 
but mainly it’s elderly people.” HTC10 
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“Like I think with children and the elderly, some people think there’s nowhere to go or they 
don’t know where to get help from or anything like that so a lot of people don’t look for help, 
don’t ask for help, it’s like an initial start for them to try and sort out their problems ... ” HTC8 
“We’ve signposted many people that have come in, who are not diabetic but who come in for 
a glucose test. We signpost them to the doctor if it is showing very high for a certain period. 
Blood pressure is the same, if they’ve come in and they’ve got low or high blood pressure we 
signpost them to the GP.” HTC1 
“I can speak for the weight loss programme because there’s a lot of little things in there like 
the Health Exchange organise walks at different surgeries and things like that. What I do is 
help them find an activity that they want to do or if they want to do something in groups, 
we’ve got a little leaflet that we’ve got for them to refer to.” HTC4 
“I would say that it’s beneficial for the customers, people that are not aware of the services 
that are there for them, especially with the elderly or those who are not very well educated 
or can’t speak the language. If we tell them that there are these services available to them 
and are free, they would be happy with us.” HTC1 
3.3.4 DIFFERENCE BETWEEN HLPS AND NON-HLPS 
When interviewees were asked to define the differences between HLPs and non-HLPs, HTC3, 
focussed on comparing the range of health services provided before and after accreditation, 
contending that the HLP accreditation had not resulted in any noticeable change. 
“I’ve personally not noticed any change in the services that we are providing now [post-
accreditation] or to what we were providing before that [pre-accreditation].” HTC3 
However, the majority of interviewees were of the view that HLPs provided a broader range of 
health services and were more proactive in the promotion of those services than non-HLPs. 
“HLPs do more services don’t they, that’s the only difference.” HT6 
“We’ve also got the schemes like stop smoking targeted to the younger generation ... We 
offer a wide range of different activities, like we offer bowel cancer screening, Chlamydia, 
pregnancy tests, all sorts.” HTC1 
“The main difference is that the HLP can offer a lot more services. We can give more advice 
on healthy living and smoking to the community because a lot of the community round here 
need our support with their medication, with healthy living, with their lifestyle.” HTC2 
“ ... Now, as an HLP we have to advertise, that if they needed help they could come to us for 
advice that we can give or signpost people ... ” HT9 
“As an HLP we’re able to advise the patient because, for example, we can give leaflets to the 
patients, explain to them that there are gyms available if they are overweight, diets to follow 
so the diabetes stays in place ... before we only had patients coming in for medication, they’d 
bring their prescriptions in and then they would go, they wouldn’t ask for any help on stop 
smoking or any schemes that they can join ... Whereas now because we’ve got more posters 
up and we actually speak to the customer. We do actually ask them ‘do you need help with 
stop smoking?’, ‘Do you need help with diabetes plan?’ We didn’t have that before.” HTC1 
HT9 also reflected that since becoming an HT, s/he was proactively signposting patients i.e. referral 
of patients (whenever the need arose) to the pharmacist or external organisations.  
“Before we became an HLP we didn’t have an HT. Now I’m a HT, if anybody came up to me 
and said I need help with this, if I could help them I would, but if it was beyond my 
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competence, I would refer them but before we became an HLP, if somebody had come up to 
me, and I didn’t know anything about it, I would say sorry we don’t do it. Now if somebody 
comes to ask me for help, I would them refer them to a pharmacist, otherwise I will signpost 
them to where they can get more help from ... ” HT9 
Furthermore, HTC10 and HT7 shared the view that the difference between HLPs and non-HLPs was 
that HLP staff were knowledgeable and able to provide credible advice, which HT7 considered 
important to ensure a professional approach when dealing with patient enquiries.  
“I would say advice, the knowledge, because we are an HLP I’ve been to the meetings so I’ve 
got the knowledge of how to use health exchange site and stuff.” HTC10 
“ ... making sure that first of all the advice you give to people is right so you have to be 
always up to date with what’s going on because when you get people coming in with random 
questions ... you can’t start Googling it, they’re going to say, ‘oh forget it he doesn’t know 
what he is talking about, even I could do that at home’. So you have to know what you’re 
talking about.” HT7 
HT7 also contended that, whilst the aim of HLPs was to be patient focussed, non-HLPs were likely to 
adopt a transactional orientation. However, upon further reflection, HT7 was of the view that the 
development of a patient-centred culture within a pharmacy was ultimately dependent on the 
pharmacist’s predisposition to be either commercially orientated and/or embrace a patient-focussed 
outlook. 
[The difference between HLPs and non-HLPs] “is probably the services that you provide and 
the time you take out. Say, a pharmacy that is an HLP and a pharmacy that is not, is doing 
smoking, the time they spend with a patient is obviously much more than a non HLP because 
with an HLP you’re dedicated to doing it, that’s your aim to help the people. Whereas that 
one [a non-HLP] is more of a money basis, a service which you offer to get money out. An HLP 
is more about helping people and giving them more support. With a non HLP, I think it 
depends on the pharmacist as well, on what their beliefs are and how they run the 
pharmacy, you get some pharmacists who want people in and out, all money orientated 
whereas you’ve got other pharmacists who always want the best for the patients. It just 
depends on the pharmacist working.” HT7 
3.3.5 METHOD OF HT/HTC RECRUITMENT 
As part of the Level 1 accreditation criteria, pharmacists were required to recruit a HT/HTC. All 
interviewees were selected for the role of HT/HTC from the existing pharmacy teams.  
According to some interviewees, the selection criteria for the HT/HTC role were generally based on 
interviewees’ experience of delivering health services and working hours. 
“I don’t know why he chose me except for the fact that I’m here all the time ... ” HT6 
“I was just chosen, [the Pharmacist] just chose me to do it because I was doing smoking 
anyway ... ”HTC5 
3.3.6 REASON FOR UNDERTAKING HT/HTC TRAINING 
3.3.6.1 Prompted by pharmacist 
All interviewees were prompted by the pharmacist/manager to undertake the relevant HT/HTC 
training. 
“Just through being offered to go on the course [HTC], I think that’s what it was.” HTC8 
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“The pharmacist told me that we needed a HT and a health champion so there were two of 
us who went for the Health Champion and after that I went for the HT, it was good, I enjoyed 
it ... ”HT9 
“Because my boss told me to, we got the training manuals sent to us from the PCT and my 
boss looked into it and obviously he wanted one of us to become a HT at that point ... ”HT6 
3.3.6.2 Acquire knowledge 
Interviewees also valued the opportunity to acquire knowledge through training, which provided 
scope for personal development. Additionally, interviewees also shared a keen sense of purpose and 
a genuine desire to contribute towards addressing health issues within the local community. 
“There’s nothing to lose. There’s more to gain, so I just gained more knowledge.” HTC10 
“I think anything that is offered it’s just better to go ... ” HTC8 
“I just wanted to experience a bit more really. I was working in the pharmacy before I 
became a HTC and I was giving out advice, we were offering top tips to patients. I just 
wanted to be more helpful, being able to advice people on healthy diets, going to gyms, 
activities that we do here for them like the stop smoking- being able to help the patient 
more.” HTC1 
“Because I thought it would help our community. Our community comes and asks for advice 
on health and there’s a lot of people in our community who need help with child health and 
there are a lot of children around our area that are becoming obese, so I thought it would 
help.” HTC2 
3.3.7 COMPARISON BETWEEN THE PHARMACEUTICAL–RELATED ROLE AND HT/HTC QUALIFICATION 
UNDERTAKEN 
A comparison between the pharmaceutical-related role and the HT/HTC qualification undertaken 
shows that the category of the pharmaceutical-related role i.e. ‘Counter Sales’, ‘Healthcare 
Assistant’ or ‘Dispenser’ was not a deciding factor in determining the level of qualification (HTC or 
HT) undertaken. Even within the same category, there was a variance as illustrated in Table 26, 
which shows that of the four interviewees who described their pharmaceutical role as ‘Counter 
Sales’, three undertook the HTC qualification whilst one undertook the HT qualification. 
Table 26: A comparison between the pharmaceutical-related role and the HT/HTC qualification undertaken 
INTERVIEWEE 
SAMPLE N=10 
CATEGORY OF PHARMACEUTICAL-RELATED 
ROLE (AS DESCRIBED BY INTERVIEWEES) 
HT/HTC QUALIFICATION UNDERTAKEN 
BY INTERVIEWEE 
n=1 Not specified HT 
n=1 ‘Counter sales’/ ‘dispensary’ HT (qualification completed prior to 
HLP set-up) and HTC 
n=1 ‘Counter Sales’ HT 
n=3  ‘Counter Sales’ HTC 
n=1 ‘Healthcare assistant’ HTC 
n=2 ‘Dispenser’ HTC 
n=1 Not specified HTC 
3.3.8 TRAINING RESOURCES 
Two sources of training were mentioned by interviewees: 
• PCT-funded formal HT/HTC training courses (delivered by external training providers) leading 
to the award of the respective qualification. 
• PCT-led PLT sessions for pharmacists and pharmacy staff, which were a source of 
information and informal training. 
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3.3.8.1 HTC and HT courses 
Usefulness of the HTC and HT courses in enhancing healthcare-specific knowledge 
The majority of interviewees asserted to having experience of fulfilling health-service related 
responsibilities prior to undertaking either the HTC or HT training. Therefore, there was an 
expectation that the training would cover aspects related to the provision of healthcare services. 
However, this was not the case with the HTC course.  
“It [referring to the HTC course content] was nothing new to myself. As an individual and 
being a healthcare trainer, it doesn’t change my job role. I’m still continuing to do what I 
used to do ... ” HTC3 
“The training was very brief because it was only two days and it went very quickly. It was like 
an introduction to the level three and we were reminded of that on the day that briefly we’re 
going through everything. So I think it was a bit quick. If there was a future training course, 
there should be a bit more in depth of what is going on.” HTC4 
“It covered quite a bit about the communities and how to help the community but there 
wasn’t enough information. It was on people’s health but it wasn’t about obesity because in 
our community there are a lot of people suffering with obesity.” HTC2 
“We get a lot of customers coming in with really dry skin ... so if they [training providers] 
talked about different skin conditions and then actually show us, we can actually understand 
so that we can get that knowledge on what you should use on this skin condition ... I would 
have liked more information I think.” HTC10 
In contrast, those who undertook the HT training generally considered the course to be useful in 
terms of enhancing their healthcare specific knowledge. 
“I’ve got more knowledge then I had because when we were doing the course we had loads 
of course work to do ... ” HT6 
“The HT [course] did more or less everything, so it did blood pressure, diabetes, smoking, 
weight management. The main things that you need in an HLP, you did them. You have 
paperwork to do, you have activities like blood pressure checking and smoking, cleanliness, 
like keeping on top of what you normally do, making sure there’s no germs spreading, if 
people come in and they smoke, always change the mouth piece to stop spreading 
contamination and also confidentiality, the protocols and all that ... Whereas in the HTC one 
you didn’t do much on them to be honest ... ” HT7 
Benefits of the HTC and HT courses 
When asked which elements of the respective courses interviewees found useful, a number of 
interviewees highlighted the benefits of the ‘communication skills’ module, which they believed 
equipped them with practical skills and knowledge on how to effectively engage with patients in 
order to identify potential opportunities for the provision of opportunistic health advice.  
 [The HTC course covered] “How to communicate and how you would work with the 
customers, basically to give them advice, there are different ways ... It was useful ... It just 
tells you how to approach the customers without scaring them or without them feeling 
uncomfortable so they are quite useful.” HTC10 
“It [referring to the HTC course] gave us a summary of what we should be targeting, just 
taught us about advice that we should be giving to patients as they’re coming in.” HTC1 
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“It [referring to the HT course] wasn’t all a waste of time I wouldn’t say because a few weeks 
ago when I was working with one of my customers, before I went to the training I wouldn’t 
have been able to talk to her but after the training I knew what sort of questions to ask her, I 
knew what I had to do and I did that, it has helped me, I’m more confident now ... It was like 
if somebody was to come up to you, how we would talk to them, what sort of questions to 
ask, open questions, closed questions, how we would communicate so they are open with 
you so they tell you everything that you need to know.” HT9 
Three interviewees, also spoke positively about the benefits of other elements of the HTC course 
which: 
• Enhanced their knowledge on demographic profiles and levels of deprivation faced by 
communities in HoB, which enhanced their understanding of the hardships faced by local 
communities.  
“It [HTC course] was more an insight into people’s way of life. I didn’t realise how they have 
to live. I didn’t realise until this course how other people have to live ... [The HTC course 
enabled] Looking at people in a different light, you know what I mean? I suppose it’s like 
judging people, first impressions. You should never judge people by first impressions until you 
know a bit more about them. I think that’s opened my eyes ... and getting the insight really ... 
just to be open and welcoming to people.” HTC5 
“It covered quite a bit about the communities and how to help the community ... ” HTC2 
For HTC5, this knowledge was instrumental in breaking down personal embedded views and 
raised awareness of the need to keep an open mind when dealing with patients. 
• Highlighted the need to infer meaning from conversations with patients. 
“I think they made us more aware of noticing, reading between the lines, with what people 
say, that there could be underlying issues ... “ HTC8 
HT/HTC course unsuccessful in clarifying the HT/HTC role and responsibilities 
Some interviewees appeared to be somewhat confused as to their designated role and their actual 
role was deduced from the duration of the course undertaken; the HT course being longer in 
duration than the HTC course.  
Interviewee: “Initially it [the training] was eight weeks but it rolled onto about sixteen 
weeks, it was two days a week going to Gee House. Interviewer: That sounds like a HT. Are 
you the HT? That’s the long course? Interviewee: No the HTC is, or is it? I went on the long 
course, there’s now a two day course which is at Gee House as well.” HT6 
“I’m a health trainer ... I had the two day training in the Gee business centre.” HTC10  
3.3.8.2 PLT sessions 
A number of interviewees highlighted the usefulness of PCT organised PLT sessions for pharmacy 
staff in terms of aiding the development of knowledge on various topics and the dissemination of 
information on any changes to programmes currently being delivered:  
“ ... Counter staff have been on training for it [pregnancy testing]. Training is once a year and 
then I think you have updates so that’s staff based. They’re all trained by PCT training events, 
on the PLT evenings. There has been one when we first started to do the scheme alongside 
Healthy Vitamins, there was training based on both of those two. The PLT training [sessions] 
are more than enough really. I have heard that they might be stopping them, so that’s 
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probably not a good thing because that’s the only training that we get. I know when you 
work for Boots, you get training events and that kind of stuff but in an independent you don’t 
get it. Yes, the PLTs are when we get most of our training.” HT6 
“I mean if there’s any changes made to a scheme put out for us to do, we’re aware of that, if 
they’ve changed any spreadsheet, any information, how we should be running the scheme. It 
does teach us what is new and this is what needs to be done.” HTC1 
“Yes they [PLT sessions] are very useful, they help me a lot. Some of them are to do with the 
pharmacist but there are quite a lot which are for pharmacy staff as well. So I find all of them 
useful ... ” HTC2 
3.3.9 SIMILARITIES IN THE HEALTH-SERVICE RELATED RESPONSIBILITIES UNDERTAKEN BY 
INTERVIEWEES ACROSS HLPS 
Prior to the HLP pilot, most interviewees had undertaken relevant health service/programme 
training (e.g. SC and WM) and fulfilled health-service related responsibilities which included 
signposting members of the public to other healthcare providers, the delivery of health 
services/programmes and providing health-related advice. Indeed, one interviewee repeatedly 
highlighted that there was little change in terms of the health-service related responsibilities fulfilled 
prior to and post accreditation or after having completed the HT/HTC training.  
“ ... I keep saying this I don’t feel like I am doing anything different to what I was doing 
before [accreditation], like I’ve always provided, like we’ve always done the pregnancy 
testing, the minor ailments and EHC and in terms of bringing the patient into the 
consultation room, and advice we can help them with, myself personally, I’ve been giving 
that, if you need the pharmacist to intervene then obviously I call the pharmacist but I’ve not 
seen any change in the role that I’ve been providing for many, many years ... ” HTC3 
Therefore there was a degree of similarity in the responsibilities undertaken by most interviewees 
irrespective of their designation. Table 27 below shows the responsibilities mentioned by 
interviewees.  
Table 27: Responsibilities undertaken by interviewees 
DESIGNATION RESPONSIBILITIES MENTIONED BY INTERVIEWEES 
HTCs 
HTC1 • Trained to deliver the WM programme 
HTC2 • Trained to deliver the SC programme 
HTC4 • Provide advice and treatments on minor ailments 
• Deliver the EPT service 
• Trained to deliver the SC and WM programmes  
HTC5 • Carry out blood glucose tests (diabetes test) 
• Trained to deliver the SC and WM programmes 
HTC8 • Provide advice and treatments on minor ailments 
• Carry out blood glucose tests (diabetes test) 
• Deliver the EPT service 
• Signpost patients 
HTC10 • Provide advice and treatments on minor ailments 
• Deliver the EPT service 
• Trained to deliver the SC and WM programmes  
HTs 
HT6 • Deliver the EPT service 
• Responsible for the completion of MAS forms 
• Trained to deliver the SC and WM programmes 
HT9 • Provide advice and treatments on minor ailments 
• Carry out blood glucose tests (diabetes test) 
• List of local community services to enable efficient signposting 
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3.3.10 BENEFIT OF UNDERTAKING THE HEALTH-SERVICE RELATED ROLE 
The majority of interviewees when asked to define the benefits of undertaking the HTC or HT role, 
based their responses upon their general experience of fulfilling health-service related activities (as 
per Table 27), as opposed to the responsibilities associated with HT/HTC roles as defined by the NPA.  
Interviewees spoke of various aspects of the health service role that were considered to be 
rewarding for example opportunities for interaction with patients enriched their roles and job 
satisfaction was derived from a belief that their interventions had a positive impact on the health of 
the patients they interacted with:  
“See in my job role, I help a lot of customers and I enjoy that, knowing that you’re helping 
someone. You see it’s not always about working and doing things, when someone comes in 
and says ‘thank you for doing that’ or ‘it’s helped me’, you feel good, you feel much better 
and when people give you praise, you feel good about yourself, that you’ve helped someone. 
It’s much better than me standing behind the counter and talking to the customers for two 
seconds and then having to run back to do prescriptions ... ” HT7 
“ ... I really like doing it [delivering SC programme] because it helps people and I’ve actually 
helped a lot of people stop smoking. It makes you feel like you help the community achieve 
something.” HTC2 
“I think it’s the relationship that you build with the customers because when you’re 
dispensing and you’re in the back, they don’t really know what’s going on in the back 
because they’ll just see you when you go out to give the medicines, whereas when you’re 
running a programme, you’re interacting more with them and you start to build up this 
relationship or trust with them. So I guess that’s the best thing out of it.” HTC4 
“ ... I do enjoy it [HT role] because now when people come to me I can help them a bit more, 
before I couldn’t do that much so it has made a difference.” HT9 
“ ... I can help them depending on what their requirements are- to see the patient walk out of 
here a happy person and [they] thank you for the information that I have been able tell them. 
Just makes me happy that I’ve done something and made someone aware of something that 
they didn’t know ... If I’m providing a service and it has actually benefitted somebody it, gives 
you a sense of reward- that is your job satisfaction, that you’re actually doing something that 
is benefitting somebody. It’s a wonderful feeling that you can’t explain. When I did the 
weight management programme, this one person, she actually lost a considerable amount of 
weight and it was so nice to see her happy that she had benefited from a service that we 
were providing.” HTC3 
3.3.11 STAFF SUPPORT AND GUIDANCE 
The pharmacist/manager was the primary source of information, support and guidance for the 
majority of interviewees. 
3.3.11.1 Staff meetings 
Most interviewees felt supported in their health-service related role and benefitted from regular 
team meetings with the pharmacist, which were reported to take place on a weekly, a monthly or on 
an informal ad-hoc basis as and when required. 
Team meetings whether they took place on a formal or informal basis provided an opportunity to 
discuss and resolve issues (both personal and pharmacy related) with the pharmacist and other 
members of the team and instilled a sense of a team spirit. 
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Interviewee: “We have regular informal meetings, nothing formal. Interviewer: Do you find 
it useful? Interviewee: Yes, because you can convey any issue or problems rather than letting 
them build up then forgetting about them. I find it quite helpful.” HT6 
“Yes we have staff a meeting every week or every other day, whenever you feel that there is 
something going wrong or you need help on something or just generally all of us just sit 
down and you talk to each other and address the issues, how we can solve them and how 
things have been going the last week and stuff like that. We do that every week between us 
and the pharmacist ... It’s all about team work because if you don’t have team work you 
can’t do the HLP.” HT7 
“We don’t have a set day for meetings but he is always available for me to ask any questions 
it’s not a problem or if I need any advice. [Scheduled team meetings] could help but because 
we’re small pharmacy, I don’t think it’s a problem for us to communicate or to get advice 
from each other.” HTC4 
“Yes we do, we had a meeting yesterday, we have a meeting every month ... which includes 
everything about the pharmacy, how we should improve the services. The meeting that we 
recently had was about Healthy Living and the pharmacist advised us that we should start 
telling people a bit more about our Healthy Living and asking them to fill out the survey while 
they are waiting for a prescription.” HTC2 
However, one interviewee reported an absence of meetings with the pharmacist owing to the busy 
nature of work at his/her pharmacy: 
“It’s not easy to speak to the pharmacist, he’s too busy. We don’t have hardly any meetings, 
one or two in the whole year. No we don’t have regular meetings [to discuss] how to 
progress and what else can we do to better the service or are we making any mistakes. It’s 
always a good thing to sit down, the longest you should leave it is probably three months, 
you need to sit down as a group and discuss ‘are there any things we could do better’ in a 
general meeting but this doesn’t happen at all. Where can we point out our concerns? You 
can’t even go back and say ‘I had this patient in or I don’t know if I’ve done the right thing’. I 
then speak [to health professionals within the family] ... because there is not the time here to 
be able to discuss something or be told ‘yes you’ve done the right thing’. It’s too busy its 
prescriptions, prescriptions, prescriptions.” HTC3 
3.3.11.2 Opportunity to network 
The majority of interviewees stated that they had not had an opportunity to network with their 
peers. When interviewees were asked if they would find networking meetings useful, there was a 
consensus of opinion that formal peer networking meetings would be beneficial in aiding 
transference of knowledge, exchange of ideas/experiences and the sharing of best practice across 
the HT/HTC community.  
“It would be [useful] because you’d get to see how they do their work and how they give 
advice out.” HTC1 
“No that is one thing [network meeting] that I think would be good, having a meeting with 
all other HTCs, in that way we will know their views because that is one thing that would help 
other pharmacy staff, talking to people and knowing people and how other pharmacies are 
doing, it would actually help out ... You can learn a lot by talking to individuals, in the way 
they operate and in the way we do, we should be able to do that and then decide ‘they’re 
doing it like that perhaps we should try, it might work better for us’.” HT9 
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“Everybody could all discuss what the things that have been going on in their shops, see if 
other people have similar problems or if the same things crop up ... ” HTC8 
3.3.12 FEELING VALUED BY THE PHARMACIST 
When interviewees were asked if they felt valued by the pharmacist and other members of the 
team, the majority of interviewees reported that they did feel valued. 
“Yes, I think so, I think we all are really, because we all work as a team here. I suppose 
everybody else does but I personally think we’ve got a good team here.” HTC5 
“Yes I do, we work as a team here, no one feels undervalued or anything like that.” HTC4 
The exception to this was HTC3, who expressed his/her dismay at being subjected to disparaging 
comments (made by the pharmacist) for being conscientious in fulfilling a role that was assigned to 
the interviewee.  
“ ... Even if you’re sitting in the consultation room, you know that you’re being timed 
basically and you have to get out of here [consultation room] as soon as possible and if you 
do take a length of time, you get comments sent to you ... for example, I might be in here 
doing a pregnancy test and then you get a comment sent to you saying, ‘what took you so 
long, were you delivering the baby?’ I don’t like these things said to me and I find that 
happens a lot. ‘What were you doing?’ and remarks like that being said to you [by the 
pharmacist]. It makes me question how I do my job basically, you’re [referring to the 
pharmacist] asking me to provide a service so I’m trying to do it to the best of my ability but 
yet you’re [referring to the pharmacist] still not happy, you’re throwing these comments. 
How do you draw the line?” HTC3 
3.3.13 HEALTH SERVICE ADVICE/DELIVERY PROCESS 
All interviewees were involved in the provision of a range of health services. However, at the time of 
the interview, one HLP was in the process of training a member of staff to enable provision of the SC 
service, whilst another HLP was awaiting authorisation for the provision of two services; EPT and 
EHC.  
3.3.13.1 Recording of data 
General recording of HT/HTC activity did not appear to be commonplace unless there was a 
requirement to complete forms to enable delivery of a health service/programme. However, HTC8 
was informed (by the pharmacist) of the need to do so in the future. 
“No but he [the pharmacist] did say we’ve got to start doing ... ” HTC8 
“No we just deliver the services.” HT6 
3.3.13.2 Paperwork’ completed for certain health services 
Data capture activity was predominantly associated with EPT, MAS, WM and SC, which required the 
completion of ‘paperwork’ i.e. a form. These forms therefore guided service deliverers through a 
step-by-step process which included assessment of symptoms, evaluation of a patient’s eligibility for 
free treatments (particularly for the EPT, MAS and SC programme) etc. 
Interviewee: “That’s the paperwork [interviewee shows the paper to the interviewer] that 
we get given for minor ailments so we just have to keep them filed ... So we’ve got all the 
patient’s details, their GP address that we have to double check to see if their GP is on the 
scheme then we can give the products out, if they’re not, then we can’t because obviously we 
don’t get paid for that so any symptoms that they’re presenting, that’s like a prescription the 
pharmacist signs and they put their exemption and stuff on the back and we give the 
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products accordingly. Interviewer: So the pharmacist fills that bit in then? Interviewee: Well 
we fill that part in for the patient and take down what symptoms they’ve got, sore throat 
and stuff like that, staff will get the drugs out and then the pharmacist double checks 
everything, makes sure that there’s no interactions with medication and then signs it off and 
we give it out.” HT6 
“We have records, for weight management we have their cards that we write every data on 
them so we have different folders for different things ... ” HTC10 
3.3.13.3 Monitoring of patient progress 
Both the SC and WM programmes required patients to attend a series of weekly sessions over a 
period ranging from six to twelve weeks, during which time various measurements such as carbon 
monoxide levels (for SC service), blood pressure, weight, etc., would be taken and recorded onto a 
form. The collection and recording of clinical data, enabled staff to monitor progress and discuss 
with the patients concerns or issues that could result in patients not meeting their target goals. 
“That’s the smoking paperwork that we have and say on week one we will go through all the 
patient details plus their smoking history and then that’s where we put in when the patient 
comes in for their appointments, that’s where we put the dates and the products that we 
have given and anything that we have discussed or any problems ... ” HT6 
“ ... With the smoking it’s a twelve week course and they have to attend the clinic every week 
for twelve weeks and what we do is, obviously we give them the free patches and everything 
but we have a CO [carbon monoxide] reading every time they come in and obviously if their 
CO reading isn’t coming down there’s obviously an underlying problem that they’re smoking, 
lying to me and then I have to say something has got to be done ... “ HTC5 
3.3.14 MULTI-SKILLED WORKFORCE FACILITATED PROVISION OF HEALTH SERVICES ON A WALK-IN BASIS 
The multi-skilled capabilities of pharmacy staff facilitated provision of health services on a walk-in 
basis and generally ensured continuity of health service provision even during peak hours.  
“If someone came in for a service, we’ve got counter staff and a pharmacist and a dispenser 
here. So if they came in for a service we would help them straight away, we wouldn’t make 
them wait because we don’t like our patients waiting, we like our service to be perfect, so if 
someone came in for advice and needed help on emergency contraception the pharmacist 
would be there straight away because here, there’s a dispenser who dispenses everything so 
the pharmacist is free to leave but the pharmacist will do the final check. There’s always 
someone to help out.” HTC2 
“If we are free, you can have a talk because there will always be someone available to talk 
because there’s either me or the pharmacist or the other members of staff who can take the 
query down ... ” HT7 
Interviewee: “For smoking cessation we have an appointment system ... If a patient can’t 
come back we will see the patient then, we won’t just turn round and say you have to come 
back for your appointment, we will do it. On the smoking cessation scheme you have to be 
accredited to do it, so we’ve got four or five people here accredited, so someone will always 
be able to see the patient. Interviewer: What happens if a member of staff that provides the 
service is busy or isn’t here? Interviewee: There’s three pharmacists who can do it so 
depending which pharmacist is in on that day, my boss is also smoking accredited and I am, 
so someone will always be here who is free.” HT6 
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3.3.15 CHALLENGES TO SERVICE DELIVERY 
3.3.15.1 Cultural sensitivities/religious factors 
HTC8 highlighted a minimal uptake of the SC service owing to religious and/or cultural factors. 
“ ... we haven’t got that many people who come for the smoking [smoking cessation 
programme] ... like I said, we have got a lot of Muslims in the area. I think the smoking in the 
area has been cut by quite a lot because Muslim ladies don’t really smoke that much- I’m not 
saying that none of them do.” HTC8 
HT6 reflected that elderly patients considered male pharmacists to be more experienced and an 
authoritative figure in comparison to female pharmacists or younger members of the pharmacy 
team. Consequently, elderly patients were reticent about consulting with younger members of the 
pharmacy team on health issues and were more inclined to request a consultation with a male 
pharmacist. On such occasions, when possible, staff would endeavour to accommodate patients’ 
requests or they would be asked to come back at another time. 
“ ... Sometimes, especially our elderly patients, they like to speak to a male, older male, like 
we’ll tell them and they’ll want confirmation from the boss, sometimes when we have a 
female pharmacist, they like to speak to a guy, the man gives them more authority or 
something. Generally it’s ok but sometimes you get patients who specifically say ‘you look 
too young or too little’ or ‘can I speak to the pharmacist’ ... if they want to speak to a male, 
my boss, he’s in the office, if not, we do have male members of staff, so they’ll speak to 
them. Failing that they’ll speak to whoever or like if someone wanted to speak to a male 
pharmacist today, I’ve got a male pharmacist who is in tomorrow so I would have to tell 
them to come back tomorrow if my boss wasn’t here.” HT6 
However, for the EHC and EPT services, patients’ preferred to consult with a female pharmacist. 
Interviewer: “Do you ever get people asking for a female? Interviewee: Yes especially for 
EHC and pregnancy testing, a lot of patients want to speak to a female ... ” HT6 
3.3.15.2 Language barriers 
The majority of interviewees stated being multi-lingual and or being supported by other members of 
the team conversant in a range of languages. The breadth of languages spoken within local 
communities caused pronounced communication difficulties in certain circumstances: 
“Myself, I can speak Mirpuri and Urdu and Punjabi so I’m quite valuable like that. Our 
pharmacist is only English but we’ve got a pre-reg student who is Bengali, so we’re quite 
alright like that.” HTC4 
“We speak Punjabi, Urdu, English, we’ve got a man who speaks Arabic, Farsi, Bengali, 
Mirpuri. We’ve got quite a range.” HTC2 
“I speak a bit of Urdu but mainly I speak English, I can work around my Urdu and make them 
understand about the medicines they use and the health conditions and stuff.” HTC10 
“We have staff speaking all the different languages, the Somalian girl who works here is only 
part time and our community is a Somalian community, so when people come in, we find 
that with some people, you couldn’t understand them. It’s really hard to communicate with 
them, they don’t know a single word of English, so what I have to do is go out onto the street 
and find somebody and they have to translate for us, that’s the best that we can do.” HT9 
“ ... To be honest with you, the way that people come across [referring to health 
professionals’ communication skills] is quite confusing for a lot of people who don’t 
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understand English and people who don’t understand big words and stuff like that. They 
don’t even know what half the stuff means so that’s what I think. For example, they don’t 
know what the morning after is ... it’s confusing for the people who don’t understand what 
things mean. It’s like you going to the optician or the dentist and they’re in there talking 
about things, you have no idea of what is going on but people who work there know exactly 
what is being talked about. It’s the same when you’re explaining things to patients, speak to 
them on their level so they understand and they feel more comfortable talking to you. If you 
speak to them and you say you’re a HT and you’re someone big or a pharmacist or a doctor 
and you start speaking posh and fancy words, they won’t have a clue what you’re talking 
about and they will walk out.” HT7 
3.3.15.3 Familiarity with pharmacy staff  
A further possible obstacle to service uptake, which was highlighted by two interviewees, was the 
familiarity that potential service users had with pharmacy staff. It was suggested that this had the 
potential to cause embarrassment and precluded uptake of certain services: 
 [Regarding] “Weight Management, I think a lot of people don’t want to come in and start 
talking about their weight to people they see every day. It’s like when you go to the doctor’s, 
you can go in and it’s between you and the doctor. Whereas if they come here, it’s still 
between you and the HT but it’s like when you see them, (the doctors they live in the posh 
areas you don’t really see them), so if you see normal people like us who walk around after 
lunchtime and you probably see them and then it’s like, I don’t know if this is even true but 
it’s like embarrassing for them to look at someone outside of the place, especially if you see 
them in a takeaway or something and they’re doing Weight Management they’re stuck.” 
HT7 
“I think it’s the community we live in ... if somebody from this area wanted a chlamydia test 
they wouldn’t come to the local pharmacy because we would know that they are from here 
and they would get embarrassed that we know them. I think they would go to a far 
pharmacy to get that service.” HT9 
3.3.15.4 Difficulty with balancing dual roles (i.e. health service and pharmaceutical-
related roles) during peak periods  
A number of interviewees highlighted tension between their involvement in HT/HTC-related activity 
and their more traditional, pharmaceutical-related focus. Given the workload of those interviewees, 
it was common for the pharmaceutical-related activities to be given primacy over the health-service 
related activities: 
“The amount of work you have to do, because HT is like a part time, like on the side, whereas 
you’ve got your daily job routine which is prescriptions and serving customers and bringing in 
business but this [HT role] on the other hand is just like part-time. If someone comes in and I 
have to do this [provide HT service] but then when I finish here I have to go back to the work 
that I have to do but obviously that’s the only downfall.” HT7 
“My original job [pharmaceutical-related] that is what I mainly do. If somebody is waiting for 
their medicine or prescription when the pharmacist is getting it ready, I will probably have a 
word with them and say ‘are you interested, what do you think about your health’. I will 
explain my job role ... ” HT9 
The pressure to prioritise pharmaceutical-related activities was deeply frustrating for HTC3, who felt 
unable to fulfil his/her HTC role satisfactorily due to the constant interruptions, whilst in 
consultation with a patient and felt pressurised (by the pharmacist) into completing consultations 
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quickly. Consequently, this gave rise to both personal and professional conflict within the HTC, who 
questioned why s/he had been asked to undertake the health-service related role. 
“Actually patient advice suffers sometimes because sometimes I’m sat in the consultation 
room and the door is constantly being knocked to say you need to get out of there. I don’t 
really like that at all because it takes time to talk to a patient and we’re not given this time at 
all but on the other hand they say we need to provide these services but the time is just not 
there ... I feel I am a counter assistant, I am not a dispenser but I feel that I am pulled into 
there, there is still a requirement for myself to have to sort out prescriptions ... I’m being 
drawn away from everything [and] into the dispensary [therefore], not being able to provide 
these services- I don’t think there’s the time at all.” HTC3 
3.3.15.5 Time to fulfil HT/HTC responsibilities 
HTC1 and HTC3 both spoke of the lack of time to fulfil their health-service related duties due to the 
need to prioritise the primary pharmaceutical-related role. HTC3 recommended increasing staffing 
levels to enable provision of a good standard of service. 
“If we had more time we would target every single customer that comes in but it’s hard to do 
that, in a day we would maybe give advice to five or six patients.” HTC1 
“The barriers are time, you know when they say that pharmacies are not all about 
prescriptions, I personally feel that when it comes to providing a service, the assistants are 
not given the time that they require and I think that is a big barrier within itself. I’ve 
mentioned to you about patients asking if we do diabetes, ‘do you do blood pressure’, I 
would personally like to provide these services but I don’t think that we would have the 
availability of time because I don’t think we’ve got sufficient staff, our pharmacy 
concentrates more so on prescription side ... I think he [the pharmacist] needs to take on 
more staff and there’s the staff that work strictly in the dispensary and deal with that side 
and then there should be the staff who are able to be at the forefront, give the customers the 
best service we possibly can for their requirements.” HTC3 
However, interviewees that did not find the dual aspect of their job role challenging were either/or;  
• Able to exercise control over how they managed their time i.e. diarise tasks on a 
 daily basis and prioritise them in order of importance (based on in-depth 
 understanding of the requirements of both the pharmacy and health-service related roles). 
• Supported by other members of the team. 
• able to refer patients’ health-service related enquires to another member of the 
 team. 
• Responsible for the delivery of either the WM or SC programmes which were delivered on 
an appointment basis and as such enabled effective management of time. 
“Well we have a patient who comes in and I can’t fit them in, let’s say I’m overloaded with 
work that day, either I will refer them onto the pharmacist or I book an appointment and tell 
them to come in later.” HT6 
“ ... we have a diary of what needs to be done and then you work out what needs to be done. 
I’ve been working here for a while so you know what are the important things and what are 
not so important and the things that could be done the next day if needs be but to be honest 
with you, we’re here for eight/nine hours a day and there’s a lot of drugs.” HT7 
“ ... dispensing it is myself and another member of staff as well and we’ve got the pre-reg 
student, so I get help on that side as well but the weight loss programme is all appointment 
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based, so I know when I have an appointment, so I have to free myself for that time so we’ve 
just really managed it so far.” HTC4 
3.3.16 FACILITATORS TO HEALTH SERVICE UPTAKE 
This section outlines interviewees views on why patients choose to access health 
services/treatments and/or advice via pharmacies. 
3.3.16.1 Convenient access to health services/treatments and advice 
Interviewees believed that the extended opening hours (in comparison to GP surgery opening hours) 
facilitated convenient access to an alternative source of credible health advice and a broad range of 
health services, especially MAS. Consequently, convenience was considered to be the principal 
reason for patients’ inclination to access a health service via a pharmacy and especially useful to 
individuals unable to take time off work to attend GP appointments. 
“I think with the GP you have to make an appointment, with the pharmacy they can pop in at 
any time so I think that’s the reason. It’s more convenient ... ” HT9 
“For minor things really like headaches, coughs, something that they can actually purchase 
over the counter instead of waiting for a doctor’s appointment.” HTC1 
“The people who work, it’s a big benefit for them because most of them buy medication over 
the counter. They’re the people who usually work, they’re the ones who are always on the 
go, they have no time to go to the doctor and sit there and have a discussion. It’s like they 
are always running around doing things ... If you’ve go to the doctor they’ll say the 
appointment is at this time, you haven’t got the freedom of choosing.” HT7 
“Because they’ve got someone else to speak to other than a doctor whereas the doctor, if 
you’re ill you have to get up a certain time and ring and try and get an appointment before 
fifty other people and it’s like a race, to be the first one to get through and get an 
appointment, whereas if you’re poorly and you’re working you don’t finish until five, six, 
seven and by then you can’t book an appointment, you can’t see a doctor. So if they can just 
see the HLP pharmacy ... you’ve got that comfort of having someone there who knows what 
they’re talking about and they won’t give you a rubbish answer or you can just purchase 
something until you can actually see a doctor or you might not even have to, it depends on 
what the problem is.” HT7 
“They’re [HLPs] probably better for our community because you get more access to them, 
with the doctor’s surgery they are only open certain hours and the doctor is not always there, 
whereas we’re open 9-7 six days six days a week. So I think it’s better for the patients, it’s 
more access, they can speak to the pharmacist, they can speak to myself, they can speak to 
the other HT that we’ve got ... ” HT6 
3.3.16.2 Trusting relationships 
A number of interviewees commented on their HLP benefitting from a regular client base, which 
over a period of time had enabled development of trusting relationships between the pharmacist 
and regular patients. Trust was considered to be pivotal in patients’ feeling at ease to consult with 
the pharmacist and in some cases, to corroborate GPs’ diagnosis.  
“I think it’s more of the relationship that they build with the pharmacy, they see us day in and 
day out as they are coming in and it’s probably easier for them to approach us ... They’ll go 
to the doctor and they’ll come here, often they’ll say to the pharmacist, because of the 
relationship they have with him, often they will say ‘you know he [GP] said this to me and I’m 
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not sure’ and the pharmacist will be there for fifteen/twenty minutes reassuring them what 
the doctor has said because they have that trust in him ... ” HTC4 
“A lot of them, ... they’ve just come in and ask the pharmacist for his advice to see what he 
recommends. They’re very trust worthy with the pharmacist so if the pharmacist has asked 
them to do this or change their diet plan they are willing to have a go.” HTC1 
“I think it’s because it’s local [the HLP], especially around this area, as you can see there’s 
quite a lot of pharmacies, it’s local and they trust us like we’ve had a lot of customers more 
than thirty years so obviously the trust has been on the pharmacist for a very long time. So 
they just come for advice, it’s like a walk-in, you need no appointments so it’s easy to come 
and ask for advice.” HTC10 
3.3.17 PATIENTS’ UNDERSTANDING OF ‘HLP’ AND ‘HT’ TERMINOLOGY 
There was general agreement that understanding of the term ‘HLP’ at a local level was considered to 
be very poor. This was attributed to low levels literacy in English resulting in each word within the 
term being interpreted separately. Consequently, the meaning of the term ‘Healthy Living Pharmacy’ 
was misinterpreted as, the pharmacy team living healthily.  
“They think we’ve become healthy living so they don’t really understand, because a lot of 
people round here don’t speak English and they don’t understand English. You have to 
explain what HLP means. What they look at, is each single word so ‘healthy’ then ‘living’ then 
‘pharmacy’ but they don’t put it altogether, so you have to explain and say ‘we help you in 
your general life’ and then that’s when they get happy and think ‘oh ok, I need this, can you 
do this for me ... ” HT7 
The term ‘Health Trainer’ was also misinterpreted as being synonymous to the role of a fitness 
instructor. 
“ ... A lot of them, you know when we were doing the HT thing and they were like HT so 
you’re going to give me gym advice, so that kind of Health Trainer! Not like healthy lifestyle 
advice trainer. I think ‘HT’ seems to bring this gym thing and it’s quite funny ... ” HT6 
3.3.18 LEVEL OF LOCAL AWARENESS OF THE HLP CONCEPT AND HEALTH SERVICES PROVIDED 
There was general agreement that awareness of the HLP concept amongst the local population was 
low. 
“Since we’ve been accredited ... we’ve not had anyone walk in and notice that we are an HLP. 
Nobody has come in and questioned or noticed this. I personally haven’t had anyone come in 
and pick up on this [HLP status] ... ” HTC3 
“ ... People aren’t aware of it [HLP concept], nobody comes in here and says you’re one of 
those Healthy Living Pharmacies, people don’t know about it.” HTC8 
“There are a lot of people who are unsure about it [HLP concept] at the moment, they still 
don’t know that we run this scheme but we advertise as much as we can when they come in 
... ” HTC1 
“Well they [people who walk into the pharmacy] wouldn’t know anything [about the HLP 
concept] until I explained it to them.” HTC5 
However, HTC4 and HTC2 were both of the view that proactive promotion of the HLP had improved 
awareness of the HLP concept and generated patient enquiries regarding healthy living lifestyles. 
This view was also shared by a number of interviewees, who stated having noticed an increase in the 
number of patients enquiring about health services being offered, following HLP accreditation.  
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“Since we’ve been advertising HLP, we have got a lot of people come through here to ask for 
our advice and ask for information on healthy living and how we can help them or if we can’t 
we signpost them.” HTC2 
“I think they’re getting more aware of it now because we are promoting it, but before, they 
weren’t that aware of it, because for us we were running most of the services before and 
now we’ve just got that title and it’s something extra to work on and hopefully go on and do 
more services so they do understand ... so it’s just really we’ve been promoting it so they are 
more aware of it now.” HTC4 
“More busy and people actually coming for advice; if they pass and see the HLP kite mark 
they will actually come in and ask.” HTC10 
“The things that have changed are that we do get a lot more people coming in asking for 
more so instead of your regular patients you get a few other people coming in saying we 
want to do this or that so you’ve got to go out and talk to more people than you used to ... ” 
HT7 
Furthermore, some interviewees highlighted the role of the GP in aiding local awareness of the 
health services available via pharmacies, through patient referral. 
“Yes, we do a lot of the weight management - the doctor’s recommending now, so we will 
get patients coming from doctors’ surgeries.” HTC10 
“I think the GPs, they do help us out. The surgery from across the road they refer to us, if 
someone has phoned in for a cough or something minor and the receptionist normally does 
say to them ‘you can have an appointment for this day but you know across the road they 
run the minor ailment scheme’ so they’ve also recommended us because of the relationship 
we have with them and I’ve noticed even with the pregnancy testing, other local surgeries do 
refer their patients to us for the pregnancy test so that helps as well.” HTC4 
3.3.19 PROMOTIONAL ACTIVITIES UNDERTAKEN TO RAISE AWARENESS OF THE HLP CONCEPT 
HLP-led promotional activities to raise awareness of the HLP concept were undertaken by most 
interviewees, and generally included interviewees talking to clients to inform them about the HLP 
concept.  
“When they walk into the pharmacy ... the staff that are in the pharmacy tell patients or 
customers about what is an HLP and what services we provide and how it benefits them. 
Every pharmacy is trying to do that at the moment. It’s trying to advertise and making 
people aware that they can get stuff without going to the GP and making people aware of 
the help.” HTC2 
“Basically we bring it into the conversation because when we’re running the services, we’ll 
say to them ‘we’re an HLP now’ so then they’re more aware of it - just by telling them really.” 
HTC4 
Promotional materials such as posters, HLP leaflets, HLP banner etc. were also used to improve 
awareness of the HLP concept. Some interviewees reported having informed local GPs of the 
accreditation of the pharmacy as an HLP and one interviewee suggested that a mobile phone app 
had played a role in promoting HLP:  
“We are planning on getting some posters up and we’ve got an HLP signboard up there 
before we never had that, so when people see that they ask what it is about so you tell them 
all about that.” HT9 
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“Yes we have, we have been to a couple of surgeries and given out letters as well to our 
nearby surgeries that these are the services that we are providing if anyone is interested.” 
HTC10 
“We’re on the map more, I’m not sure how it works but someone phones them and then they 
get a message or a text saying ‘this is your nearest pharmacy’ so you can go there, more 
people are coming in, they are more aware of. I think we’ve been promoted more since that.” 
HTC4 
3.3.20 PROMOTIONAL ACTIVITIES UNDERTAKEN TO RAISE AWARENESS OF THE HEALTH SERVICES 
OFFERED BY HLPS 
Proactive promotion of health services was undertaken by all interviewees. The promotional 
materials used included posters (listing services being provided) displayed in the pharmacy window, 
leaflets and generating word of mouth.  
“We’ve got quite a few of these [leaflets] and we put them in people’s bags.” HT7 
“We advertise, we’ve got leaflets ... ” HTC2 
“Word of mouth, letting patients know when they come in if they question ‘do you provide 
this service’, we’ve got posters in the window saying what services we are providing, it does 
clearly state in the window what services we are providing, so anybody who notices that 
comes in and we take it from there.” HTC3 
Targeted promotion of health services and proactive recruitment of patients into services was 
commonplace through the provision of opportunistic health advice based on various prompts or as a 
result of identifying health needs during interactions with patients.  
“You’ve got to be careful not to offend anyone but you mostly go off a question that they’ve 
asked and that’s how you start the conversation and by their medication they normally do 
mention something and then you go on from their question and then you offer them the 
service that is available ... We also talk to our customers, even by having a normal 
conversation, they’ll mention something, maybe about quitting and we’ll say we run a Stop 
Smoking clinic ... “ HTC4 
3.3.21 PROMPTS WHICH INSTIGATED PROACTIVE PROMOTION OF HEALTH SERVICES 
• General observation 
“I remember once somebody came in and I was talking to them and I could smell that they 
smoke, so I was talking to them about the stop smoking services that we do ... Now he’s on 
the smoking cessation programme, which is really good.” HT9 
• Awareness of presenting health issues 
“When prescriptions come in, we look through the prescriptions like the asthmatics, we’ll ask 
them if they smoke or not or if they know how to use the inhaler because some of the 
patients do not know how to use inhaler, then we’ll refer them to the pharmacist and then 
the pharmacist himself will take them to a consulting room and talk them through how to 
use the inhaler ... In a general we would just ask, we would say these are the services we 
provide, if you are interested, if anyone else is interested then you can come in, book an 
appointment to see myself.” HTC10 
• Medicines listed on prescriptions or over the counter purchases 
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“Like for example if they are asthmatic and they’ve got a prescription for an inhaler and 
they’ve also wanted to purchase something over the counter for a chesty cough but more of 
a smokers cough we would advise them ‘would you like to try the stop smoking scheme or 
the reducing scheme’ and see if they want to join that because someone here is always 
trained to do the paperwork, to give them advice, even if they don’t want to join we do still 
give them advice and they can go back and think about it and they always come back. We 
get loads of patients bringing their scripts in for like heart medication, blood pressure, 
diabetes, overweight, whilst they’re waiting for medication, we give them leaflets to read 
through, if they’re unsure about anything then we can translate to them or give them advice 
... ” HTC1 
• New medication prompted the New Medication Service or Medicines Use Reviews 
Also when they come in we do MURs and NMS so whenever the pharmacist comes in and 
they are on new medication or they go through a medication, he can always say to them’ you 
need to do this or that and this is what we offer’ and stuff like that.” HT7 
3.3.22 VALUE PLACED ON THE HEALTH SERVICES PROVIDED BY HLPS 
This section provides an understanding of interviewees’ perceptions of the value placed by patients, 
health professionals and the PCT on the health services provided by HLPs. 
3.3.22.1 Patients 
Some interviewees were of the view that patients were appreciative of the health advice provided 
by HLP staff and welcomed being made aware of the range of services on offer. 
“It’s a positive response because everyone round here is friendly and caring so they would 
take your advice. Because they’re not too aware of all the schemes that are running they 
would be happy to hear that we provide it and they don’t have to see the doctor for it.” HTC1 
“We see a lot of patients coming in and they want to know a bit more about healthy living 
and about other things that we can provide for them and it is helping. Even with the healthy 
living, it is helping with our other services like smoking and it’s helping with our healthy life 
scheme, so healthy living is a good point ... ” HTC2 
HT6 and HTC2 also viewed repeat custom as an indication of customer satisfaction and value of the 
services provided by HLPs. 
“Yes because they’re the ones who are using us so it’s like the better service you provide they 
will come back to you, whether it be with prescriptions or they’re using your other services, 
you’re doing it for them.” HT6 
“Yes they do, our patients are really good and they are really happy with our services- that is 
why they come back ... ” HTC2 
3.3.22.2 Health professionals 
Referral of patients for pregnancy, blood pressure and diabetes tests was considered to be an 
indication of the value placed by local GPs on the services provided by HLPs. There was uncertainty 
as to whether this was a reflection of the value placed on the concept by GPs themselves or the 
value placed on HLPs by the staff of the practice more generally: 
“Our local GP, any pregnancy test he will send them to here to do the pregnancy test and 
blood pressure and glucose testing.” HT9 
 103 | P a g e  
 
Aston University HLP Study 
“Definitely by the receptionists and stuff, I don’t know with doctors and stuff because I don’t 
really speak to them but with the receptionists definitely yes.” HT6 
3.3.23 RECOMMENDATIONS 
3.3.23.1 Further training required to enable service improvement 
Two interviewees stated a desire for additional or refresher training to enhance their knowledge on 
health services to facilitate improvements to service delivery.  
“The health training is just like one thing, you should have a day where you can just go back 
in and they refresh your thoughts and things like that and then if there’s any more that can 
be added they can add things in.” HTC10 
“More training to train yourself more that would help to get more information, be able to 
deliver better advice to the customers.” HTC4 
3.3.23.2 Further training required to enable provision of blood pressure and diabetes 
tests  
A number of interviewees highlighted that both blood pressure and diabetes tests were often 
requested by patients. It was believed that this was a reflection of the high burden of cardiovascular 
disease and diabetes in the local community. Interviewees highlighted the need for additional 
training to enable delivery of these services.  
Interviewee: “Probably a bit more training. Interviewer: What specifically on? Interviewee: 
The diabetes stuff that we don’t do, the blood pressure that we kind of do but not officially, 
these services that we do, we already get quite a lot of training for those. It’s the services 
that might come in the future, definitely we’ll need training for those, more so because we 
don’t know, like I wouldn’t know how to do a diabetes check or anything like that and even if 
I did, I wouldn’t know what the results mean, like blood pressure test, to check the results, 
then we refer them to the pharmacist. I don’t know what is normal blood pressure, that kind 
of stuff.” HT6 
Blood pressure because I get a lot of patients coming in and asking if we take blood pressure 
in here and the other one is diabetes checking, so I think if we were able to provide those 
services as well it would benefit the community that we are working in because there are a 
lot of people that are diabetic and a lot of people that are on blood pressure medication, 
definitely two aspects that are worth looking into as well for us to be able to provide those 
services. Obviously we would have to be trained up and I think, I don’t know if training costs 
money or if there is anybody available to give us that training, I have mentioned a couple of 
times to the pharmacist that it would be nice if we could provide these additional services as 
well but nothing is ever done about it so I don’t know really. If somebody was able to provide 
us this training we’ve already got the place, the consultation room then we could provide 
these services with no problems. I’m always for doing anything that would benefit the 
patient but unfortunately we don’t have the training, we can only do what we’ve been 
trained up to do really.” HTC3 
“ ... We need more practical stuff, like I said before with the glucose one was practical, we 
could see how to do it properly, some of the other PCT training (after work, we work 9-7) we 
went to, we just talked about it. You don’t take much information in, some of them weren’t 
that helpful but if you do something practically, it sticks in your head.” HT9 
3.3.23.3 Improve the HTC course 
A number of interviewees suggested that the HTC course could be improved by the inclusion of 
content on the topics listed below: 
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• Asthma techniques 
• Skin conditions; it was believed that information on different skin conditions would enable 
pharmacy staff to better understand the needs of the many patients presenting with skin 
conditions, thereby enabling pharmacy staff to make knowledge-based recommendations. 
• Obesity; this was considered to be a prevailing health issue within the local community and 
that training would have been pertinent given that it is a sensitive issue for patients. 
3.3.23.4 Improve awareness of HLPs 
Two interviewees suggested that it was necessary for more pharmacies to become HLPs in order for 
the idea to become embedded in the public consciousness: 
“To be honest I think it’s a good idea and if more pharmacies were to become it [HLP] then I 
think more people would know about it [HLP] because you’ve got a few pharmacies, one here 
and one on that side and one there so you’ve got odd pharmacies and not everyone uses 
them ... If I didn’t work here I wouldn’t have a clue what an HLP is.” HT7 
“I think you need to advertise it [HLPs] a bit more and make people more aware that the 
service is here. Like an open day sort of thing, like a counter, something more eye catching, 
leaflets, a coffee morning, let them drop in.” HTC8 
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Chapter 4 STAGE C – THE VIEWS OF THE SERVICE USERS 
4.1 METHODOLOGY 
The service user questionnaire (see Appendix 5) was developed by the Aston research team to gain 
an understanding of service user experience of one of four health services (being reviewed i.e. SC, 
MAS, EHC and EPT) accessed via an HLP. A draft questionnaire was reviewed by the Steering Group, 
and following amendment, piloted amongst pharmacists from the Aston University Pharmacy 
Practice staff (who were not directly involved in the project). 
The final version of the questionnaire (see Appendix 5) was deployed electronically via the touch-
screen health-kiosks located in the ten HLPs included in the study. In addition to patients being 
signposted to the questionnaire by pharmacy staff, a poster was also displayed within each HLP 
highlighting the questionnaire and study (see Appendix 6). 
At the time of the study, the kiosks were owned by the Cluster; however, responsibility for the 
maintenance and management of the kiosks, including the online content (i.e. health-related 
information), was undertaken by Health Exchangeh CIC, a social enterprise.  
The Aston research team worked in close collaboration with Health Exchange to develop an effective 
method of deploying the questionnaire via the kiosks, whilst maintaining data security and 
confidentiality. The deployment plan entailed development of: 
1. Ten unique URLs (web-addresses) for the ten HLPs.  
o Ten distinct URLs were required to ensure that the questionnaire was only accessible 
via kiosks located in HLPs and not via kiosks located in non-HLPs. 
2. A distinctive touch-button on the display screen which, when clicked, navigated the service-
user directly to the questionnaire (ease of access to the questionnaire was considered 
important in encouraging participation). 
3. Data security measures to safeguard respondent data. This was achieved by firstly hosting 
the questionnaire on a secure Aston University server i.e. the electronic questionnaire files 
were saved in a secure folder on an Aston University server. The URL (link) to the folder 
containing the questionnaire files was then forwarded to Health Exchange for upload onto 
the touch screen system of the kiosks located in the ten HLPs included in the study. 
o This method of deployment ensured electronic transmission of encrypted data (from 
each completed questionnaire), directly to a member of the Aston research team, 
via an email.  
o The encrypted respondent data contained within the email was decrypted upon 
importing the email into the SNAP Surveysi software. 
Following the initial deployment of the questionnaire, two members of the Aston Research team, 
visited all HLPs to check if the questionnaire had been deployed successfully and to demonstrate the 
questionnaire to pharmacy staff. Technical issues related to the kiosks were evident and the 
questionnaire was not initially available for access at all the ten HLPs. The issues were resolved by 
Health Exchange and the questionnaire was subsequently launched on 15th August 2012 and closed 
on 15th February 2013. Kiosk malfunctions were reported intermittently by a small number of 
pharmacists throughout the duration but any problems were swiftly rectified and did not 
significantly impinge on data collection. 
                                                            
 
 
h Further information on Health Exchange CIC can be accessed via http://www.healthexchange.org.uk/about/. 
i See http://www.snapsurveys.com/. 
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All HLPs were kept informed (via weekly emails) of the number of questionnaires submitted per HLP 
for each of the four health services (SC, MAS, EHC, EPT).  
Note: The launch of the Aston HLP Study touch screen Service-User questionnaire coincided with the 
Royal Pharmaceutical Society’s paper-based questionnaire, which was prioritised by HLP pharmacists 
at the request of the Cluster. j 
4.2 RESULTS 
Descriptive statistics are presented for all returns received from the participating HLPs. A number of 
bivariate analyses were undertaken to determine whether there were associations between 
variables. Data were categorical in nature and where p-values are stated, they are a result of a chi-
squared test of association. 
4.2.1 NUMBER OF RETURNS 
In total, 445 service-users completed questionnaires via the touchscreen kiosk (aided, if appropriate, 
by a member of the pharmacy team). The returns received by the research team, split by individual 
pharmacy are as follows (see Table 28). 
Table 28: Questionnaire returns by pharmacy 
PHARMACYk NUMBER OF RETURNS (PERCENTAGE OF TOTAL RETURNS) 
Pharmacy A 40 (9.0%) 
Pharmacy B 17 (3.8%) 
Pharmacy C 19 (4.3%) 
Pharmacy D 36 (8.1%) 
Pharmacy E 27 (6.1%) 
Pharmacy F 5 (1.1%) 
Pharmacy G 78 (17.5%) 
Pharmacy H 151 (33.9%) 
Pharmacy I 17 (3.8%) 
Pharmacy J 55 (12.4%) 
TOTAL 445 (100.0%) 
Of the total number of respondents, 85.8% of questionnaire respondents (n=364/424) indicated that 
the HLP at which the questionnaire was completed was their regular pharmacy, with 14.2% 
(n=60/424) indicating that it wasn’t. A total number of n=21 respondents did not answer this 
question. 
4.2.2 NHS HEALTH SERVICE – CURRENT AND PAST ACCESS 
All respondents were then asked which of the four NHS health services within the study they had 
used at the pharmacy. Patients were only signposted to the study on the touchscreen kiosk if they 
had accessed one of the four services within the study; however, it was possible for respondents to 
complete the questionnaire without staff referral and therefore a proportion of respondents will not 
have accessed one of the four services in the study. 
This split between the four services is detailed in Table 29. By far the greatest number of 
respondents (41.3%; n=184/445) had accessed the pharmacy for the minor ailments service. 
Respondents answering “other” to this question were removed from the remainder of the data 
collection (n=68), leaving a remaining study total of n=377). 
                                                            
 
 
j The Aston University service-user questionnaire started on 15th August 2012 and completed on 15th February 2013. 
k The pharmacies have been randomly assigned a letter to preserve anonymity. 
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Table 29: Frequency of use of the different NHS health services 
NHS HEALTH SERVICE PERCENTAGE (n=445) 
Minor Ailments 41.3% (n=184) 
Early Pregnancy Testing 18.9% (n=84) 
Stop Smoking 17.3% (n=77) 
Other 15.3% (n=68) 
Emergency Hormonal Contraception 7.2% (n=32) 
Cross-tabulation of these data with responses to the question as to whether this pharmacy was their 
regular pharmacy did not show any statistically significant differences (Chi, n=424, p=0.136)l. 
The remaining respondents (n=377) were asked if this was the first time they had used the service 
that they had indicated in the previous question. Just over one third (37.8%, n=128/339) indicated it 
was with the remainder (62.2%, n=211) indicating it wasn’t. A total of n=38 individuals didn’t answer 
this question. Cross-tabulation of these data with responses to the question as to whether this 
pharmacy was their regular pharmacy indicated statistically significant differences with respondents 
answering from their regular pharmacy more likely to have used the service before (see Table 30) 
(p=0.002). 
Table 30: Results of the cross-tabulation between whether a respondent had used a particular NHS service before and 
whether they were responding from their regular pharmacy 
IS THIS YOUR REGULAR PHARMACY? (n=326) IS THIS THE FIRST TIME YOU HAVE USED ONE OF THESE NHS SERVICES? 
Yes (n=120) No (n=206) 
Yes (n=280) 33.2% (n=93) 66.8% (n=187) 
No (n=46) 58.7% (n=27) 41.3% (n=19) 
Further cross-tabulation with the responses related to the NHS health service accessed also 
indicated statistically significant differences (see Table 31) (p=0.001), with Minor Ailments service 
users much more likely to be repeat services users, followed by Stop smoking, Emergency Hormonal 
Contraception and finally Early Pregnancy Testing service users (see Table 31). 
Table 31: Results of the cross-tabulation between whether a respondent had used a particular NHS service before and 
the type of service accessed 
TYPE OF SERVICE (n=339) IS THIS THE FIRST TIME YOU HAVE USED ONE OF THESE NHS SERVICES? 
Yes (n=128) No (n=211) 
Minor ailments (n=161) 27.3% (n=44) 72.7% (n=117) 
Stop Smoking (n=70) 40.0% (n=28) 60.0% (n=42) 
Emergency Hormonal Contraception (n=30) 46.7% (n=14) 53.3% (n=16) 
Early Pregnancy Testing (n=78) 53.8% (n=42) 46.2% (n=36) 
Respondents who indicated that this wasn’t their first time of accessing one of these NHS health 
services (n=211) (or didn’t provide an answer to that question, n=38) were asked how long ago they 
last accessed one (n=249). The results are detailed in Table 32 (n=7 individuals didn’t answer this 
question). 
                                                            
 
 
l One cell indicated an expected frequency of less than 5. With the removal of all responses relating to “Emergency 
Hormonal Contraception” (n=31), the results of the cross-tabulation remained statistically insignificant (Chi, n=393, 
p=0.093). 
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Table 32: Time since repeat users last accessed any of the NHS health services 
TIME OF LAST ACCESS PERCENTAGE (n=242) 
Last week 18.6% (n=45) 
1-4 weeks ago 28.9% (n=70) 
1-3 months ago 26.9% (n=65) 
3-6 months ago 11.6% (n=28) 
More than 6 months ago 7.4% (n=18) 
Can’t remember 6.6% (n=16) 
4.2.3 PHARMACY STAFF 
Respondents (n=377) were asked which staff member they spoke to during their current visit. The 
results split as follows (see Table 33). A total of n=10 individuals didn’t answer this question. 
Table 33: Summary of the staff the respondents spoke to during their current visit 
STAFF MEMBER PERCENTAGE (n=367) 
Pharmacist 51.2% (n=188) 
Other staff 28.1% (n=103) 
Health Trainer 9.5% (n=35) 
Health Trainer Champion 6.3% (n=23) 
Not sure 4.9% (n=18) 
Respondents (n=377) were then asked who they would most have liked to have spoken to during 
their current visit. The results showed that a majority of respondents (49.2%; n=175/356) didn’t 
mind, and where respondents did have a preference, the pharmacists was the overwhelming choice 
(43.0%; n=153/356). The full results split as follows (see Table 34). A total of n=21 respondents didn’t 
answer this question. 
Table 34: Summary of the staff member the respondents would most like to have seen during their current visit 
STAFF MEMBER PERCENTAGE (n=356) 
I don’t mind 49.2% (n=175) 
Pharmacist 43.0% (n=153) 
Health Trainer 5.6% (n=20) 
Health Trainer Champion 2.2% (n=8) 
Respondents were then asked a series of questions about the staff member who provided advice on 
their current visit. Results are detailed in Table 35. A total number of n=9, n=20 and n=24 
respondents respectively didn’t answer these questions. 
Table 35: Respondents’ responses to a series of statements relating to the staff member who provided advice on their 
current visit 
 STRONGLY 
AGREE 
AGREE NEITHER 
AGREE NOR 
DISAGREE 
DISAGREE STRONGLY 
DISAGREE 
The person I spoke to today, had enough 
time to deal with my enquiry (n=368). 
71.2% 
(n=262) 
26.9%  
(n=99) 
1.1%  
(n=4) 
0.5% 
(n=2) 
0.3% 
 (n=1) 
I felt comfortable talking about my 
health with the person I spoke to today 
(n=357). 
65.5% 
(n=234) 
31.9% 
(n=114) 
1.7%  
(n=6) 
0.6%  
(n=2) 
0.3%  
(n=1) 
I would like to be seen by the same 
person every time (n=353). 
56.1% 
(n=198) 
26.9% 
 (n=95) 
15.3%  
(n=54) 
1.4%  
(n=5) 
0.3%  
(n=1) 
Overall, respondents either Strongly Agreed or Agreed with all statements, indicating that they were 
generally satisfied with the staff member they saw during their visit and would want to deal with the 
same staff member again. 
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4.2.4 THE HEALTH ADVICE 
Respondents were then asked a series of questions about the health advice they received on their 
current visit. Results are detailed in Table 36. A total of n=16, n=25 and n=30 respondents 
respectively didn’t answer these questions. As with responses to the questions about the staff 
member the respondents saw, respondents were also happy with the advice provided during their 
visit with a majority of respondents who either Strongly Agreed or Agreed that the advice was easy 
to understand, that they trusted the advice and that they were satisfied with the advice provided. 
Table 36: Respondents’ responses to a series of statements relating to the health advice they received on their current 
visit 
 STRONGLY 
AGREE 
AGREE NEITHER 
AGREE NOR 
DISAGREE 
DISAGREE STRONGLY 
DISAGREE 
The health advice I was given was easy 
to understand (n=361). 
70.1% 
(n=253) 
28.3% 
(n=102) 
1.4% 
 (n=5) 
0.0%  
(n=0) 
0.3% 
 (n=1) 
I trust the health advice given to me 
(n=352). 
69.0% 
(n=243) 
28.1% 
 (n=99) 
2.3% 
 (n=8) 
0.3%  
(n=1) 
0.3%  
(n=1) 
I am satisfied with the health advice 
provided (n=347). 
68.0% 
(n=236) 
29.7% 
(n=103) 
2.0%  
(n=7) 
0.0% 
 (n=0) 
0.3%  
(n=1) 
Respondents were then asked a further series of questions regarding the health advice they 
accessed at the pharmacy during their current visit. Results are detailed in Table 37. A total of n=11, 
n=23, n=20 and n=21 respondents respectively didn’t answer these questions. 
Table 37: Respondents’ responses to a further series of statements relating to the health advice they received on their 
current visit 
 STRONGLY 
AGREE 
AGREE NEITHER 
AGREE NOR 
DISAGREE 
DISAGREE STRONGLY 
DISAGREE 
I preferred to go to a pharmacy to get 
health advice rather than going to my 
GP (doctor) (n=366). 
56.6% 
(n=207) 
30.1% 
(n=110) 
10.7% 
 (n=39) 
2.5% 
 (n=9) 
0.3%  
(n=1) 
Pharmacy opening times are more 
convenient than GP (doctor) opening 
times (n=354). 
63.8% 
(n=226) 
33.3% 
(n=118) 
2.3%  
(n=8) 
0.3% 
 (n=1) 
0.3%  
(n=1) 
Getting health advice at {this pharmacy} 
when I need it, has helped me to take 
better care of myself (n=357). 
58.0% 
(n=207) 
37.8% 
(n=135) 
3.9%  
(n=14) 
0.0%  
(n=0) 
0.3%  
(n=1) 
I would recommend the NHS health 
service I have used at {this pharmacy} to 
friends or family (n=356). 
68.5% 
(n=244) 
30.1% 
(n=107) 
1.1%  
(n=4) 
0.0% 
 (n=0) 
0.3%  
(n=1) 
With responses to these questions, as with others, a majority of respondents either Strongly Agreed 
or Agreed that they preferred to go to the pharmacy than their GP for health advice and that the 
opening times were more convenient than the opening times of their GP surgery. In addition, a 
majority of respondents either Strongly Agreed or Agreed that the advice helped them take better 
care of themselves and that they would recommend the health service they accessed to friends or 
family. 
4.2.5 LOCATION OF CONSULTATION 
Respondents were asked if the consultation which formed part of their last visit took place in a 
private room. Nearly three-quarters of respondents (70.2%, n=214/305) stated it did, with 29.8% 
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(n=91) stating it did not (72 respondents didn’t answer this question). Cross-tabulation of these data 
with whether the respondent was in their regular pharmacy did not show any statistically significant 
difference (p=0.276). However, further cross-tabulation with the health services accessed did show a 
statistically significant difference (see Table 38; p=<0.0001), with over three-quarters of 
consultations for all services except Minor Ailments taking place in a private room. 
Table 38: Results of the cross-tabulation between whether a respondent’s consultation took place in a private room and 
the type of service used 
TYPE OF SERVICE (n=305) DID THE CONSULTATION TAKE PLACE IN A PRIVATE ROOM? 
Yes (n=214) No (n=91) 
Stop Smoking (n=64) 95.3% (n=61) 4.7% (n=3) 
Early Pregnancy Testing (71) 88.7% (n=63) 11.3% (n=8) 
Emergency Hormonal Contraception (n=21) 76.2% (n=16) 23.8% (n=5) 
Minor Ailments (n=149) 49.7% (n=74) 50.3% (n=75) 
Further cross-tabulation with whether this was the first time the respondent had accessed one of 
these NHS services also showed a statistically significant difference (see Table 39; p=0.013) with 
respondents more likely to be taken into a private room if this was the first time they had accessed a 
particular service. 
Table 39: Results of the cross-tabulation between whether a respondent’s consultation took place in a private room and 
whether this was the first time the respondent had accessed one of these NHS services 
IS THIS THE FIRST TIME YOU HAVE USED ONE OF THESE 
NHS SERVICES? (n=278) 
DID THE CONSULTATION TAKE PLACE IN A PRIVATE ROOM? 
Yes (n=196) No (n=82) 
Yes (n=104) 79.8% (n=83) 20.2% (n=21) 
No (n=174) 64.9% (n=113) 35.1% (n=61) 
Further analysis by the member of staff who provided advice also indicated statistically significant 
differences (see Table 40; p<0.0001)m with services delivered by pharmacists being more likely to 
take place in a private room than services delivered by other staff members. 
Table 40: Results of the cross-tabulation between whether a respondent’s consultation took place in a private room and 
the member of staff who provided the advice 
STAFF MEMBER (n=299) DID THE CONSULTATION TAKE PLACE IN A PRIVATE ROOM? 
Yes (n=210) No (n=89) 
Pharmacist (n=151) 82.8% (n=125) 17.2% (n=26) 
Health Trainer Champion (n=20) 75.0% (n=15) 25.0% (n=5) 
Not sure (n=15) 66.7% (n=10) 33.3% (n=5) 
Health Trainer (n=33) 63.6% (n=21) 36.4% (n=12) 
Other staff (n=80) 48.8% (n=39) 51.2% (n=41) 
Owing to the fact that a majority of respondents either Strongly Agreed or Agreed with the range of 
statements relating to the pharmacy staff (see above), full cross-tabular analysis was statistically 
invalid. However cross-tabular analysis on the agreement level options for the statement relating to 
whether the staff member had sufficient time did indicate differences whereby respondents were 
more likely to strongly agree to the statement if they had not undertaken a consultation within a 
private room (see Table 41; p=0.022). 
                                                            
 
 
m One cell indicated an expected frequency of less than 5. With the removal of all responses relating to “Not sure” (n=15), 
the results of the cross-tabulation remained statistically significant (p<0.0001). 
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Table 41: Results of the cross-tabulation with the agreement level from respondents for the statement relating to 
whether the staff member had sufficient time and whether a respondent’s consultation took place within a private 
room 
THE PERSON I SPOKE TO TODAY, HAD ENOUGH TIME TO 
DEAL WITH MY ENQUIRY (n=294)n 
DID THE CONSULTATION TAKE PLACE IN A PRIVATE ROOM? 
Yes (n=206) No (n=88) 
Strongly Agree (n=212) 68.0% (n=140) 81.8% (n=72) 
Agree (n=82) 32.0% (n=66) 18.2% (n=16) 
When asked about the importance of talking in private about their health, over ninety present either 
strongly agreed (59.6%, n=218/366) or agreed (31.1% (n=114) with this statement (Neither agree nor 
disagree, 7.9%, n=29); Disagree, 1.1%, n=4; Strongly Disagree, 0.3%, n=1). 
4.2.6 AWARENESS OF HEALTHY LIVING PHARMACIES 
Respondents were asked if they had heard about Healthy Living Pharmacies, with 68.1% 
(n=252/370) indicating that they had (with 31.9% (n=118) indicating that they hadn’t). A total n=7 
respondents did not answer this question. Cross-tabulation of these results with whether the 
pharmacy was the respondent’s regular pharmacy indicated that respondents answering from their 
regular pharmacy were much more likely to have heard of Healthy Living Pharmacies (see Table 42; 
p<0.0001). 
Table 42: Results of the cross-tabulation between whether respondents had heard of Healthy Living Pharmacies and 
whether they were responding from their regular pharmacy 
IS THIS YOUR REGULAR PHARMACY (n=354) HAVE YOU HEARD ABOUT HEALTHY LIVING PHARMACIES? 
Yes (n=240) No (n=114) 
Yes (n=306) 71.6% (n=219) 28.4% (n=87) 
No (n=48) 43.8% (n=21) 56.2% (n=27) 
Respondents were also asked if they were aware that the pharmacy they were in was a Healthy 
Living Pharmacy. A similar percentage (68.7%, n=252/367) responded that they were aware (with 
31.3% (n=115) indicating that they were not aware). A total of n=10 respondents did not answer this 
question. As before, respondents who were answering from their regular pharmacy were more likely 
to be aware that the pharmacy was a Healthy Living Pharmacy (see Table 43; p<0.0001). 
Table 43: Results of the cross-tabulation between whether respondents were aware that the pharmacy they were in was 
a Healthy Living Pharmacy and whether they were responding from their regular pharmacy 
IS THIS YOUR REGULAR PHARMACY 
(n=351) 
DID YOU KNOW THAT THIS PHARMACY IS A HEALTHY LIVING PHARMACY? 
Yes (n=242) No (n=109) 
Yes (n=303) 72.6% (n=220) 27.4% (n=83) 
No (n=48) 45.8% (n=22) 54.2% (n=26) 
Owing to the fact that a majority of respondents either Strongly Agreed or Agreed with the range of 
statements relating to the health advice (see above), full cross-tabular analysis was statistically 
invalid. However cross-tabular analysis on the agreement level options for the statement relating to 
whether the respondent trusted the advice given to them did indicate differences whereby 
respondents were more likely to strongly agree to the statement if they knew the pharmacy was a 
Healthy Living Pharmacy (see Table 44; p=0.020). 
                                                            
 
 
n Cross-tabulation was only undertaken for respondents who answered “Strongly agree” or “agree” to this question as 
numbers of respondents who answered “Neither agree nor disagree”, “Disagree” or “Strongly disagree” were minimal 
making any statistical comparisons invalid. 
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Table 44: Results of the cross-tabulation between whether respondents were aware that the pharmacy they were in was 
a Healthy Living Pharmacy and whether they trusted the health advice given 
I TRUST THE HEALTH ADVICE GIVEN 
TO ME (n=334)o 
DID YOU KNOW THAT THIS PHARMACY IS A HEALTHY LIVING PHARMACY? 
Yes (n=234) No (n=100) 
Strongly Agree (n=235) 74.4% (n=174) 61.0% (n=61) 
Agree (n=99) 25.6% (n=60) 39.0% (n=39) 
Next, respondents were asked how they became aware of the NHS Health Service they used during 
their current visit. The results are summarised in Table 45 (respondents could select more than one 
option) with awareness via pharmacy staff (44.7%, n=180/377) being the most frequent response. 
Table 45: How respondents became aware of the NHS Health Service they used 
METHOD NUMBER OF RESPONSES (PERCENTAGE OF VALID RESPONDENTS) 
Pharmacy staff 180 (47.7%) 
Friends/family 95 (25.2%) 
Word of mouth 87 (23.1%) 
Advertisement 58 (15.4%) 
GP 46 (12.2%) 
Other 7 (1.9%) 
Furthermore, respondents were asked where they had seen any advertisements relating to Healthy 
Living Pharmacies. The results are summarised in Table 46 (respondents could select more than one 
option) with advertisements in pharmacies (70.3%, n=265/377) being the most frequent response. 
Table 46: Where respondents had seen any advertisements relating to Healthy Living Pharmacies 
METHOD NUMBER OF RESPONSES (PERCENTAGE OF VALID RESPONDENTS) 
In a pharmacy 265 (70.3%) 
Don’t remember seeing any 55 (14.6%) 
On the local NHS website 46 (12.2%) 
At an NHS roadshow 21 (5.6%) 
Other 20 (5.3%) 
Finally, in this section, respondents were asked if they had seen any of the Healthy Living Pharmacy 
logos. The results are summarised in Table 47 (respondents could both logos). 
Table 47: Healthy Living Pharmacy logos seen by respondents 
LOGO NUMBER OF RESPONSES (PERCENTAGE OF VALID RESPONDENTS) 
HLP Kitemark 255 (67.6%) 
“First Stop Pharmacy” 194 (51.5%) 
Have not seen either 53 (14.1%) 
4.2.7 DEMOGRAPHICS OF RESPONDENTS 
The gender of respondents was provided as follows (see Table 48; 51 respondents did not answer 
this question), with female respondents making up the greater proportion 70.6%, n=230/326). 
                                                            
 
 
o Cross-tabulation was only undertaken for respondents who answered “Strongly agree” or “agree” to this question as 
numbers of respondents who answered “Neither agree nor disagree”, “Disagree” or “Strongly disagree” were minimal 
making any statistical comparisons invalid. 
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Table 48: Gender of respondents 
GENDER PERCENTAGE (n=326) 
Female 70.6% (n=230) 
Male 27.3% (n=89) 
Do not want to say  2.1% (n=7) 
The age of respondents was provided as follows (see Table 49; 5 respondents did not answer this 
question). 
Table 49: Age of respondents 
AGE RANGE PERCENTAGE (n=372) 
Under 18 4.0% (n=15) 
18-19 3.5% (n=13) 
20-29 28.0% (n=104) 
30-39 34.7% (n=129) 
40-49 15.9% (n=59) 
50-59 5.1% (n=19) 
60-69 6.2% (n=23) 
70-79 1.3% (n=5) 
80 and over 0.0% (n=0) 
Do not want to say 1.3% (n=5) 
The ethnic group of respondents was provided as follows (see Table 50; 2 respondents did not 
answer this question). 
Table 50: Ethnic group of respondents 
ETHNIC GROUP PERCENTAGE (n=375) 
Pakistani 40.3% (n=151) 
Bangladeshi 11.7% (n=44) 
Indian 10.1% (n=38) 
English/Welsh/Scottish/Northern Irish/British 9.9% (n=37) 
Caribbean 6.1% (n=23) 
Arab 3.5% (n=13) 
Do not want to say 3.5% (n=13) 
African 3.2% (n=12) 
White and Asian 3.2% (n=12) 
White and Black Caribbean 2.1% (n=8) 
Any other Black/African/Caribbean background 1.9% (n=7) 
Irish 1.3% (n=5) 
Any other Asian background 0.8% (n=3) 
Any other ethnic group 0.8% (n=3) 
White and Black African 0.8% (n=3) 
Any other Mixed/Multiple ethnic Background 0.5% (n=2) 
Any other white background 0.3% (n=1) 
Gypsy or Irish Traveller 0.0% (n=0) 
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Chapter 5 Discussion and Conclusions 
5.1 SUMMARY OF PROJECT FINDINGS FROM STAGE A 
5.1.1 SMOKING CESSATION 
Almost three-quarters of participants accessing the smoking cessation scheme via community 
pharmacies between 1st April 2011 and 31st October 2013 were from the most deprived quintile of 
Lower Super Output Areas (LSOAs) in England. Participants accessing the smoking cessation scheme 
via community pharmacies were more likely to be female than participants accessing NHS Stop 
Smoking services (i.e. NHS funded smoking cessation services provided across all settings including 
GPs and pharmacies) in HoBtPCT between April 2012 and March 2013 (41% of all participants and 
35% of all participants respectively).50 The age profile of participants accessing the smoking cessation 
scheme via community pharmacies was broadly similar to that of those accessing wider NHS Stop 
Smoking services in HoBtPCT.50 Data on the ethnicity and occupational status of participants 
accessing NHS Stop Smoking Services in HoBtPCT were not available for comparison. 
Almost half (48%) of all participants enrolled onto the smoking cessation programme between 1st 
April 2011 and 31st October 2013 had successfully stopped smoking four weeks post-enrolment. This 
is slightly lower than the comparable figure for people accessing NHS Stop Smoking services in 
England between April 2012 and March 2013 (52%) but identical to the comparable figure for people 
accessing NHS Stop Smoking services in HoBtPCT between April 2012 and March 2013 (48%).50 When 
examining quit rates at four weeks in pharmacy-specific smoking cessation programmes, the quit 
rate reported in the present study is similar to that reported in pharmacy-based programmes in 
Sheffield, Hereford and North Yorkshire.51 
Older participants and male participants had higher quit rates than younger participants and female 
participants. This reflects patterns observed across both HoBtPCT and England.50 Participants from 
higher occupational groups were also more likely to successfully quit than those from lower 
occupational groups. While data from NHS Stop Smoking services concerning differential quit rates 
dependent on occupational status is not available, previous research has also suggested that those 
from higher socioeconomic groups are more likely to successfully quit than those from lower 
socioeconomic groups.52–54 
Participants in HLPs were older and were more likely to have been male, been from a black or 
minority ethnic group, have never worked or been long-term unemployed, and been from the most 
deprived areas of central Birmingham than participants at non-HLPs. While quit rates were slightly 
higher in non-HLPs than in HLPs, this difference was not statistically significant. Given the 
associations observed between quit rates and demographic characteristics, when comparing 
outcomes data between HLPs and non-HLPs, this heterogeneity in demographics should be 
considered. 
To examine the effects of HLP accreditation on the provision of the smoking cessation programme, 
data covering quarter 3 (July-September) 2011 were compared with data from a period after which 6 
HLPs had received their accreditation (quarter 3 (July-September) 2012). Data from the same 
quarter of each year were selected to minimise the impact of seasonal variations in both activity and 
quit success rates. 
Activity rates in the post-accreditation period were 12% lower than in the pre-accreditation period. 
A 12% reduction in activity was also seen between quarter 3 2011 and quarter 3 2012 nationally.50 
Whilst the number of consultations in non-HLPs was 14% lower in the post-accreditation period than 
in the pre-accreditation period, the number of consultations in HLPs was 7% higher post-
accreditation than in the pre-accreditation period. An increase in smoking cessation activity was also 
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observed in the post-accreditation period in the evaluation of the national HLP pathfinder 
programme although, in both that evaluation and in the present one, any increase in activity cannot 
be claimed to be as a result of HLP accreditation.7 
Overall, participants with a 4 week quit date in quarter 3 of 2012 were slightly less likely to have 
successfully quit smoking than participants who had set a quit date in quarter 3 of 2011 although 
this difference was not statistically significant. The decrease in the proportion of participants 
successfully quitting at four weeks between the pre-accreditation and post-accreditation period was 
more pronounced in HLPs (53% pre-accreditation versus 41% post-accreditation) than in non-HLPs 
(48% versus 48%). Data from the pathfinder evaluation are inconclusive as to the effect of HLP 
accreditation on quit rates with increases in quit rates recorded in some areas and decreases in 
others.7 There was no evidence to suggest that HLP accreditation in HoBtPCT improved quit rates in 
smoking cessation services. 
5.1.2 MINOR AILMENTS SCHEME 
In the period from 1st January 2012 to 31st November 2012, there were a total of 194,315 MAS 
consultations. Where Indices of Multiple Deprivation (IMD) 2010 scores could be matched to 
participants’ postcodes, over 90% of these consultations were with individuals resident in the most 
deprived quintile of LSOAs in England. The mean number of consultations per pharmacy per month 
was higher in non-HLPs than in HLPs in all eleven months studied. The mean number of 
consultations per HLP increased post-accreditation but this increase was not statistically significant 
and was in line with the year-on-year increase in the number of MAS consultations between 2011 
and 2012. An increase in the mean number of consultations per HLP in the period post-accreditation 
was also observed in the small number of pharmacies in the three areas examined in the evaluation 
of the HLP pathfinder programme (although no indication is provided in the evaluation report as to 
whether these increases were statistically significant).7 Costs per consultation (excluding drug costs) 
were higher in HLPs (£2.13 per consultation) than in non-HLPs (£1.79 per consultation) although this 
difference was not statistically significant. 
Headache/earache/temperature was the subject of over half of all MAS consultations. Given this, it 
is unsurprising that analgesics (paracetamol or ibuprofen) were also supplied in an identical 
proportion of consultations. One aspect of the medicines supplied via the MAS which may be a focus 
for rationalisation in the future is the provision of medicines which are not supported by a robust 
evidence base. For example, there were 16,068 supplies of Simple Linctus Paediatric (200 ml), 
14,997 supplies of Simple Linctus (200 ml) and 2071 supplies of Dentinox Teething Gel (15 g). Using 
data from the November 2012 Drug Tariff and the Boots website (for Dentinox Teething Gel as no 
figure for this product is provided in the Drug Tariff), the total spend on these products was 
£32,779.64.55,56 
In almost every consultation the patient reported that they would have consulted their GP in the 
absence of the service (99.9% HLP, 98.2% non-HLP, 98.4% overall). This proportion is higher than the 
proportion reported in other evaluations of MASs (47-92%).36 Based on the proportion of 
participants reporting that they would have consulted their GP in the absence of the service, the 
cost per consultation and figures for GP costs from the widely used Unit Costs of Health and Social 
Care, the ‘savings’ to the NHS produced by diversion of participants from GPs to participating 
pharmacies for minor ailments consultations are estimated to be around £2,000,000 per annum.48 
Whilst the HoBtPCT MAS may reduce demand amongst GPs for minor ailment consultations the 
extent to which MASs shift demand away from higher to lower cost settings is yet to be established 
and there is no evidence to suggest that the MAS reduces overall demand for GP time.36 
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Patients accessing the MAS via HLPs were more likely to report having heard about the MAS through 
promotional material than patients at non-HLPs. Furthermore, the proportion of patients accessing 
the MAS via HLPs who reported that they had heard about the scheme via promotional materials 
was higher in the post-accreditation period than in the pre-accreditation period. This may be a 
reflection on the emphasis placed on proactive health promotion and accessibility as part of the HLP 
programme in HoBtPCT. 
5.1.3 EMERGENCY HORMONAL CONTRACEPTION 
Data collection yielded very few observations relating to provision of EHC via PGD in HLPs. 
Observations from comparator non-HLPs were even scarcer. However, the data retrieved highlight 
that over three-quarters of individuals accessing the scheme were normally resident in the most 
deprived quintile of LSOAs in England. In addition, the data suggest that accreditation as an HLP did 
not appear to have any significant effect on activity. 
5.1.4 EARLY PREGNANCY TESTING 
Nine out of every ten people accessing the EPT programme were from the most deprived quintile of 
LSOAs in England. People who accessed EPT via non-HLPs were more likely to be from the two most 
deprived quintiles within the cohort accessing EPT. There was an overall trend of fewer consultations 
taking place in the post-accreditation periods than in the pre-accreditation periods. This trend was 
most pronounced in HLPs where 42% of consultations took place post-accreditation. This is in 
marked contrast to provision in non-HLPs where provision increased in the post-accreditation 
periods (53%). Neither of these observations can be attributed to accreditation as an HLP. 
5.1.5 LIMITATIONS OF THE APPROACH ADOPTED FOR STAGE A 
The approach utilised for the analysis of services data can broadly be described as a non- 
randomised, retrospective, observational comparison of provision of the stated services in HLPs and 
non-HLPs. The lack of randomisation of service users to either an intervention (i.e. HLP) group or a 
control (i.e. non-HLP) group led to heterogeneity between some comparator groups and means that 
any associations between HLP status and service activity and/or quality levels cannot be causally 
attributed to HLP accreditation status (they may, for example, be a result of bias introduced by the 
heterogeneity between groups). 
Wherever possible, data were collected from as many non-HLPs as possible (i.e. for the SC and MAS 
analyses) so as to avoid the introduction of any selection bias which may have resulted from the 
selection of specific non-HLP comparator pharmacies. However, when considering the results of the 
EHC and EPT services – where, owing to the nature of the available data, and the time and financial 
constraints of the project, specific comparator pharmacies were identified – selection bias may have 
been introduced. Some heterogeneity between HLP and non-HLPs was observed in these small 
cohorts and is reported in the relevant results sections. 
5.2  SUMMARY OF PROJECT FINDINGS FROM STAGE B 
5.2.1 MOTIVES FOR ENGAGEMENT WITH THE HLP PROGRAMME 
The majority of interviewees reported that they were undaunted by the HLP accreditation criteria as 
they were already meeting most of the accreditation criteria prior to engaging in the HLP 
programme.  
The most commonly reported motivation for engagement with the HLP programme was that 
accreditation as an HLP would differentiate the pharmacy from other, competitor pharmacies. It was 
believed that HLP accreditation would identify the pharmacy as being one which could be relied 
upon, by both patients and NHS commissioners, to provide consistently high quality services. 
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Pharmacists believed that pharmacies with HLP accreditation would come to be seen as ‘preferred 
providers’ of future locally commissioned services therefore securing their pharmacies a competitive 
advantage over non-HLPs and helping to ensure the financial sustainability of their businesses in the 
short- to medium-term. Similar views were expressed by interviewees in an evaluation of the HLP 
programme in Portsmouth.14 
The other prime motive for engagement in the HLP programme was an altruistic desire on the part 
of pharmacists to improve the health of the communities which they serve. Pharmacists expressed a 
desire to combat the preeminent health problems in their localities with many pharmacists also 
describing their proactive approaches to providing health-improving services, including the provision 
of an isolated number of interventions without any NHS funding. An intrinsic motivation to improve 
the health of their local population was also identified as an important driver for HLP engagement in 
Portsmouth.14 
5.2.2 CHALLENGES TO IMPLEMENTATION OF THE HLP PROGRAMME 
While Interviewees were positive about the opportunities offered by HLP accreditation, a number of 
challenges to the successful implementation of the HLP programme were identified. These included: 
• Role extension placing ever greater pressures on pharmacist workload particularly in the 
context of year-on-year increases in the volumes of prescriptions to be dispensed. 
• Remuneration for extended services being insufficient to cover recruitment of extra staff to 
accommodate for an increasing workload. 
• In the light of the above, precedence being given to the dispensing of prescriptions amidst fear 
of regulatory action being taken against the pharmacist in the event of a dispensing error. 
• Poor recognition of the HLP brand as a quality kite mark by members of the public primarily as a 
failure of the PCT-led marketing and promotional activities.  
• A difficulty in persuading clients of the differences in daily operations before and after 
accreditation as the local populations were accustomed to accessing health services via 
pharmacies for several years before the introduction of HLPs. 
• Some interviewees did not consider that the HT/HTC training had been of benefit in altering and 
developing their practice. 
• A lack of clarity amongst pharmacists as to the differences in the defined roles of HTs/HTCs. 
Workload pressures and inadequate levels of remuneration were also highlighted as particular 
challenges to successful implementation of HLPs by pharmacy staff interviewed as part of an 
evaluation of HLPs in Portsmouth.14 
5.2.3 EFFECTS OF HLP ACCREDITATION ON PHARMACY STAFF 
The majority of HTs/HTCs felt: 
• Able to consult pharmacists readily about any issues they had regarding their working practice.  
• Supported by their employer in their ‘new’ role, a role which had become more ‘client-centred’ 
and this had led to HTs/HTCs feeling ‘valued’ by their employer. 
Echoing the results from qualitative interviews undertaken with pharmacy staff in Portsmouth HLPs, 
HTs and HTCs were highly motivated to support the HLP objectives and this was inextricably linked 
to job satisfaction.14 The majority of HTs/HTCs felt a sense of achievement and pride in fulfilling a 
health-service related role and were of the view that patients valued and appreciated the 
advice/health service provided. 
However, HTs/HTCs reported that peer support was virtually non-existent. There was no 
communications amongst HTs/HTCs working in different pharmacies and there was a belief that 
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peer networking would be valuable in enabling transfer of knowledge and sharing of best practice 
amongst HTs and HTCs to facilitate continued improvement of service delivery in HLPs. The 
experience of HTs/HTCs in Birmingham is in marked contrast to their colleagues in Portsmouth who 
reported that a “pharmacy community” had been created by the HLP programme with pharmacies 
working together in an attempt to improve outcomes.14 
To summarise the views of the pharmacy staff interviewed in the study, a SWOT analysis was 
undertaken and the findings are summarised in Figure 6. 
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Figure 6: SWOT analysis of the internal and external challenges faced by pharmacy staff interviewed in the study 
STRENGTHS WEAKNESS  
• All pharmacies in the sample group 
had several years of experience of 
delivering Health services prior to the 
roll-out of the HLP programme. 
Consequently, there was good 
awareness (at a local level) of the 
availability of health services via 
community pharmacies. 
• The majority of pharmacists who 
undertook HLP accreditation were 
already meeting most of the HLP 
accreditation criteria prior to 
embarking upon HLP accreditation. 
• Extended opening hours; providing 
convenient access to 
health/pharmaceutical services. 
• Pharmacists’ reputations established 
over many years resulting in the 
development of trusting relationships 
with local communities. 
• Pharmacists’ familiarity with their 
clientele and with successive 
generations; enabling continuity of 
care. 
• A culture of continuous training (of 
the pharmacy team) resulting in the 
development of a multi-skilled 
workforce, enabling pharmacists to 
delegate certain health-service 
related tasks to appropriately trained 
staff, thereby reducing pharmacists’ 
work burden.  
• Multi-lingual pharmacy teams 
conversant in the dominant languages 
spoken in HoB facilitated 
communication with clientele not 
fluent in English. 
• Pharmacists with good relationships 
with the local GP(s) benefitted from 
GP referrals. 
• Barriers to communication 
experienced with newly established 
communities i.e. Eastern European 
and Somali. 
• Difficulties experienced with 
establishing relationships with multi-
partner GP practices. 
• Perception that GPs were generally 
unaware of the extended role of 
pharmacists. 
OPPORTUNITIES THREATS 
• The HLP programme; as a means of 
differentiation to gain a competitive 
advantage. 
• Uncertainty about the future financial 
sustainability in a highly competitive 
arena. 
• Demanding consumer expectations 
resulting in the need to maintain 
reputations. 
• Fear of negative word of mouth. 
• Uncertainty of the impact of the NHS 
reforms on commissioned services. 
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5.3 SUMMARY OF PROJECT FINDINGS FROM STAGE C 
5.3.1 KEY FINDINGS 
The collated returns from the service user questionnaire provided a useful snapshot of the views of 
service users who accessed HLPs for all four services within the study (Early Pregnancy Testing, 
Emergency Hormonal Contraception, Minor Ailments and Stop Smoking). The majority of 
respondents were female and most were between 20-49 years of age. By far the greatest number of 
responses was received from respondents who classified themselves as being from the Pakistani 
ethnic grouping. 
Variability was seen from the responses in the number of consultations for the different services, 
with a majority of responses from service users who had accessed the HLP for the Minor Ailments 
service. However, consideration should be given to the fact that the proportion of services users 
who may complete a questionnaire would be expected to vary by service type (with, for example, 
service users accessing a sexual health-related service potentially being less likely to complete a 
questionnaire). A majority of respondents were in their regular pharmacy and around two thirds 
were accessing the service for the first time. Respondents accessing the Minor Ailments service were 
also more likely to be repeat service users than respondents from the other three service areas. 
Overall, there was strong support for the staff member who provided the service, with a majority of 
respondents stating that they were seen by the pharmacist (as opposed to any other pharmacy staff 
member), but with slightly fewer stating that they would prefer the pharmacist over other staff 
members (with either the pharmacist or no particular preference being the core choices). There was 
strong agreement with a series of statements relating to the staff member the respondent 
interacted with, indicating that they were happy with the amount of time the staff member had to 
deal with the enquiry, how comfortable they felt dealing with that member of staff and indicating a 
wish to be seen by the same staff member again. 
Turning to the advice provided, again there was strong support for all aspects of the advice, with 
respondents stating that it was easy to understand, that they trusted the advice and that they were 
satisfied with the advice. When examining the service provided compared to what the respondents 
could obtain from their general practitioner, again there was strong support for the services 
provided through the HLP with respondents agreeing (87% ‘Strongly agree’ or ‘Agree’) that they 
preferred to go to the pharmacy for this type of health advice, that the pharmacy’s opening times 
were more convenient than the GPs’ opening hours (97%) and that the advice they have received 
has helped them keep better care of themselves (96%). Respondents were also happy to 
recommend the services they had accessed to friends or family (99%). These high levels of 
satisfaction were also seen in the national evaluation of the pathfinder HLP programme where 81% 
of service users rated the service they had used as ‘excellent’ and 98% stated that they would 
recommend the service to others.7 
Variability was seen in whether the consultation took place in a private consultation room by the 
type of service accessed. Stop Smoking service consultations almost always took place in private 
compared to only half of minor ailment services and consultations involving pharmacists being more 
likely to take place in a private room than with other staff members. Owing to the variability in the 
services provided and the likelihood that the pharmacist, rather than any other staff member, dealt 
with the more complex or personal enquiries, this level of variability was to be expected. 
Just over two-thirds of respondents indicated that they had heard of HLPs.7 This is more than twice 
the proportion of respondents who reported that they had heard of HLPs in the national pathfinder 
evaluation, perhaps indicating that awareness of the HLP concept amongst pharmacy users was 
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growing as time progressed.7 Similarly, over two-thirds of respondents reported that they were 
aware the pharmacy they were in was an HLP, with respondents being more likely to indicate both 
that they had heard of HLPs and that they aware that the pharmacy they were in was an HLP if they 
were answering from their regular pharmacy. Almost half of respondents were aware of the NHS 
service they used through the pharmacy staff, rather than through other external sources (via their 
general practice surgery, for example). This echoes the findings of the national pathfinder evaluation 
where 44% of respondents to a questionnaire reported that they were made aware of the NHS 
service they used by a member of the pharmacy’s staff.7 A majority of respondents who had seen 
any advertisements for HLPs had done so in a pharmacy and the HLP ‘Kitemark’ was the more 
commonly recognised HLP logo. 
Overall, the views of the service users indicated high levels of support for all the services provided 
and a reassurance that the respondents were happy with the service provided and the staff 
members who provide the service. Respondents stated that they would prefer to access these 
services via their local HLP, rather than general practice surgery, and would recommend the services 
they accessed to friends and family. 
5.3.2 LIMITATIONS 
The service user questionnaire stage of the study has a number of limitations which needs to be 
taken into consideration when interpreting the results. These are as follows: 
• The completion of the service user questionnaire was variable across the ten HLP 
pharmacies within the study and so analysis by individual HLP was not possible. In addition, 
although a good number of responses were received, the number of respondents for certain 
questions meant that full cross-tabular analysis was not possible in some cases. 
• The questionnaire was in English and so it may not have been easy for some service users to 
engage with the study owing to language barriers, especially taking into consideration the 
ethnic diversity found within the centre of Birmingham. Although it was possible for the staff 
members to assist service users in completing the study questionnaire where language may 
have caused a problem, it was unknown how many times this took place. 
• In addition, it is accepted that response levels may have varied between the different 
services included in the study as respondents may have felt less inclined to complete the 
study instrument for services relating to, for example, early pregnancy testing and 
emergency hormonal contraception compared to stop smoking and minor ailments. 
• Finally, it should be noted that the questionnaire was only administered to service users (and 
so the views of the non-service users were not captured). In addition, owing to the need to 
protect anonymity, the data collection method chosen meant that there was no way to 
identify the proportion of service users over the study period who completed a 
questionnaire and therefore, how representative the views from the respondents are to the 
general service user population. 
5.4 CONCLUSIONS AND RECOMMENDATIONS 
5.4.1 CONCLUSIONS 
The community pharmacies of central Birmingham are located in some of the most deprived areas of 
England. Their location affords an opportunity to counter the inverse care law whereby those most 
in need of access to healthcare services are paradoxically those who find it most difficult to access 
such services.57 Data on service provision presented in this report suggests that people accessing the 
services provided by the community pharmacies in central Birmingham are, unsurprisingly given 
 122 | P a g e  
 
Aston University HLP Study 
their geographical location, predominantly from areas of high socioeconomic deprivation. While 
logic suggests that community pharmacies located in areas of socioeconomic deprivation improve 
access to health services in areas of great need, further research is encouraged to establish whether 
community pharmacies enable access to health services amongst the people who find it most 
difficult to access such services. 
Data from the smoking cessation scheme suggest that participants at HLPs are more likely to have 
been from sections of society commonly considered to be ‘hard-to-reach’ – men, people from black 
and minority ethnic groups, those who had never worked or were long-term unemployed and those 
from the most-deprived areas of central Birmingham. While this phenomenon was not observed 
universally across all four services analysed, smoking is the most important single behavioural cause 
of health inequalities making such observations notable.37 
Of particular note in relation to the analysis of the data from the MAS was the large number of items 
which were supplied via the scheme but which are not supported by a robust evidence base. Any 
continuation or extension of the MAS should be accompanied by a review of the items which are 
available for supply to ensure that resources are not being devoted to ineffective interventions. 
All of the services examined were already being provided across the pharmacy network in HoBtPCT 
prior to the introduction of HLPs locally. In the case of SC and MAS, these services were well 
established, widely available and well used by the local population. Given this context, it is perhaps 
unsurprising that this evaluation has revealed no evidence that HLP accreditation improves activity 
levels or outcomes in the services examined.  
However, data from the MAS suggests that HLP accreditation may influence how participants 
become aware of the services offered by pharmacy with participants at HLPs being much more likely 
to report that they had heard about the existence of the scheme via promotional material than 
participants in non-HLPs. This phenomenon was also observed in the service-user questionnaire 
where a large proportion of respondents reported hearing about the existence of the NHS services 
provided from a member of pharmacy staff. Further research is needed to establish whether the 
existence of pharmacy-based health services is more actively promoted in HLPs than in non-HLPs 
and whether more active promotion increases activity levels and improves the outcomes of such 
services. 
Results from the service-user questionnaire suggest that satisfaction with the services provided by 
HLPs is very high. Particularly notable are the high proportions of respondents who reported that 
they preferred to access the service they had used at the HLP rather than at their GP surgery and the 
very high proportion of respondents who would recommend the service they had used to their 
friends and family. Over two-thirds of respondents to the questionnaire indicated that they had 
heard about HLPs, with the HLP ‘Kitemark’ also being widely recognised. The views of service users 
on the visibility of HLPs were in contrast with those expressed by the pharmacy staff who were 
interviewed as part of this evaluation who believed that awareness of the HLP concept amongst 
their local populations was low – principally as a result of a perception of a failure of the PCT’s 
publicity drive. Whilst these divergences in perception between service providers and service 
providers may need to be addressed, and taking into consideration that the views of the public were 
limited to those actively accessing the services on offer, such public approval provides an excellent 
foundation on which to develop the HLP programme. 
A motive for pharmacist engagement with the HLP programme was a belief that accreditation of 
their pharmacies as HLPs would provide reassurance to commissioners that they were consistent 
deliverers of high quality services and that the accreditation would help to differentiate HLPs from 
non-HLPs with HLPs being favoured in future commissioning decisions. The NHS landscape had 
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changed markedly since the data were collected with the PCTs that pharmacists were referring to as 
commissioning organisations being abolished and the commissioning of pharmacy services being 
fragmented between Clinical Commissioning Groups (CCGs), Local Authorities (LAs) and NHS Area 
Teams. Furthermore, after the abolition of PCTs, the responsibility for accrediting HLPs has been 
assumed by Local Pharmaceutical Committees (LPCs – the local representative bodies for pharmacy 
contractors). While there is no evidence that this has altered the mechanics of the accreditation 
process or decreased the degree of oversight of HLPs, there is a potential risk that accreditation of 
HLPs by a contractor body may be viewed as partial by commissioning bodies. Given such upheaval, 
additional effort will need to be made to ensure that faith in the accreditation process for HLPs is 
maintained and that the initial momentum behind HLPs in central Birmingham is not lost. 
Amidst discussion of the commissioning landscape, the concern of pharmacy contractors around 
remuneration for additional services should be noted. There was a belief that remuneration for such 
services was insufficient to divert activity away from the dispensing function towards patient-
centred care. Whilst such considerations may be outside the scope of local pharmacy and health 
bodies, strategic level consideration should be given to how remuneration for pharmacies can be 
altered to support role extension and the HLP concept. Furthermore, issues around the level of 
training provided (especially for HT/HTCs) and the awareness of the HLP scheme by local general 
practitioners were also highlighted as potential barriers to future HLP development and should be 
considered in any development of the HLP scheme. 
5.4.2 RECOMMENDATIONS 
The review of the implementation of Healthy Living Pharmacies within the area formerly covered by 
the Heart of Birmingham teaching Primary Care Trust described in this report has produced a 
number of recommendations. 
Although no evidence of an increase in the levels of services provided for the four services examined 
from HLPs, when compared to non-HLPs, within HoBtPCT was seen, the analysis did indicate that 
service users accessing the stop smoking service from HLPs, rather than non-HLPs were from 
traditionally ‘hard-to-reach’ groups. Further work is warranted to examine the potential benefit of 
HLPs in relation to the provision of stop smoking services in other geographical areas of the country 
to see if this observation can be replicated. 
• Recommendation 1 – Further research is recommended to identify whether the uptake of 
the stop smoking service in traditionally ‘hard-to-reach’ groups via Healthy Living 
Pharmacies can be replicated in other geographical areas. 
The present study has revealed no evidence that HLP accreditation improves activity levels or 
outcomes in the services examined within this one geographical area. However, data from the minor 
ailments scheme has suggested that HLP accreditation may influence how participants become 
aware of the services offered by pharmacy with participants at HLPs being much more likely to 
report that they had heard about the existence of the scheme via promotional material than 
participants in non-HLPs. This phenomenon was also observed in the service-user questionnaire 
where a large proportion of respondents reported hearing about the existence of the NHS services 
provided from a member of pharmacy staff. 
• Recommendation 2 – Further research is needed to establish whether the existence of 
pharmacy-based health services is more actively promoted in Healthy Living Pharmacies 
than in non-Healthy Living Pharmacies and whether more active promotion increases 
activity levels and improves the outcomes of such services. 
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Analysis of the items provided via the minor ailments scheme indicated that a large number of items 
were supplied via the scheme which were not supported by a robust evidence base. Any 
continuation or extension of the minor ailments scheme should be accompanied by a review of the 
items which are available for supply. 
• Recommendation 3 – Any continuation or extension of the minor ailments scheme should 
be done in parallel with a review of the items provided via the scheme to ensure that any 
medicines included are supported by a robust evidence base so as to minimise any 
expenditure on potentially ineffective interventions. 
One reason for the initial motivation of pharmacists to engage with the HLP programme was in 
relation to the belief that they would be seen my commissioners as consistent deliverers of high 
quality services. It was understood that the accreditation would help to differentiate HLPs from non-
HLPs with HLPs being favoured in future commissioning decisions. It is important that this 
momentum is not lost so as to facilitate the continuation and development of future services. 
Results from the present study have shown high levels of motivation within the HLP staff group 
(pharmacists and HT/HTCs) and very high levels of acceptance by service users of the services 
covered by this study. Particularly notable are the high proportions of respondents who reported 
that they preferred to access the service they had used at the HLP rather than at their GP surgery. To 
obtain a more complete picture of the opportunities for service delivery through community 
pharmacy, it would be beneficial to conduct future research in non-HLPs providing these services to 
examine if satisfaction in non-HLPs is as high as it is in HLPs. 
However, it was also noted that some pharmacy staff (HT/HTCs especially) stated that the depth of 
training in relation to the delivery of certain services was insufficient and that the awareness levels 
of the HLP scheme by general practitioners were low. Furthermore, the remuneration for certain 
activity was highlighted as an issue and future roll-out should ensure adequate levels of 
remuneration along with research conducted at the local level to examine the impact of HLP 
accreditation on non-HLPs within an area. 
• Recommendation 4 – In any future commissioning of services through pharmacies, 
consideration needs to be given to the role pharmacies with Healthy Living Pharmacy 
accreditation, with their high level of service user acceptance, can offer in the effective 
delivery of health care services. Given the lack of randomisation in observational studies, a 
randomised study – perhaps in the form of a pragmatic cluster randomised controlled trial – 
should be conducted to establish whether HLPs achieve better outcomes than non-HLPs. 
• Recommendation 5 – In order for the number of Healthy Living Pharmacies to expand and 
for the number of services offered via Healthy Living Pharmacies to increase, further 
consideration needs to be given to the levels of training and support made available to 
pharmacy staff, especially at the Health Trainer/Health Trainer Champion level, and the level 
of awareness of the programme within the local general practitioner population. 
• Recommendation 6 – To ensure the success of any future roll-out of services via Healthy 
Living Pharmacies, consideration should be given at a strategic level as to how remuneration 
for pharmacies can be altered to support role extension and the Healthy Living Pharmacy 
concept, along with research conducted at the local level to examine the impact of Healthy 
Living Pharmacy accreditation on non-Healthy Living Pharmacies within an area. 
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APPENDICES 
Appendix 1 - HLP Pharmacist Structured Interview Schedule 
Preamble – If calling on the phone: 
Good morning/afternoon. My name is [insert name] from the Pharmacy School at Aston University. 
Further to our previous conversations, I am calling to carry out a telephone interview about your 
views and opinions of your experience of participating in the Healthy Living Pharmacy or HLP 
Programme.  
As you will now be aware, the Pharmacy Practice Research Group at Aston University has been asked 
by the PCT to carry out an independent evaluation of the HLP programme and this short interview 
will only take around 45 minutes to complete. 
Just to let you know that I will record the next part of this telephone conversation so I can go over 
the answers I receive to the questions; however, anything you say during the call will remain 
anonymous and no-one can be identified from their responses. 
Preamble – If face to face: 
• Introductions. 
• Purpose of the interview. 
• 45 minutes to complete. 
• I will record the interview so I can go over the answers. 
• Your responses may be used in the report but you will not be identified. 
General Awareness of Health Issues in the Local Community and Understanding of the HLP 
Concept 
1. Before we begin with the interview, please can you describe the make-up of the community 
your pharmacy serves e.g. ethnicities, languages spoken, age profiles etc.  
2. What would you consider to be the differences between an HLP and a pharmacy that is not an 
HLP? 
3. What would you consider to be the main objectives of an HLP? 
Motivation to participate 
4. Please can you tell me when your pharmacy became HLP accredited? 
5. Why did your pharmacy decide to participate in the HLP Programme? 
6. What in your opinion are the benefits to the pharmacy of becoming an HLP? 
6.1. Have you experienced any of these benefits yet? 
Programme set-up 
7. Were you involved in the set-up of the HLP programme at your pharmacy? 
8. How did you find out about the HLP programme? 
9. How was information about the HLP programme disseminated by the PCT? 
9.1. How well did you understand what you had to do to become an HLP? 
10. Could you please tell me what you had to do in order to become HLP Level 1 accredited? 
10.1. What changes did you have to implement in order to achieve HLP Level 1 
accreditation?  
10.2. Please can you tell us about your experiences of working through the accreditation 
criteria that you had to meet in order to gain Level 1 status? 
10.3. How easy/difficult was the process of becoming a Level 1 HLP? 
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11. Did you undertake mystery shopper and premises audit?  
11.1. If yes, was this useful? Did you implement any changes owing to this? 
 
12.2 Going forward, what level of support do you hope to receive from the PCT, post 
accreditation? 
HT/HTC Recruitment/Training 
13. How many Health Trainer/Health Trainer Champions (HT/HTCs) do you currently have? 
14. How did you recruit them to become HT/HTCs? 
15. What training have they undertaken for the role e.g. (college/PCT/on the job)? 
16. How easy was if for staff to undertake the training in relation to their other duties? 
17. Do you think the training you mentioned earlier (recall response to Q15) provided them with 
adequate skills and knowledge required to provide this advice?  
17.1. If not, why not? 
18. What activities have your HT/HTCs been involved with up until now? 
19. What other duties do your HT/HTCs have aside from the HT/HTC roles? 
20. How do HTs/HTCs balance their various roles i.e. how do they prioritise HT/HTC duties with 
other work-related commitments? 
21. What factors do you think affect how effective an HT/HTC is within their role?  
Information/Resources/Training provided by the PCT 
22. Were you offered training sessions by the PCT? 
22.1. If yes, what was provided? 
22.1.1.  Who attended the training sessions? (not just leadership training, MUR training, 
monthly meetings etc.) 
22.1.1.1. What was covered in the training sessions? 
22.1.1.2. How useful were the training sessions? 
22.2. If no, what training would you have liked to have been made available? 
23. Were you offered any resources by the PCT?  
23.1. If resources, what resources were provided? 
23.1.1.1. How useful were they? 
23.1.1.2. What additional resources would be useful? 
 Services Provided 
24. Which HLP health services do you currently provide? 
25. Which HLP service(s) would you say are most frequently requested in your pharmacy? 
25.1. Why do you think that might be? 
10.3.1. If difficult, what issues/difficulties did you experience as you worked through the 
criteria? 
10.3.2. What would have helped make the process easier? 
12. Do you feel that there was a sufficient level of support from the PCT to help you through the 
accreditation process? 
12.1 At the start of the programme? 
12.1.1 If yes, please can you explain what type of support was provided? 
12.1.1.1 How important was the support you have just mentioned (in 
achieving accreditation)? 
12.1.2 If no, what type/level of support did you hope for at the start? 
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26. Which HLP service(s) would you say are least frequently requested in your pharmacy? 
26.1. Why do you think that might be? 
27. Are there any HLP services that you would like to provide but are unable to at present? 
27.1. If yes, please can you tell us about this/these service(s) is/are? 
27.1.1. What is preventing you from providing this/these service(s)? 
28. How do you promote services to members of the public? 
Health Advice Process 
29. Please can you talk me through the health advice process i.e. please imagine a member of the 
public has just walked in and asks about a service, what would happen next? 
30. Do you have an appointment system for certain services? 
30.1. If yes, for which services do you have an appointment system? 
30.1.1. Would ‘regular’ patients have an opportunity to see the same person each time they 
visit? 
31. How do you monitor a patient’s progress if patients have to return to the pharmacy to complete 
a programme? 
 Probe for various data collection tools, method of collating information 
(paper/electronic) etc. 
32. What evidence do you collect with regards to the interventions you make and their outcomes? 
33. How do you pro-actively provide health advice? 
34. Are patients/members of the public signposted to other resources available within the 
community? 
35. Does the pharmacy have standard operating procedures for the four main services? 
35.1. If yes, where do they come from and are there any aspects of the SOPs that are 
 carried out by HT/HTCs? 
35.2. What training has the HT/HTC received in order to deliver this aspect? 
Patients’ registered or not registered with a GP 
36. At any stage during the consultation process, are you able to find out whether the patient is 
registered with a GP? 
35.1 If yes, when might the opportunity arise? 
 Probe find out if information is captured on an ad hoc basis, or captured routinely 
Patients’ reasons for accessing health services via a pharmacy 
37. What would you say are the main reasons why members of the public choose to access health 
services via pharmacies rather than going to a GP? 
38. In your experience, would you say that when advised, patients do consult their GP after having 
sought advice from yourself? 
38.1. If yes, please could explain how you know and why you think this might be the case? 
Public’s awareness of HLPs and health services being offered 
39. In your opinion, how well understood is the term ‘Healthy Living Pharmacy’ by people who walk 
into the pharmacy? 
39.1. What level of understanding would you say people who walk into the pharmacy have 
about your role as healthcare advisor? 
39.1.1. If low, how do you think this could be improved? 
40. What level of awareness would you say members of the public have about the range of health 
services offered by HLPs? 
40.1. If low, how do you think this could be improved? 
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41. In general, how do the patients accessing your services originally hear about the service? 
 HT/HTC actively promotes the services by attending local community group meetings. 
 Word of mouth 
 PCT promotional events/posters/media 
 Signposted by an HTC or other member of staff 
 GP/hospital referrals 
41.1. If in-house publicity: How did you publicise the HLP programme? 
41.2. If PCT publicity: Please can you explain what the PCT did to raise awareness of HLPs within 
your local community? 
41.2.1. How effective were the publicity campaigns,  
41.2.2. Are there any aspects of the publicity campaigns which you thought worked 
particularly well? 
42. What contact have you had with your local GP practice? 
Prompts: To promote services, to develop the relationship, to formalise protocols etc. 
42.1. Did you feel this was beneficial? 
43. What contact have you had with other healthcare professionals? 
43.1. Did you feel this was beneficial? 
 
44. Are there any particular groups of patients that you find hard to engage with? 
44.1. If yes, please tell us a little more about these groups. 
44.2. What issues have you experienced? 
 
45. Do you think the service you provide as an HLP is valued by: 
45.1. The Primary Care Trust? Why? 
45.2. Other Healthcare Professionals? Why? 
45.3. Patients? Why? 
Recommendations and Future Plans 
46. Do you intend to progress to Level 2 and Level 3 accredited HLP? 
46.1. How do you see the role of HLPs developing with regards to the services they could 
provide? 
47. What changes would you recommend to improve the provision of health services via HLPs?  
48. Are there any other points about the HLP programme you would like to make? 
Thank you for your time in participating in this interview. 
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Appendix 2 – HT/HTC Structured Interview Schedule 
Preamble – If calling on the phone: 
Good morning/afternoon. My name is [insert name] from the Pharmacy School at Aston University. 
Further to our previous conversations, I am calling to carry out a telephone interview about your 
views and opinions of your experience of participating in the Healthy Living Pharmacy or HLP 
Programme.  
As you will now be aware, the Pharmacy Practice Research Group at Aston University has been asked 
by the PCT to carry out an independent evaluation of the HLP programme and this short interview 
will only take around 45 minutes to complete. 
Just to let you know that I will record the next part of this telephone conversation so I can go over 
the answers I receive to the questions; however, anything you say during the call will remain 
anonymous and no-one can be identified from their responses. 
Preamble – If face to face cover the following points: 
• Introductions. 
• Purpose of the interview. 
• 45 minutes to complete. 
• I will record the interview so I can go over the answers. 
• Your responses may be used in the report but you will not be identified. 
HT/HTC’s General Awareness of Health Issues in the Local Community and Understanding of the 
HLP Concept 
1. Before we begin with the interview, please can you: 
1.1. Tell me when your pharmacy became an HLP? 
1.2. Describe the make-up of the community your pharmacy serves e.g. ethnicities, languages 
spoken, age profiles etc.  
2. What do you think are the main differences between an HLP and one that is not an HLP? 
3. How do you think HLPs can help improve the health of local communities? 
3.1. Probe – who do you think would most benefit from the health services provided by HLPs? 
Motivation to become an HT/HTC 
4. To get a little background information about your role as a Health Trainer/Health Trainer 
Champion, please could you tell me how long you have been an HT/HTC? 
4.1. Are you an HT or an HTC? 
4.2. How did you become an HT/HTC? 
4.3. Are you the only HT/HTC in your pharmacy? 
5. What prompted you to take on the HT/HTC role? 
6. Would you say you have personally benefited from taking on the role of HT/HTC? 
6.1. If no, why is that? 
6.2. If yes, please can you tell me more? 
 Probe; Job satisfaction, Job enrichment, personal development, financial 
7. What do you find most rewarding/enjoyable about being an HT/HTC? 
8. What aspects of your HT/HTC role do you find challenging/frustrating? 
9. In addition to being an HT/HTC what other roles do you perform as part of your original job? 
10. How do you balance the roles of HT/HTC with your original job roles? 
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HT/HTC Roles and Responsibilities 
11. Were you involved in the HLP accreditation process? 
11.1. If yes, how did you find it? 
12. Could you describe the HT/HTC activities you undertake on a weekly/monthly basis (e.g. admin, 
promoting the NHS health services etc.)? 
12.1. How do you record your activities as an HT/HTC? 
13. What would you consider to be important aspects of your HT/HTC role? 
14. Have you noticed any changes since your pharmacy became an HLP 
14.1. If yes, please can you tell me more? 
15. Do you feel valued by the pharmacist or other members of the team? 
Services Provided 
16. Which services do you offer at your pharmacy? 
16.1. Which services do you yourself deliver and which do you pass on to other members 
of staff? 
17. Which service(s) would you say are most frequently requested in your pharmacy? 
17.1.  Why do you think that might be? 
18. Which service (s) would your say are least frequently requested in your pharmacy?  
18.1. Why do you think that might be? 
19. How do you promote services to members of the public? 
Health Advice process 
20. Please can you talk me through the health advice process i.e. please imagine a member of the 
public has just walked in and asks about a service, what would happen next? 
20.1. What would happen if the member of staff that normally provides the service was busy or 
was not at work that day? 
21. Do you have an appointment system for certain services? 
21.1. If yes, for which services do you have an appointment system? 
21.1.1. Would ‘regular’ patients have an opportunity to see the same person each time they 
visit? 
22. How do you monitor a patient’s progress if patients have to return to the pharmacy to complete 
a programme? 
 Probe; Data collection tools, method of collating information (paper/electronic) 
etc. 
23. What is the general response that you receive when offering health advice? 
24. How do you target people for health advice? 
 Probe; Publicity Campaigns, individual advice 
25. Are patients/members of the public signposted to other resources available within the 
community? 
26. Does the pharmacy have standard operating procedures for the four main services? 
26.1. If yes, where do they come from and are there any aspects of the SOPs that are 
carried out by HT/HTCs? 
26.2. What training has the HT/HTC received in order to deliver this aspect? 
Patients’ registered or not registered with a GP 
27. At any stage during the consultation process, are you able to find out whether the patient is 
registered with a GP? 
27.1. If yes, when might the opportunity arise? 
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 Probe find out if information is captured on an ad hoc basis, or captured routinely 
Patients’ reasons for accessing health services via a pharmacy 
28. What would you say are the main reasons why members of the public choose to access health 
services via pharmacies rather than going to a GP? 
29. In your experience, would you say that when advised, patients do consult their GP after having 
sought advice from yourself? 
29.1. If yes, please could explain how you know and why you think this might be the case? 
Training, Skills and Knowledge 
30. What training have you had to help you carry out your role as an HT/HTC? 
(HT/HTC should have completed their respective college courses).  
30.1. If none, why is that? 
30.2. Regarding training on the job/college: 
30.2.1. Was the training completed in your own time or were you given study leave? 
30.2.2. How did you find the training? 
30.2.3. What did the training cover? 
30.2.4. Did the training provide sufficient knowledge to enable you to confidently carry out 
the HT/HTC role? 
30.2.5. Did you find any of the training irrelevant? 
30.2.6. Is there anything you would have liked to have been included in the training 
provided to enable you to provide a better health advice service? 
 
30.3. Regarding training by the PCT, 
30.3.1. How did you find the training? 
30.3.2. What did the training cover? 
30.3.3. Did the training provide sufficient knowledge to enable you to confidently carry out 
the HT/HTC role? 
30.3.4. Is there anything you would have liked to have been included in the training 
provided by the PCT to enable you to provide a better health advice service? 
30.4. What particular skills/knowledge do you have which you feel have been useful in 
helping you carry out your role as an HT/HTC? 
Internal Support Mechanisms 
31. Which member of staff at your pharmacy would you speak to for guidance or support in your 
role as an HT/HTC? 
32. Do you have regular meetings with [the person stated in Q31] to discuss issues arising? 
32.1. If yes, are the meetings with [the person stated in Q31] scheduled on a regular basis or do 
you catch-up as and when you can? 
32.1.1. How helpful have you found these meetings? 
32.2. If no, do you think you would find it useful to have regular meetings? 
External Support Mechanisms 
33. Have you had opportunities to attend network meetings with HTs/HTCs from other pharmacies, 
other health professionals or community groups? 
33.1. If yes, please can you tell me more? 
33.1.1. How often do meetings take place?  
33.1.2. What is discussed? 
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33.1.3. How useful are networking meetings and how have the meetings helped you carry 
out your role?  
33.2. If no, would you find it helpful to attend networking meetings? 
33.2.1. If yes, please can you explain? 
Service-user awareness of HLPs and HTs/HTCs 
34. In your opinion, how well understood is the term ‘Healthy Living Pharmacy’ by people who walk 
into the pharmacy? 
34.1. What level of understanding would you say people who walk into the pharmacy have 
about your role as an HT/HTC? 
34.1.1. If low, how do you think this could be improved? 
35. In general, how do the patients accessing your services originally hear about the service? 
 HT/HTC actively promotes the services by attending local community group meetings. 
 GP/hospital referrals. 
 Word of mouth. 
 PCT promotional events/posters/media. 
 Signposted by an HTC or other member of staff. 
35.1. What level of awareness would you say members of the public have about the services 
offered by HLPs? 
35.1.1. If low, how do you think this could be improved? 
36. Are there any particular groups of patients that you find hard to engage with? 
36.1. If yes, please tell us a little more about these groups. 
36.2. What issues have you experienced? 
37. Do you think the service you provide as an HLP is valued by: 
37.1. The Primary Care Trust? Why? 
37.2. Other Healthcare Professionals? Why? 
37.3. Patients? Why? 
Recommendations and Future Plans 
38. What aspects of your HT/HTC role would you change to enable you to provide a better quality of 
service to patients? 
38.1. Why would you make these changes? 
39. How do you see the role of HLPs developing with regards to the services they could provide? 
40. What changes would you recommend to improve the provision of health services via HLPs?  
Thank you for your time in participating in this interview. 
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Appendix 3 – Letters of invitation 
 
 
Name & Address 
 
 
 
Date 
 
Dear [member of pharmacy staff] 
 
Aston University Healthy Living Pharmacy (HLP) Study 
 
Evaluation of the implementation and impact of Healthy Living Pharmacies (HLPs) in the 
Heart of Birmingham (HoB) 
 
In collaboration with the 
Heart of Birmingham teaching Primary Care Trust (HoBtPCT) 
 
Brief overview 
You will already be aware that the Pharmacy Practice Research team at Aston University has been 
commissioned by HoBtPCT to conduct an independent evaluation of the effectiveness of Level 1 
Healthy Living Pharmacies (HLPs) in helping to improve access to health services in the communities 
they serve (in the Heart of Birmingham), and the health gains generated. The study itself is 
independently funded by The Pharmaceutical Trust for Educational and Charitable Objects (PTECO). 
For the purpose of this study, three services will be evaluated; Smoking Cessation, Sexual Health 
(incorporating the provision of emergency hormonal contraception (EHC) via a patient group 
Direction (PGD) and Early Pregnancy Testing) and the Minor Ailments Scheme. Approval for the HLP 
programme had been granted by the previous HoBtPCT Professional Executive Committee (PEC) 
and John Morrison, Associate Director for Medicines Management, Birmingham & Solihull NHS 
Cluster, has approved the evaluation of the HLP programme by the Pharmacy Practice Research 
Group at Aston University. We will also obtain approval from the Aston University Ethics committee 
before the study starts. NHS Research Ethics Committee approval will not be required as the project 
has been classified as a service evaluation.  
The evaluation comprises of three stages: 
1. Stage A; analysis and comparison of HLP and non-HLP monthly activity data submitted to 
HoBtPCT.  
2. Stage B; interviews with HLP pharmacy staff (responsible for the provision of the HLP 
services) to determine motivation for involvement in the HLP programme. We hope to 
conduct two interviews per HLP i.e. with:  
a. A Pharmacist, and 
b. A Health Trainer (HT) or Health Trainer Champion (HTC). 
3. Stage C; a short service-user questionnaire will be deployed via touchscreen health kiosks 
(located in pharmacies) to determine service-user views and satisfaction with the service. 
Invitation to participate 
It is with reference to Stage B, which we write to invite pharmacists and HTs/HTCs who have been 
involved in the HLP programme at [INSERT PHARMACY NAME], to participate in a short research 
interview. The purpose of interviews is to gain health service providers’ perspectives on and 
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motivations for involvement in the HLP programme, the facilitators and barriers to delivery of the 
programme, opinions on the benefits the programme provides to the local community, 
recommendations for future improvement, etc.  
The interviews are expected to take between fifteen minutes to half an hour to complete and we 
hope to schedule interviews between mid-July and August 2012. However prior to this, a member 
of research team will contact all Level 1 HLPs (in HoB) with a view to arranging mutually convenient 
dates and times to conduct the interviews. Ideally, we would like to conduct face-to-face 
interviews, at the pharmacy for your convenience, however, if you prefer, we would be happy to 
accommodate telephone interviews. 
Your cooperation and participation in the Stage B interviews would be appreciated. Enclosed with 
this letter is a Participant Information Sheet (PIS), which provides further information, a portion of 
which is the Consent Form. We would be grateful if you could please complete the Consent Form 
and post it to Aston University in the pre-paid envelope provided. 
Please be assured that any views and opinions later referred to in the study report will be 
anonymised and it will not be possible to link responses back any individual interviewee. If you have 
any concerns about participating please feel free to contact a member of research team at Aston 
University or Sajj Raja, Community Pharmacy Development Manager, HoBtPCT; please see below 
for contact details.  
Further information 
If you would like any further information about the study contact details are as follows: 
• the Project Manager (Alpa Patel) on a.patel10@aston.ac.uk, or 
• the Research Pharmacist (Jane Haworth) on j.e.haworth@aston.ac.uk, or 
• the Community Pharmacy Development Manager (Sajj Raja) on sajjad.raja@nhs.net. 
 
Yours sincerely 
 
 
 
 
Professor Chris Langley 
Deputy Head of Pharmacy 
Professor of Pharmacy Law and Practice 
Enc. 
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Participant Information Sheet 
Appendix 4 – Participant Information Sheet and consent form 
 
Aston University Healthy Living Pharmacy (HLP) Study 
 
Evaluation of the implementation and impact of Healthy Living Pharmacies (HLPs) in the 
Heart of Birmingham (HoB) 
 
In collaboration with the 
Heart of Birmingham teaching Primary Care Trust (HoBtPCT) 
 
 
 
 
What is the study about? 
The overall aim of the study is to evaluate the implementation and impact of Level 1 accredited 
HLPs within HoBtPCT. 
What will I have to do? 
We are inviting all HLP staff in the Heart of Birmingham who have been involved in the HLP 
programme, to participate in a short research interview.  
A member of the Aston University research team will contact you to schedule a mutually 
convenient time to conduct an interview. We can conduct either a face-to-face interview at the 
pharmacy or a telephone interview, whichever is easiest for you. The researcher will ask you 
questions about your motivations for involvement in the HLP programme, the facilitators and 
barriers to delivery of the programme and uptake of health services, your opinions on the benefits 
of the programme, recommendations for future improvement, etc. We will not ask any personal or 
intrusive questions. 
Do I have to take part? 
Participation is voluntary, therefore the decision to take part is entirely yours. You can decide not 
to take part in the study. If you do decide to take part, you will still be able to withdraw from the 
interview at any point in time. 
What are the risks in taking part? 
You will not be put at any risk. If you feel uncomfortable with the questions being asked, you can 
exit the interview at any time. 
What are the advantages of taking part? 
One of the PCT’s missions is to firmly establish community pharmacies as an integral component of 
the NHS healthcare system; playing a key role in helping to reduce health inequalities and 
improving the general health and wellbeing of the local communities pharmacies serve. Your 
perspective of the issues (arising at grass roots level), the benefits associated with becoming an 
HLP, practices implemented in your HLP that have worked well, your views/opinions on how 
uptake of health services (via community pharmacies) could be improved etc., will form an 
essential element of this study.  
What will you do with the results of the interviews? 
The information (data) collected from the interviews, will be analysed and the knowledge acquired 
will be assimilated into a report along with the analyses of Service-User questionnaire and 
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pharmacy returns data. The report will initially be made available to the study Steering Group and 
thereafter information will be disseminated via publications and conferences. 
Will the information provided be kept confidential? 
Yes. The interviews will be audio recorded (with your consent) and stored securely. The data will 
only be accessible to members of the Aston University research team; the recordings will not be 
accessible by the Medicines Management team at the PCT.  
Any views and opinions that you share with the research team will be considered as confidential 
data and comments later referred to in the study report will be anonymised, therefore, it will not 
be possible to identify individuals by the comments made. 
The data will be kept for three years post study and thereafter deleted.  
Who is funding the study? 
The study is being funded by The Pharmaceutical Trust for Educational and Charitable Objects and 
the research is conducted by the Pharmacy Practice Research Team at Aston University, in close 
collaboration with the Medicines Management team at HoBtPCT. 
Who has reviewed the study? 
Ethical permissions for this study have been sought from the Aston University Ethics Committee.  
Whom can I contact if I have concerns about the study? 
If you have any concerns or questions, please contact a member of the Aston University research 
team and we will do our best to address your queries. Our contact details are: 
• the Project Manager (Alpa Patel); a.patel10@aston.ac.uk,  0121 204 4963 
• the Research Pharmacist (Jane Haworth); j.e.haworth@aston.ac.uk,  0121 204 4967 
If you wish to make a formal complaint, please contact please contact the Secretary of the Aston 
University Ethics Committee on j.g.walter@aston.ac.uk or telephone 0121 204 4665. 
What do I have to do if I want to take part? 
If you would like to take part, please complete the enclosed Contact Details and Consent Form and 
post it back to us in the reply paid envelope provided. 
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Aston University Healthy Living Pharmacy (HLP) Study 
 
Please complete and return in the reply paid envelope provided 
 
CONTACT DETAILS 
Your name:  
Pharmacy name:  
Telephone:  
Email Address:  
Please indicate below your preference for an interview at the pharmacy or a 
telephone interview: 
 
  Interview at pharmacy 
 
 Telephone interview 
Days of the week you would be available for interview: 
Best time for interview:  
 
CONSENT FORM 
I agree to take part in the Aston University Healthy Living 
Pharmacy (HLP) study.  
 
I have read and understood the information provided in the 
Participant Information Sheet. 
 
I understand that agreeing to take part means that I am happy 
to: 
 
 
Please 
initial both 
boxes below 
1. Participate in an interview in which I will be asked questions 
by a member of the research team at Aston University about 
my views and opinions of delivering health services and my 
motivations for involvement in the Healthy Living Pharmacy 
programme. 
 
2. I have had the chance to think about the information and 
ask questions. Any questions I have had have been 
answered. 
 
 
 
 
During the study: 
• We (the research team) will not pass on your details to anyone else. 
• We will keep any information you give us confidential. 
 
After the study has finished: 
• We will delete any computer folders where we have stored interview data.  
• We might refer to comments and opinions shared in the study report but all data used 
will be anonymised. 
 
 
_________________________ ________________ ___________________ 
Name of volunteer    Date    Signature 
 
 
_________________________ _______________ ___________________ 
Researcher     Date    Signature 
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Appendix 5 – Service User Questionnaire 
This appendix contains a copy of the questionnaire which was deployed on the touchscreen 
healthkiosks in the HLPs participating in the study. 
HEALTHY LIVING PHARMACY SURVEY 
To take part ... 
 
1 Please touch the purple box below to show that you have understood the previous information. 
   I agree to take part and understand that all data are anonymous and my individual responses will be 
kept confidential. 
 
 Thinking about the pharmacy you are visiting today ... 
 Please SELECT ONE only 
 
2 Please tell us which pharmacy you are visiting today. 
  Advance Pharmacy   Health Plus Pharmacy   Hustans Pharmacy  
  Ladywood Pharmacy   Lloyds Pharmacy   Pauls Pharmacy  
  Saydon Pharmacy   Shah Pharmacy   Soho Pharmacy  
  Sparkbrook Pharmacy   Other   
 
 
3 Is {Q2} your regular pharmacy? 
 Yes  No 
 
 Thinking about the NHS health service you have used at {Q2} today ... 
 Please SELECT ONE only 
 
4 Which ONE of the following NHS health services have you used at {Q2} today? 
[Minor Ailments includes: coughs, constipation, diarrhoea, hayfever, headache, headlice, heartburn, earache, 
indigestion, nasal congestion, sore throat, tummy upset, temperature, thrush] 
 
 Emergency Hormonal 
Contraception (EHC) e.g. 
morning after pill  
 Stop Smoking  Minor Ailments   Early Pregnancy 
Testing 
 Other 
               
  
 Thinking about the NHS health service you have used at {Q2} today ... 
 For each question, please SELECT ONE only 
 
5 Is this the first time you have used one of the NHS health services listed below at this pharmacy? 
[Emergency Hormonal Contraception (EHC), Stop Smoking Service, Minor Ailments, Early Pregnancy Testing] 
 
 Yes  No 
 
 
6 When did you last use one of the NHS health services listed below at this pharmacy? 
[Emergency Hormonal Contraception (EHC), Stop Smoking Service, Minor Ailments, Early Pregnancy Testing] 
 
 Last week  1 - 4 weeks ago  1 - 3 months 
ago 
 3 - 6 months 
ago 
 More than 6 
months ago 
 Can't remember  
                   
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 Thinking about the pharmacy staff who gave you health advice at {Q2} today ... 
 For each question, please SELECT ONE only 
 
7 Who did you speak to for health advice today? 
 Health Trainer  Health Trainer 
Champion 
 Pharmacist  Other staff  Not sure 
               
 
8 Who would you most like to have spoken to for health advice today? 
 Health Trainer  Health Trainer 
Champion 
 Pharmacist  I don't mind 
            
 
 Thinking about the pharmacy staff who gave you health advice at {Q2} today ...  
 For each statement please SELECT ONE from each line 
 
9 How strongly do you agree or disagree with the following statements? 
  Strongly 
Agree 
 Agree  Neither 
agree nor 
disagree  
 Disagree   Strongly 
disagree  
 The person I spoke to today, had enough time 
to deal with my enquiry. 
              
 I felt comfortable talking about my health with 
the person I spoke to today. 
              
 I would like to be seen by the same person 
every time. 
              
 
 Thinking about the health advice provided today at {Q2} ... 
 For each statement, please SELECT ONE from each line 
 
10 How strongly would you agree or disagree with the following statements? 
  Strongly 
Agree 
 Agree   Neither 
agree nor 
disagree  
 Disagree   Strongly 
disagree  
 The health advice I was given was easy to 
understand. 
              
 I trust the health advice given to me.                
 I am satisfied with the health advice provided.               
 
 Thinking about the reason for getting health advice at {Q2} today ... 
 For each statement, please SELECT ONE from each line 
 
11 How strongly would you agree or disagree with the following statements? 
  Strongly 
Agree 
Agree  Neither 
agree nor 
disagree  
Disagree  Strongly 
disagree  
 I preferred to go to a pharmacy to get health 
advice rather than going to my GP (doctor). 
          
 Pharmacy opening times are more convenient 
than GP (doctor) opening times. 
          
 Getting health advice at {Q2} when I need it, has 
helped me to take better care of myself. 
          
 I would recommend the NHS health service I 
have used at {Q2} to friends or family. 
          
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 Thinking about the facilities at {Q2} ... 
 For each question, please SELECT ONE only 
 
12 Did your consultation with pharmacy staff at {Q2} take place in a private room? 
 
 Yes  No 
 
 
13 How strongly would you agree or disagree with the following statement? 
  Strongly 
Agree 
 Agree   Neither 
agree nor 
disagree  
 Disagree   Strongly 
disagree  
 Talking about my health in private is important 
to me. 
              
 
 Do you know about Healthy Living Pharmacies? 
 For each question, please SELECT ONE only 
 
14 Have you heard about Healthy Living Pharmacies? 
 Yes  No 
 
 
15 Did you know that {Q2} is a Healthy Living Pharmacy? 
 Yes  No 
 
 Nearly there, please tell us ... 
 Please SELECT ALL THAT APPLY 
 
16. How did you find out about the NHS health service you used today? 
 Advertisements   Pharmacy staff 
told me about 
them 
 Word of mouth  Heard about 
them from 
friends / family 
 GP told me about 
them 
Other  
                   
 
 
17. Have you seen NHS Healthy Living Pharmacy advertisements? 
  On the local NHS 
website? 
 In a pharmacy?  At an NHS 
roadshow? 
 Do not remember 
seeing any 
 Other  
                 
 
 
18. Touch the logo(s) you have seen before your visit to {Q2} today? 
     Have not seen these 
logos before 
 
          
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About yourself 
 Please SELECT ONE only 
 
19. Are you male or female? 
 Male  Female  Do not want to say  
          
 
 
20. How old are you? 
 Under 18 18-19 20-29 30-39 40-49 50-59 60-69 70-79 80 and 
over 
Do not 
want to 
say 
 
                      
 
 
21. Which Ethnic Group do you belong to? 
   English/ 
Welsh/Scottish/ 
Northern Irish/British 
 
   Irish    Gypsy or Irish 
Traveller 
   Any other white 
background 
 
   Indian    Pakistani    Bangladeshi    Any other Asian 
background 
 
 
   African    Caribbean    Any other Black / 
African / Caribbean 
background 
 
   Arab  
   White and Black 
Caribbean 
   White and Black 
African 
   White and Asian    Any other Mixed / 
Multiple ethnic 
background 
 
   Any other ethnic 
group 
   Do not want to say        
 
 
To finish please touch the blue Submit button 
 
Thank you for taking the time to complete this survey 
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Appendix 6 – Copy of service poster 
 
 
